Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AADAC	"CES5A1, DAC"	ENSG00000114771	"Arylacetamide deacetylase"	P22760	3	151814037-151828488	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 66.2;intestine: 81.7;liver: 123.1"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 610.4"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 153.4"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 11.9;ASC diff: 4.5;EFO-21: 6.4;HBEC3-KT: 5.7"	"Not detected"	"Not detected"							HPA002911	Approved					NA	NA					"HPA002911: AB_1078074"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.41e-2)"		"unprognostic (9.23e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (5.58e-6)"	"prognostic unfavorable (5.02e-4)"			"prognostic unfavorable (2.19e-4)"	"unprognostic (1.22e-1)"		"unprognostic (1.27e-1)"	3.9	66.2	0.1	0.1	1.6	0.0	2.1	0.1	0.1	0.1	26.1	0.5	0.4	29.6	0.1	0.3	0.3	0.2	4.3	0.2	0.1	0.0	0.1	123.1	1.7	0.1	0.1	0.1	0.1	22.7	0.0	0.1	1.7	0.2	0.3	0.0	0.1	0.3	0.1	0.2	1.7	81.7	0.1	0.1	0.1	7.3	0.3	0.1	0.1	0.2	4.8	1.3	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	4.5	0.2	0.3	0.0	0.0	0.1	0.0	1.1	0.1	0.2	6.4	0.0	0.1	0.4	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.7	0.1	0.1	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.3	0.2	1.4	0.3	0.2	0.4	2.1	0.0	2.3	0.2	1.9	0.3	0.1	0.0	0.0	0.0	0.0	2.5	0.0	2.4	1.4	0.0	0.4	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	11.0	0.0	0.0	0.2	0.0	1.1	58.6	4.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.2	0.0	0.0	610.4	0.2	0.0	0.0	3.7	10.8	0.0	0.0	0.0	3.3	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.2	0.0	0.0	0.1
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276367-99291028	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	322	"liver: 250.3"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 212.0"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"ASC diff: 11.2"									"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		12000000	"Plasma membrane, Cytosol"		"CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	250.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	11.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	212.0	0.0	0.0	0.0	7.4	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304964-99352760	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 253.5;liver: 466.3"	"Cell type enriched"	"Detected in many"	38	"Hepatocytes: 3603.2"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Group enriched"	"Detected in some"	5	"midbrain: 2.3;pons and medulla: 1.6"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 394.3"									"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		16000000	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	253.5	12.3	0.2	21.8	0.0	0.4	78.7	0.2	0.4	18.3	60.0	0.4	5.7	3.5	12.8	14.4	33.5	22.3	31.9	24.2	0.3	0.0	9.2	466.3	43.8	17.5	2.3	0.1	18.0	8.7	0.8	5.3	0.9	1.6	30.7	10.1	2.3	11.2	3.9	20.5	11.9	25.4	30.8	2.4	5.9	10.9	18.0	0.2	0.2	16.1	9.7	2.0	42.3	76.0	0.6	0.2	1.2	0.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	394.3	57.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.2	0.1	0.1	0.2	0.4	0.1	0.0	0.6	0.3	0.4	1.2	0.8	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.0	2.3	0.1	1.6	0.2	0.0	4.3	14.0	0.4	19.8	0.0	8.9	66.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.4	9.2	0.0	46.7	0.0	0.0	81.0	0.3	1.1	3603.2	0.1	0.0	0.0	93.9	77.5	0.0	51.2	1.0	27.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	43.7	0.0	0.0	11.4	0.1	12.5	0.0	0.1
ADH1C	ADH3	ENSG00000248144	"Alcohol dehydrogenase 1C (class I), gamma polypeptide"	P00326	4	99336492-99353027	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 47.1;liver: 149.4;stomach 1: 43.1"	"Cell type enhanced"	"Detected in many"	15	"Exocrine glandular cells: 606.8;Hepatocytes: 378.8;Undifferentiated cells: 355.3"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 238.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC TERT1: 5.2;HSkMC: 15.4"									"HPA047814, HPA060902"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		9700000	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (3.98e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.55e-4)"	"prognostic favorable (2.99e-4)"	"unprognostic (8.25e-2)"	"unprognostic (8.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.37e-2)"	4.7	0.0	0.0	18.5	0.0	0.0	1.1	0.0	0.0	1.1	37.9	0.0	1.1	43.4	0.3	1.2	1.7	0.0	12.0	2.0	0.0		8.3	149.4	1.1	0.0	0.2	0.0	1.1	11.4	0.0	0.0	0.0	0.0	2.5	13.6	0.0	1.1	0.8	6.0	0.0	47.1	0.9	0.5	0.0	43.1	1.6	0.0	0.0	0.5	2.0	0.2	1.3	0.7	0.2	0.2	0.3	0.1	0.1	0.3	0.1	0.0	2.3	0.0	0.1	1.8	5.2	1.1	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.1	0.5	1.4	0.3	15.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.4	1.0	0.4	0.0	0.1	0.1	0.9	2.2	0.9	0.0	0.4	1.6	0.7	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.3	0.2	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.1											3.0	5.3	1.5	3.6	0.0	0.0	0.8	50.9	80.3	45.5	27.9	0.0	0.0	0.0	141.2	2.4	0.0	51.2	23.3	606.8	0.0	0.0	1.2	0.0	378.8	0.0	0.0	20.7	12.9	12.9	0.6	9.8	0.0	0.0	3.6	36.7	0.0	99.5	63.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	355.3	2.0
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 345.2"	"Cell type enriched"	"Detected in some"	34	"Hepatocytes: 802.6"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	11	"Hep G2: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		5300000	"Nucleoplasm, Cytosol"		"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	0.3	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.2	3.6	0.0	0.1	11.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.2	345.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.1	4.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.1	0.1	0.5	1.2	0.7	2.8	0.5	0.4	0.9	0.1	0.3	0.3	0.2	0.3	0.5	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.2	0.5	0.3	0.0	0.2	0.3	0.0	0.2	0.4	0.3	0.1	0.6	0.8	22.4	0.1	1.8	0.5	0.3	0.0	0.2	0.2	0.2	0.1	0.2	0.4	1.0	0.1	0.3	0.3	0.6	0.4	0.0	0.2	0.2	1.8	0.5	0.2	0.4	0.2	0.3	2.0	0.3	0.0	0.3	0.5	0.0	0.4	0.5	0.2	0.5	0.1	0.6	0.4	0.7	0.1	0.7	0.1	2.8	0.4	0.5	0.9	0.5	0.8	0.4	0.5	0.5	0.1	1.2	0.8	0.8	1.0	0.4	0.5	0.7	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.2	15.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	21.9	0.0	0.0	23.3	0.5	0.0	0.0	0.0	0.0	802.6	0.0	0.0	0.0	13.5	20.9	2.6	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0
ADH5	"ADH-3, ADHX, FDH, GSNOR"	ENSG00000197894	"Alcohol dehydrogenase 5 (class III), chi polypeptide"	P11766	4	99070978-99088801	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044578, HPA061919"	Approved					NA	NA		6800000			"HPA044578: AB_2679002, HPA061919: AB_2684638"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.14e-3)"	"prognostic favorable (9.90e-5)"	"unprognostic (2.63e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (4.58e-10)"	"unprognostic (1.79e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	35.6	19.8	17.3	18.5	18.5	6.3	28.6	11.2	22.3	34.1	39.4	19.8	17.0	24.9	53.8	40.3	43.5	28.6	20.8	31.9	13.7	16.6	46.6	69.7	19.9	15.3	15.7	16.1	39.1	12.8	10.5	15.1	19.9	18.6	45.0	27.7	28.7	17.3	35.9	20.7	13.8	28.5	43.6	13.5	20.5	27.0	27.2	10.0	35.2	30.4	18.4	18.6	60.0	22.0	13.9	12.5	18.2	11.1	26.2	25.3	17.0	15.9	13.0	38.6	21.7	70.2	65.3	23.2	26.6	46.9	28.9	25.3	14.9	19.0	18.5	15.5	38.4	18.6	13.6	26.5	36.9	27.9	13.3	11.1	12.8	17.7	58.6	68.0	22.3	10.4	58.7	28.7	21.6	17.1	30.2	22.2	19.5	23.6	10.6	38.0	18.1	30.0	20.1	31.0	3.9	15.7	22.0	21.6	9.7	45.6	18.7	14.8	19.4	16.0	19.0	29.0	29.6	15.4	15.7	16.6	26.4	16.7	17.2	18.2	11.1	13.8	25.6	27.0	14.8	26.7	9.8	11.1	18.2	18.4	9.8	16.7	13.9	20.3	17.1	12.5	13.1	19.9	18.3	1.6	26.2	7.1	10.8	25.3	17.0	17.3	18.5	11.2	22.3	13.7	16.6	15.7	16.1	18.6	10.0	98.3	64.6	43.8	63.4	35.1	30.0	106.4	73.9	30.8	44.3	52.4	9.8	240.9	167.5	86.8	17.9	51.9	76.6	0.0	73.3	214.7	80.7	31.1	25.5	170.8	104.3	36.5	76.5	49.1	42.8	12.1	173.4	41.1	50.6	74.9	93.0	139.4	66.9	77.2	239.7	228.9	45.0	109.9	78.7	24.1	44.7	20.1	69.5	40.6	88.1	46.7
ADH6	ADH-5	ENSG00000172955	"Alcohol dehydrogenase 6 (class V)"	P28332	4	99202638-99219537	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 123.3"	"Group enriched"	"Detected in some"	10	"Hepatocytes: 299.7;Proximal tubular cells: 76.3"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 46.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"Hep G2: 31.3"					"Not detected"	"Not detected"			"HPA067946, HPA069081"	Enhanced					NA	NA		480000			"HPA067946: AB_2732776, HPA069081: AB_2732127"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.86e-3)"	0.1	0.1	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	6.0	0.0	0.0	7.2	0.1	0.2	0.2	1.5	5.6	0.1	0.1	0.1	10.6	123.3	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	1.4	0.0	0.1	0.0	0.1	0.6	23.7	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.5	0.0	1.3	0.1	0.2	0.2	0.3	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	31.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	6.6	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.2	0.0	0.0	0.3	0.1	0.2	1.3	0.2	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.3	1.4	0.0	0.5	0.0	0.3	15.3	18.7	1.2	5.2	0.0	0.0	6.6	0.0	0.0	0.0	12.6	0.0	0.2	0.0	0.0	0.0	0.0	299.7	0.0	0.0	11.6	5.5	2.7	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	2.6	0.0	76.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.9	0.1
ADH7	ADH-4	ENSG00000196344	"Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide"	P40394	4	99412261-99435737	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 75.0;lymphoid tissue: 30.7;tongue: 68.7"	"Group enriched"	"Detected in some"	15	"Ciliated cells: 8.1;Club cells: 10.3"	"Group enriched"	"Detected in some"	17	"cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4;urothelial cancer: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC TERT1: 4.0;HaCaT: 4.5"	"Not detected"	"Not detected"							HPA039695	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039695: AB_10795681"		"unprognostic (1.02e-2)"			"unprognostic (8.64e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.66e-1)"					"unprognostic (2.02e-1)"			"unprognostic (1.88e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.1	0.0	68.7	30.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	8.1	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6
ADHFE1	"ADHFe1, FLJ32430"	ENSG00000147576	"Alcohol dehydrogenase, iron containing 1"	Q8IWW8	8	66430185-66471601	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.5"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 32.1;Syncytiotrophoblasts: 97.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.6;HHSteC: 3.0;HSkMC: 2.7;hTERT-RPE1: 2.9;RPTEC TERT1: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023062	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA023062: AB_1844611"	"prognostic favorable (5.76e-5)"	"unprognostic (8.69e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (9.90e-5)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.43e-2)"	"prognostic favorable (4.55e-5)"	"unprognostic (1.37e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.94e-3)"	12.5	3.2	10.3	2.2	9.7	1.8	4.3	2.2	10.7	5.9	3.8	10.9	4.8	2.7	4.2	8.6	3.1	5.9	5.0	34.6	6.9	5.4	11.8	44.5	3.6	2.3	8.6	7.5	5.2	8.3	11.6	9.8	3.7	6.9	7.3	3.1	10.7	6.6	10.5	35.7	2.4	2.4	6.9	4.8	2.8	8.6	3.2	7.3	0.0	4.5	12.9	2.5	6.2	1.9	1.3	0.4	3.4	1.1	2.2	2.6	0.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.5	0.4	0.3	0.0	0.0	1.7	0.0	0.0	0.7	0.3	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	3.0	0.0	0.2	2.7	0.0	0.0	1.3	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.2	0.9	0.0	0.5	1.2	1.4	2.0	0.0	0.0	0.3	0.2	0.0	0.0	1.2	0.1	0.1	0.8	0.0	0.3	3.4	1.1	0.0	2.6	0.0	2.4	1.3	0.5	2.2	0.4	0.8	0.7	2.2	0.1	2.2	0.0	0.3	0.0	0.6	10.3	9.7	2.2	7.8	6.9	5.4	8.6	7.5	6.9	7.3	8.9	12.4	2.7	3.8	0.9	1.4	32.1	15.3	20.1	13.6	8.7	9.8	7.1	10.0	1.1	0.3	1.6	2.0	0.0	0.6	0.8	2.7	4.3	8.1	23.7	2.1	0.0	3.5	7.4	1.0	1.0	22.2	1.4	0.0	0.0	1.5	6.7	0.8	5.8	25.5	10.9	7.6	0.0	3.3	0.2	0.2	0.9	97.4	8.7	1.8	2.0
AKR1B10	"AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI"	ENSG00000198074	"Aldo-keto reductase family 1 member B10"	O60218	7	134527592-134541408	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 41.5;intestine: 99.7;stomach 1: 68.6"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 275.2;Enterocytes: 221.4;Pancreatic endocrine cells: 89.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 353.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	99	"A549: 217.4;Hep G2: 60.3;OE19: 227.4"									"HPA020280, CAB070163, HPA073633"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA		68000000	Cytosol	"Plasma membrane"	"CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (1.29e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.91e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (4.80e-9)"	"unprognostic (2.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	0.6	0.8	0.6	2.2	0.6	0.0	0.6	0.6	0.6	13.1	11.5	0.6	0.6	99.7	0.6	0.9	41.5	0.0	28.9	0.6	0.6	0.0	4.0	6.3	2.0	0.6	0.6	0.6	0.6	0.6	0.0	2.5	0.6	0.6	2.0	7.3	1.3	6.1	0.6	0.6	1.0	54.1	7.1	0.6	0.6	68.6	0.8	0.6	0.9	0.7	28.6	3.6	16.3	22.9	0.4	0.1	1.8	0.2	0.4	0.2	0.1	0.0	217.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	60.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	227.4	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.2	1.8	0.4	0.1	0.1	0.1	0.1	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6	0.0	0.0	0.5	1.9	2.5	0.0	0.4	275.2	5.3	1.2	0.0	0.0	0.2	0.0	21.5	0.3	0.0	221.4	23.3	23.1	0.1	0.1	0.3	0.0	31.6	0.0	0.0	3.4	3.7	1.6	0.4	3.1	0.0	0.0	1.0	11.7	0.0	89.4	24.6	1.8	1.4	0.0	0.0	0.9	0.0	0.0	9.2	0.2	0.0	41.3	5.2
AKR1B15		ENSG00000227471	"Aldo-keto reductase family 1 member B15"	C9JRZ8	7	134549136-134579875	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 61.7;placenta: 31.8"	"Cell type enhanced"	"Detected in some"	27	"Early spermatids: 2.3;Late spermatids: 2.7;Syncytiotrophoblasts: 8.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"A549: 15.5;HDLM-2: 12.3;Hep G2: 10.8;SK-BR-3: 5.2;U-87 MG: 6.6"									"HPA020280, HPA073633"	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (2.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (9.74e-3)"	"unprognostic (2.74e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (8.36e-4)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (5.04e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-7)"	"unprognostic (6.88e-2)"	"unprognostic (4.29e-1)"	"unprognostic (2.99e-3)"	"prognostic unfavorable (1.90e-5)"	2.7	0.1	0.1	0.1	0.1	0.0	61.7	0.1	0.2	1.6	0.6	0.2	0.1	5.6	0.1	1.5	3.8	0.0	2.2	0.1	0.1	0.0	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	31.8	0.2	0.8	0.2	0.5	2.9	0.1	11.6	1.9	1.7	0.8	0.4	0.1	5.0	0.6	0.1	0.3	0.4	16.1	1.8	1.5	3.0	0.1	0.0	1.8	0.1	0.4	0.0	0.3	0.0	15.5	0.2	0.0	0.6	0.5	1.0	0.0	0.4	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.7	0.1	0.0	0.1	0.0	12.3	0.1	0.1	0.2	10.8	0.0	0.2	0.5	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.2	3.2	0.3	0.0	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.6	5.2	0.0	0.1	0.1	0.3	0.0	0.1	0.7	0.4	0.0	0.2	0.2	0.2	6.6	0.2	0.2	1.8	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.7	0.0	0.0	0.1
AKR1C1	"DD1, DDH, DDH1, HAKRC, MBAB"	ENSG00000187134	"Aldo-keto reductase family 1 member C1"	Q04828	10	4963253-4983283	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 145.9;tongue: 74.5"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 239.5;Exocrine glandular cells: 290.3;Hepatocytes: 511.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 64.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"ASC diff: 185.8;Hep G2: 315.1;OE19: 134.5"									"CAB047303, HPA068265"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"CAB047303: , HPA068265: AB_2685966"	"unprognostic (1.54e-2)"	"prognostic favorable (3.05e-4)"	"unprognostic (4.04e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.05e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (8.03e-9)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.30e-2)"	52.0	3.8	2.1	3.4	4.1	1.4	36.0	2.6	2.7	2.2	3.2	2.6	1.2	6.2	1.4	4.0	19.2	1.7	16.1	22.1	2.6	2.6	32.0	145.9	11.2	2.5	5.4	1.4	3.8	4.9	0.6	4.1	0.7	6.6	5.1	3.2	3.8	13.1	3.4	17.1	4.7	4.6	4.8	6.8	0.9	21.9	5.2	3.2	0.0	11.5	74.5	5.0	17.4	10.8	0.0	0.9	4.2	0.1	0.3	1.7	0.8	0.0	25.5	0.1	25.7	185.8	22.4	0.0	0.8	5.7	0.3	0.2	0.4	0.0	0.0	0.3	5.7	4.4	0.2	0.0	1.3	0.1	0.0	0.0	0.7	4.1	315.1	1.8	0.1	0.0	11.4	1.6	2.6	1.6	0.0	0.6	0.1	5.4	0.0	4.4	0.1	0.0	0.0	0.0	134.5	0.0	0.0	0.0	0.2	1.4	4.8	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.4	5.0	2.2	0.1	5.9	0.2	0.1	0.0	0.0	7.9	0.7	0.0	4.2	0.1	1.1	1.7	0.0	0.1	0.0	0.7	0.4	0.2	0.0	0.3	1.5	0.9	0.3	0.0	0.9	0.4	0.8	2.1	4.1	2.6	2.7	2.6	2.6	5.4	1.4	6.6	3.2	62.5	27.2	1.5	11.8	18.8	2.5	2.4	239.5	96.4	128.5	59.3	0.0	0.0	11.6	33.9	14.9	17.8	9.3	70.0	290.3	0.0	13.4	11.4	4.6	511.8	0.3	0.0	1.7	26.4	14.5	8.0	140.4	3.8	101.3	8.2	1.7	47.9	184.6	0.9	138.6	40.8	4.3	0.0	14.4	1.7	0.7	17.9	0.1	0.9	2.6	140.8
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 127.0"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 437.4"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 1.2;gdT-cell: 1.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.2;T-cells: 1.1"	"Group enriched"	"Detected in some"	4	"HDLM-2: 11.6;OE19: 5.1"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		NA	NA		1800000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA044720: AB_2679058, HPA068265: AB_2685966"	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	127.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	1.1	0.1	0.0	1.5	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.5	0.3	1.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	5.1	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.2	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	45.9	2.7	1.2	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	23.3	0.6	0.0	0.0	0.0	0.0	437.4	0.0	0.0	0.0	14.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.6	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1
ALDH1A1	"ALDH1, PUMB1, RALDH1"	ENSG00000165092	"Aldehyde dehydrogenase 1 family member A1"	P00352	9	72900662-73080442	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 207.2"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 583.5;Hepatocytes: 620.8;Leydig cells: 376.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 399.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"classical monocyte: 34.2"	"Lineage enriched"	"Detected in many"	30	"monocytes: 34.2"	"Cell line enhanced"	"Detected in some"		"A549: 294.7;Hep G2: 90.7;RPTEC TERT1: 52.5"					"Region enriched"	"Detected in all"	6	"midbrain: 171.1"	"HPA002123, CAB020690"	Enhanced	Approved	Enhanced	Cytosol		NA	NA		62000000	Cytosol		"CAB020690: , HPA002123: AB_1844722"	"unprognostic (8.46e-3)"	"prognostic favorable (7.77e-5)"	"unprognostic (5.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-3)"	20.0	26.9	8.8	12.3	21.4	3.9	10.8	44.8	11.7	33.6	53.6	14.5	65.3	77.1	25.5	87.1	14.5	27.8	38.3	8.9	12.5	5.9	86.7	207.2	31.4	9.4	56.4	3.6	35.8	69.7	0.7	57.5	7.9	14.0	20.0	13.1	30.2	31.8	40.3	12.1	2.7	76.5	17.1	29.1	16.3	75.5	43.0	14.9	2.0	45.8	21.0	16.8	14.1	16.0	0.3	0.5	1.1	34.2	0.0	0.1	10.5	0.0	294.7	0.0	0.0	1.7	0.0	0.1	10.2	0.0	0.0	0.0	9.9	0.0	0.0	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.7	0.0	90.7	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	10.5	0.0	1.1	0.0	11.3	0.5	0.0	0.1	0.0	0.5	0.0	0.0	3.3	0.1	52.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	34.2	0.5	0.0	5.8	0.0	0.0	0.1	0.0	0.5	0.3	0.0	0.0	1.1	0.0	0.4	0.3	0.0	10.5	8.8	21.4	44.8	11.7	12.5	5.9	56.4	3.6	14.0	14.9	89.3	82.8	17.6	12.3	2.4	0.0	2.8	211.5	583.5	271.8	109.9	0.0	1.1	330.0	52.4	8.7	10.5	29.0	23.3	296.8	1.1	30.2	1.8	152.7	620.8	115.7	0.0	52.7	105.0	82.2	16.5	376.3	13.6	6.8	5.4	141.2	0.0	193.4	16.9	194.8	295.4	0.3	25.8	9.2	3.6	3.8	2.8	2.1	20.0	42.1	18.3
ALDH1A2	RALDH2	ENSG00000128918	"Aldehyde dehydrogenase 1 family member A2"	O94788	15	57953424-58497866	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 87.7;Late spermatids: 37.6;Spermatocytes: 44.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	22	"neutrophil: 22.6"	"Lineage enriched"	"Detected in single"	56	"granulocytes: 22.6"	"Group enriched"	"Detected in some"	5	"AN3-CA: 67.9;HEK 293: 22.7;JURKAT: 65.7;K-562: 58.1;MOLT-4: 70.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA010022	Approved					NA	NA					"HPA010022: AB_1844723"	"unprognostic (1.11e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.04e-4)"	"unprognostic (1.08e-1)"	"unprognostic (9.03e-3)"	"unprognostic (6.92e-3)"	"unprognostic (5.48e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.57e-3)"	"unprognostic (3.18e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.80e-3)"	11.4	2.3	0.6	1.9	1.0	1.3	6.5	0.9	0.9	23.1	1.9	0.7	32.7	0.1	43.1	14.7	2.3	29.1	16.8	17.3	1.8	0.4	8.4	1.3	7.0	0.9	0.7	1.1	12.7	1.2	19.1	18.1	12.8	2.5	13.3	0.0	24.4	2.4	29.5	3.1	1.0	0.9	11.3	2.1	1.6	0.6	39.9	0.4	2.3	1.0	2.6	0.4	2.8	12.3	0.0	0.0	22.6	0.4	0.0	0.0	0.0	0.2	0.0	0.0	67.9	0.0	0.0	0.0	0.0	0.9	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	2.1	0.0	0.1	0.0	22.7	0.0	0.6	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	4.0	65.7	58.1	0.0	0.0	0.0	70.2	0.0	0.1	1.8	3.3	0.0	0.1	0.0	11.5	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	0.2	0.0	0.0	0.0	0.6	1.0	0.9	0.9	1.8	0.4	0.7	1.1	2.5	0.4	6.0	11.5	0.0	1.5	0.6	0.4	2.2	12.7	1.4	5.7	7.0	0.0	0.2	11.6	10.1	87.7	1.5	0.0	0.0	0.3	0.4	2.0	1.3	1.1	12.9	2.1	0.0	0.0	2.5	1.8	37.6	4.9	1.9	1.7	1.0	0.0	8.4	0.5	0.0	4.9	0.3	0.0	0.0	2.5	44.7	14.8	0.4	0.5	0.0	0.1	1.2
AWAT1	DGAT2L3	ENSG00000204195	"Acyl-CoA wax alcohol acyltransferase 1"	Q58HT5	X	70234655-70240627	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"breast: 3.8;skin 1: 6.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEK 293: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA063412	Enhanced					NA	NA					"HPA063412: AB_2685009"	"unprognostic (1.12e-1)"			"unprognostic (1.78e-1)"						"unprognostic (1.96e-2)"				"unprognostic (4.90e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.78e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.4	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AWAT2	"DGAT2L4, MFAT"	ENSG00000147160	"Acyl-CoA wax alcohol acyltransferase 2"	Q6E213	X	70040542-70049938	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	10	"breast: 5.7;skin 1: 14.0"	"Cell type enhanced"	"Detected in single"	30	"Spermatocytes: 1.2"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 2.4;PC-3: 2.6;SK-BR-3: 1.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA062748	Approved					NA	NA					"HPA062748: AB_2684862"	"unprognostic (3.41e-2)"			"unprognostic (1.06e-1)"	"unprognostic (2.99e-2)"			"unprognostic (4.11e-2)"		"unprognostic (1.11e-1)"					"unprognostic (8.60e-2)"	"unprognostic (4.55e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0			0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.6	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.9			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0
BCO1	"BCDO, BCDO1, BCMO, BCMO1, FLJ10730"	ENSG00000135697	"Beta-carotene oxygenase 1"	Q9HAY6	16	81238448-81291142	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 28.1;retina: 62.0"	"Cell type enhanced"	"Detected in some"	13	"Mucus-secreting cells: 7.2;Paneth cells: 2.5;Proximal tubular cells: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 12.8;EFO-21: 9.7;HAP1: 3.7;NTERA-2: 5.2;RPTEC TERT1: 9.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA043811			Uncertain	"Actin filaments,Centriolar satellite"		NA	NA			"Actin filaments, Centriolar satellite"		"HPA043811: AB_10962487"	"unprognostic (2.78e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.05e-2)"	"unprognostic (8.01e-4)"	"unprognostic (1.65e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.09e-1)"	0.1	0.0	1.3	0.2	1.4	0.0	0.2	0.2	1.6	0.3	28.1	0.3	1.4	11.0	0.7	0.5	0.7	0.6	1.4	0.1	1.7	1.9	4.2	2.5	0.3	0.1	0.8	0.1	2.0	0.4	0.0	1.9	0.1	5.9	1.3	3.6	62.0	1.3	2.8	0.6	0.3	16.9	0.4	0.4	0.1	2.3	0.2	0.3	0.3	0.2	0.5	0.1	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	2.6	0.0	9.7	0.0	0.4	0.1	3.7	0.0	0.0	0.1	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	5.2	0.8	0.0	0.0	0.0	0.0	9.8	0.3	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.4	0.2	1.6	1.7	1.9	0.8	0.1	5.9	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.2	0.6	0.0	0.0	1.4	0.0	0.0	0.0	7.2	0.0	0.4	2.5	1.1	5.5	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	1.7	0.6
BDH2	"DHRS6, FLJ13261, PRO20933, SDR15C1, UCPA-OR, UNQ6308"	ENSG00000164039	"3-hydroxybutyrate dehydrogenase 2"	Q9BUT1	4	103079435-103099883	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 139.1"	"Cell type enhanced"	"Detected in many"	16	"Distal tubular cells: 179.1;Proximal tubular cells: 617.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 41.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036028, HPA036029"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA036028: AB_10670674, HPA036029: AB_2674909"	"unprognostic (2.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (5.21e-4)"	"unprognostic (3.92e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.82e-2)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.37e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.45e-13)"	"unprognostic (2.54e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.75e-4)"	"unprognostic (9.69e-3)"	12.4	33.1	22.6	7.7	26.0	2.8	17.6	9.6	18.5	15.7	18.9	14.8	12.3	36.7	11.6	18.8	10.4	16.6	13.5	14.9	26.6	15.4	139.1	39.3	13.8	6.0	38.2	15.6	26.2	8.3	23.5	14.8	8.1	29.0	13.0	11.2	27.0	10.2	15.2	6.9	7.9	34.8	10.2	29.7	6.7	11.8	7.2	32.4	10.4	25.1	12.0	7.6	11.0	11.8	9.5	7.5	1.4	4.1	11.6	18.5	7.5	2.6	4.5	25.9	7.8	27.1	30.1	3.7	6.2	16.0	5.9	10.0	3.6	10.3	10.7	10.9	9.5	2.4	1.2	13.4	10.0	6.8	6.3	8.1	2.0	6.6	11.8	17.4	6.2	3.1	24.0	9.4	10.1	2.3	27.0	19.9	17.7	6.5	3.4	22.7	1.4	27.8	6.1	7.8	2.4	2.1	20.1	25.0	6.3	41.3	5.0	3.5	12.5	11.0	5.8	7.0	11.4	5.2	5.1	12.2	7.0	3.7	4.4	2.4	6.5	6.5	11.0	9.3	7.5	5.8	1.4	4.1	0.2	11.9	1.8	12.8	9.5	12.1	11.3	5.8	9.0	14.2	15.3	0.3	11.6	0.3	7.5	18.5	7.5	22.6	26.0	9.6	18.5	26.6	15.4	38.2	15.6	29.0	32.4	29.8	52.6	3.4	39.4	27.0	1.3	8.5	38.2	22.7	33.0	102.9	0.0	6.7	179.1	38.9	1.1	24.3	37.4	0.0	19.3	13.9	51.4	21.0	18.5	63.8	17.7	3.2	22.0	28.3	13.2	2.1	64.7	10.3	21.9	19.8	19.9	45.8	21.4	14.1	73.2	617.5	2.2	12.9	24.2	0.7	1.7	23.3	2.9	17.3	23.0	33.1
CBR4	"FLJ14431, SDR45C1"	ENSG00000145439	"Carbonyl reductase 4"	Q8N4T8	4	168863770-169010275	"Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037499	Supported					NA	NA		33000			"HPA037499: AB_10672386"	"unprognostic (1.60e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.41e-3)"	"unprognostic (4.06e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.64e-2)"	"prognostic favorable (3.64e-14)"	"unprognostic (1.97e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.38e-3)"	9.9	15.0	13.8	8.8	13.7	6.2	14.7	18.1	18.7	10.5	12.3	14.0	14.2	12.8	10.8	21.4	11.9	10.0	8.6	17.3	13.8	14.7	27.6	48.1	7.7	10.3	15.9	18.0	13.9	13.4	12.7	27.1	8.5	16.6	12.6	14.6	13.6	13.3	17.1	15.8	15.7	11.8	12.4	16.7	10.6	10.9	14.4	13.6	9.7	16.1	10.6	11.5	12.0	10.1	11.6	7.0	9.0	7.3	8.3	10.3	3.1	6.0	4.6	14.2	8.9	12.4	14.8	2.9	4.4	6.0	5.3	4.9	5.4	6.5	12.5	2.4	3.3	5.0	6.6	13.1	13.9	5.8	4.7	6.5	21.9	10.8	7.2	7.5	8.6	7.8	9.6	12.1	3.8	6.5	12.7	15.6	10.6	11.8	10.1	8.4	3.1	8.9	14.1	5.1	4.2	7.0	7.8	5.0	5.3	18.7	6.4	12.6	9.5	5.3	7.6	11.3	12.4	8.2	5.6	9.2	5.6	3.0	6.2	4.4	10.1	6.7	6.0	9.7	10.6	3.4	8.6	6.1	9.0	10.3	5.3	6.2	8.5	7.1	10.0	5.2	11.6	8.0	10.2	4.6	8.3	7.3	7.0	5.9	3.1	13.8	13.7	18.1	18.7	13.8	14.7	15.9	18.0	16.6	13.6	0.0	6.5	22.4	28.5	20.5	34.4	26.0	28.1	10.7	9.1	47.1	37.3	35.3	43.1	51.8	12.8	15.2	25.9	46.7	36.9	21.5	17.7	26.4	2.3	66.8	22.0	58.8	28.2	18.4	25.1	19.4	41.1	19.0	33.7	21.6	21.3	37.5	33.5	28.5	29.4	68.1	45.4	58.2	15.1	50.2	34.3	17.7	16.9	25.5	23.4	19.4
CEL	"BSSL, MODY8"	ENSG00000170835	"Carboxyl ester lipase"		9	133061978-133071861	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	348	"pancreas: 1584.8"	"Cell type enriched"	"Detected in some"	19	"Exocrine glandular cells: 809.5"	"Cancer enriched"	"Detected in many"	29	"pancreatic cancer: 469.3"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 9.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA008023, HPA052701"	Enhanced				"Secreted to digestive system"	NA	NA					"HPA008023: AB_1846509, HPA052701: AB_2681921"	"prognostic unfavorable (4.14e-4)"	"unprognostic (2.30e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.98e-1)"	"unprognostic (4.41e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.02e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	2.3	0.2	0.2	0.2	0.2	0.1	0.2	2.9	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	3.5	0.2	0.2	0.2	0.8	1584.8	0.0	4.5	0.2	0.2	0.2	0.0	0.2	0.2	4.5	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	1.6	0.2	0.2	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.4	1.1	4.2	2.6	1.4	1.0	4.2	0.8	0.5	0.6	0.8	1.2	0.8	1.2	2.0	0.8	0.7	2.9	0.9	7.8	0.2	2.5	1.6	2.1	0.5	2.7	0.6	0.9	7.9	2.1	5.1	0.7	0.5	1.8	0.8	9.9	1.3	1.0	0.7	1.7	1.2	4.1	6.9	0.9	1.3	2.3	1.2	0.9	0.5	3.6	7.2	1.7	0.9	0.9	0.4	6.3	1.3	3.7	0.6	2.0	2.6	2.3	0.5	0.5	4.2	1.0	0.0	2.0	1.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.2	2.3	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	1.7	0.0	0.7	1.6	2.5	0.0	0.0	0.0	0.0	0.1	3.3	1.7	0.2	0.0	3.3	0.0	809.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.0	0.0	11.8	0.0	1.1	42.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.3	0.3	0.0	1.2	1.7
CES1	"CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1"	ENSG00000198848	"Carboxylesterase 1"	P23141	16	55802851-55833337	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 355.0"	"Group enriched"	"Detected in many"	7	"Cholangiocytes: 565.6;Hepatocytes: 2145.0"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 711.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	18	"classical monocyte: 32.6;myeloid DC: 32.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 32.9;monocytes: 32.6"	"Group enriched"	"Detected in some"	5	"Hep G2: 96.2;THP-1: 103.6"	"Not detected"	"Not detected"							"HPA012023, HPA046717"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	No	NA		40000000	"Endoplasmic reticulum"		"HPA012023: AB_1846554, HPA046717: AB_2679770"	"unprognostic (1.04e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.51e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (9.92e-4)"	27.1	1.7	0.3	0.5	0.4	2.1	24.7	0.4	0.6	3.1	8.9	0.5	1.5	2.4	7.3	2.1	4.5	6.7	57.7	8.1	0.3	0.0	0.7	355.0	19.8	2.3	0.3	0.6	3.9	1.3	0.0	0.8	1.1	0.6	11.2	1.0	3.8	3.9	4.0	1.6	1.4	3.5	10.2	0.7	4.4	7.0	1.0	0.3	0.4	1.7	2.3	1.5	8.2	16.1	0.2	32.9	0.2	32.6	0.1	1.6	12.1	0.0	0.6	0.0	0.0	14.4	0.0	0.4	0.0	0.0	0.0	0.0	6.7	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	103.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	20.8	0.0	0.0	32.6	0.1	1.3	1.8	0.5	0.2	0.2	1.6	32.9	0.2	0.2	0.4	0.2	0.1	0.4	1.7	0.1	12.1	0.3	0.4	0.4	0.6	0.3	0.0	0.3	0.6	0.6	0.3	14.9	74.9	21.0	2.5	14.8	0.0	0.6	565.6	202.1	28.4	15.7	0.0	0.4	0.0	16.2	77.2	1.5	0.0	70.0	17.2	0.8	45.8	1.1	5.8	2145.0	18.9	0.0	36.2	43.0	88.2	134.3	17.3	20.4	37.1	0.0	0.0	8.3	0.9	0.2	93.0	0.5	0.5	0.0	7.2	0.9	1.0	10.2	0.7	20.3	0.0	1.7
CES2	"CE-2, CES2A1, iCE"	ENSG00000172831	"Carboxylesterase 2"	O00748	16	66934444-66945096	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"esophagus: 46.7;intestine: 146.9;liver: 78.6"	"Group enriched"	"Detected in many"	4	"Enterocytes: 912.6;Hepatocytes: 449.6;Paneth cells: 448.9;Undifferentiated cells: 459.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA018897	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA		7500000	"Golgi apparatus"	"Endoplasmic reticulum, Cytosol"	"HPA018897: AB_1846558"	"unprognostic (8.15e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-2)"	"prognostic favorable (1.50e-5)"	"unprognostic (8.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.38e-1)"	5.8	15.3	8.5	8.8	11.7	2.4	5.1	13.0	15.9	9.5	42.3	12.1	11.2	146.9	7.0	11.9	46.7	6.1	14.5	15.2	7.4	6.6	22.5	78.6	6.7	4.6	8.2	10.7	8.4	12.0	10.0	6.8	7.3	10.3	9.7	42.6	13.0	12.7	7.9	11.6	8.9	117.3	10.4	5.6	7.8	10.9	8.5	8.2	9.0	11.7	14.1	12.1	7.6	11.6	6.9	8.9	5.0	10.6	7.9	10.7	5.2	6.9	9.1	9.6	12.8	9.5	8.9	7.3	7.9	12.8	9.3	11.9	9.8	11.5	8.1	7.9	10.3	7.0	18.0	7.0	19.9	7.3	7.2	9.7	7.9	5.2	18.4	13.4	10.4	14.0	12.9	37.7	13.2	22.1	11.5	6.9	5.7	11.1	6.0	15.7	4.4	9.3	8.7	5.2	7.5	9.2	11.0	9.7	9.5	26.4	12.1	6.2	8.2	25.8	6.5	6.7	3.9	11.2	12.9	8.5	12.3	6.5	7.6	5.9	12.0	14.3	9.6	18.9	8.2	9.2	4.7	10.4	4.7	10.1	7.8	9.2	6.1	7.7	10.7	8.9	6.9	9.5	8.6	5.0	7.9	10.6	7.7	6.8	5.2	8.5	11.7	13.0	15.9	7.4	6.6	8.2	10.7	10.3	8.2	29.8	24.0	25.9	13.7	17.3	28.5	25.4	137.6	42.8	12.5	50.6	19.6	13.0	31.5	21.9	1.5	9.8	912.6	0.0	29.5	5.6	12.7	14.5	27.6	449.6	16.6	27.0	23.2	25.2	27.6	1.3	17.3	13.9	10.1	5.4	141.3	17.6	37.9	448.9	17.0	124.1	22.7	32.3	11.3	42.6	10.2	17.9	11.3	18.7	459.3	15.2
CES3	"ES31, FLJ21736"	ENSG00000172828	"Carboxylesterase 3"	Q6UWW8	16	66961237-66975148	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.8;liver: 26.7"	"Group enriched"	"Detected in many"	5	"Enterocytes: 66.2;Hepatocytes: 40.9;Intestinal endocrine cells: 18.9;Mucus-secreting cells: 31.1;Paneth cells: 60.4;Undifferentiated cells: 31.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.1;Daudi: 8.9;JURKAT: 14.6;U-937: 7.6"					"Not detected"	"Not detected"			"HPA041008, HPA041307"	Approved		Approved	"Nuclear membrane,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		1200000	"Nuclear membrane, Endoplasmic reticulum"		"HPA041008: AB_2677247, HPA041307: AB_2677400"	"unprognostic (3.91e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.32e-2)"	"unprognostic (7.84e-4)"	"prognostic favorable (7.26e-5)"	"unprognostic (5.67e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.41e-2)"	0.5	0.1	0.8	13.3	1.3	0.2	1.0	1.6	1.3	0.6	40.7	0.7	1.4	16.8	0.4	0.7	2.2	1.5	3.0	0.7	1.5	1.0	6.8	26.7	0.9	0.2	0.8	1.1	0.5	7.8	0.0	1.1	0.4	2.2	0.4	17.9	1.1	5.9	0.6	12.9	0.5	41.8	0.5	0.9	0.2	4.6	0.9	0.6	0.5	0.4	2.4	0.5	0.4	0.3	0.7	0.6	2.7	0.6	0.3	0.9	0.2	0.4	3.2	0.4	8.1	0.3	0.2	1.3	0.3	0.2	0.4	0.5	0.5	4.0	8.9	2.7	0.0	0.2	0.7	1.2	0.6	0.1	1.5	6.0	4.4	1.3	2.6	0.1	1.0	0.7	0.3	1.0	0.9	0.2	0.3	0.0	14.6	2.8	1.9	0.3	1.2	1.5	1.6	1.4	2.7	0.5	1.4	0.7	1.4	0.1	0.5	0.4	0.9	0.2	6.1	0.2	0.7	5.4	6.8	0.4	0.4	2.6	0.7	0.2	1.0	3.6	1.3	0.3	7.6	0.2	0.6	0.6	2.7	0.3	0.3	0.5	0.5	0.6	0.4	0.6	0.7	0.9	0.6	2.0	0.3	0.4	0.3	0.9	0.2	0.8	1.3	1.6	1.3	1.5	1.0	0.8	1.1	2.2	0.6	3.0	7.0	0.8	0.0	0.5	0.0	1.0	5.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	66.2	0.0	0.8	0.0	0.0	0.2	1.1	40.9	0.2	0.0	18.9	0.0	3.2	2.6	0.0	1.4	0.0	0.0	31.1	0.2	1.0	60.4	1.1	8.2	0.0	0.0	0.0	0.6	1.3	0.3	0.0	0.0	31.9	0.1
CES5A	"CAUXIN, CES4C1, CES5, CES7, FLJ31547"	ENSG00000159398	"Carboxylesterase 5A"	Q6NT32	16	55846154-55956031	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"epididymis: 43.4"	"Group enriched"	"Detected in some"	4	"Cholangiocytes: 2.5;Collecting duct cells: 5.2;Hepatocytes: 5.5"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.6"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	44	"U-266/70: 13.3"	"Not detected"	"Not detected"												"Secreted in male reproductive system"	NA	NA									"unprognostic (2.07e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.34e-2)"	"unprognostic (4.82e-2)"		"unprognostic (3.78e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.12e-2)"		"unprognostic (1.72e-7)"	"unprognostic (1.55e-2)"	"unprognostic (2.27e-1)"			0.1	0.1	0.7	0.1	0.6	0.0	0.1	0.1	0.8	0.1	0.1	0.1	3.6	0.0	0.1	43.4	0.1	0.0	1.4	0.1	0.8	0.5	0.1	6.6	0.1	0.1	1.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.3	0.1	1.2	0.1	0.1	1.8	0.1	0.0	1.7	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.1	0.8	0.8	0.5	1.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTBP1	BARS	ENSG00000159692	"C-terminal binding protein 1"	Q13363	4	1211448-1249953	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Oxidoreductase, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004217, HPA018987, HPA044971"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004217: AB_627312, HPA018987: AB_1847307, HPA044971: AB_2679161"	"unprognostic (6.19e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.14e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (3.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.22e-2)"	"prognostic favorable (8.94e-4)"	32.3	35.8	42.4	39.8	44.4	31.3	54.6	70.7	56.1	27.6	29.4	29.2	29.0	44.9	35.8	30.8	31.9	38.2	37.6	41.2	41.5	45.7	29.3	36.0	28.5	48.4	38.0	41.2	35.4	62.2	28.4	48.1	27.2	30.2	32.6	21.6	28.2	44.9	27.9	74.2	33.9	43.6	29.7	29.3	47.0	33.5	16.7	27.2	44.9	29.4	30.5	30.2	32.2	38.6	15.6	25.0	11.6	16.2	16.1	24.5	10.3	22.8	33.9	26.2	32.1	18.4	13.3	22.5	18.1	16.9	22.5	23.0	29.0	55.6	28.1	21.0	21.0	34.9	18.4	15.8	23.8	6.8	21.3	19.1	25.4	38.3	37.0	30.7	22.8	36.3	22.9	18.3	19.1	11.1	21.9	16.8	32.1	28.8	48.3	12.4	37.8	73.3	71.9	31.0	18.7	32.8	51.9	15.8	36.6	14.4	29.2	49.3	30.9	17.3	18.7	23.9	16.5	40.9	35.2	21.4	37.7	21.3	21.6	38.7	35.2	33.5	32.5	29.8	35.6	29.5	8.6	11.9	11.6	24.5	16.2	18.4	15.3	17.2	20.8	14.7	15.6	13.5	19.5	9.3	16.1	15.8	25.0	14.6	10.3	42.4	44.4	70.7	56.1	41.5	45.7	38.0	41.2	30.2	27.2	38.7	35.8	50.6	18.9	30.3	28.2	46.2	45.9	24.1	19.4	34.9	3.9	21.5	10.0	27.3	2.7	34.3	46.6	46.7	35.0	26.5	27.8	33.2	23.1	79.0	37.1	38.1	44.3	48.5	64.1	3.6	41.7	35.1	43.9	24.4	42.4	41.9	38.2	31.6	33.6	29.3	15.7	6.5	27.0	6.0	15.1	33.1	16.6	39.6	51.0	23.8
CYP19A1	"ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM"	ENSG00000137869	"Cytochrome P450 family 19 subfamily A member 1"	P11511	15	51208057-51338610	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	49	"placenta: 440.1"	"Cell type enriched"	"Detected in some"	36	"Syncytiotrophoblasts: 1678.9"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in single"	8	"basal ganglia: 5.9"	"Cell type enriched"	"Detected in single"	17	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 45.7;HDLM-2: 7.9;HSkMC: 15.3;SuSa: 8.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000355, HPA051194"	Enhanced		Uncertain	Mitochondria		NA	NA			Mitochondria		"CAB000355: , HPA051194: AB_2681381"	"unprognostic (9.41e-2)"	"unprognostic (7.44e-2)"	"unprognostic (9.52e-5)"	"unprognostic (6.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.25e-4)"	"unprognostic (5.18e-5)"	"unprognostic (1.54e-3)"	"unprognostic (2.38e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.54e-5)"	"unprognostic (2.52e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.11e-1)"	9.0	4.6	0.2	0.2	5.9	0.1	2.1	0.2	0.3	0.9	0.3	0.3	0.2	0.4	0.2	0.3	0.3	0.2	0.3	1.3	0.2	0.7	0.3	0.2	0.6	0.2	0.2	0.2	4.4	0.6	0.1	0.2	440.1	0.2	0.5	0.1	0.2	0.9	1.4	0.8	2.3	0.2	0.7	0.5	0.5	0.1	3.0	0.2	0.3	3.0	0.2	0.2	1.2	0.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	45.7	2.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	7.9	0.0	0.3	0.1	3.7	0.3	0.0	0.0	15.3	0.0	0.1	1.9	0.1	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	8.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	1.4	0.6	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	5.9	0.2	0.3	0.2	0.7	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	46.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	6.9	1.4	0.0	0.0	0.0	13.4	0.0	0.0	0.0	1.6	4.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	6.5	0.3	7.7	0.2	0.0	1678.9	0.0	0.0	0.0
CYP1A1	"CP11, CYP1, P1-450, P450-C, P450DX"	ENSG00000140465	"Cytochrome P450 family 1 subfamily A member 1"	P04798	15	74719542-74725610	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Lyase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 38.3;lung: 144.1;urinary bladder: 40.0"	"Cell type enhanced"	"Detected in some"	21	"Glandular cells: 1.5;Hepatocytes: 6.0;Urothelial cells: 3.2"	"Group enriched"	"Detected in some"	24	"liver cancer: 18.6;urothelial cancer: 54.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 22.0;hTCEpi: 12.0;HUVEC TERT2: 11.5;SK-BR-3: 9.0;SuSa: 23.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB018654	Uncertain					NA	NA					"CAB018654: AB_2088699"	"unprognostic (1.71e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.45e-3)"	"unprognostic (6.34e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.21e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.28e-1)"	9.3	0.4	0.1	0.4	0.2	0.2	7.7	0.2	0.5	2.3	0.7	0.4	3.9	0.5	3.8	4.4	1.2	0.2	11.3	3.0	0.1	0.0	0.7	38.3	144.1	0.2	0.1	0.1	0.5	0.5	0.2	0.1	3.5	0.3	0.2	0.2	0.8	2.1	0.5	1.5	8.1	10.7	5.9	0.2	0.2	0.4	0.3	0.1	0.1	0.8	0.8	8.0	40.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.3	0.1	0.0	0.3	0.0	7.2	0.0	0.0	0.4	0.2	22.0	0.9	0.2	5.9	0.0	5.4	6.9	0.4	4.4	0.2	0.0	0.6	0.3	1.5	3.2	0.1	0.2	7.1	0.0	12.0	0.1	0.9	0.2	11.5	0.2	1.3	0.2	0.0	0.4	0.0	0.2	0.1	7.2	1.8	0.7	0.0	0.2	0.0	1.4	0.3	0.1	1.0	9.0	2.3	23.3	0.3	0.1	0.6	1.0	0.3	3.2	0.0	0.4	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.2	0.3	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	3.2
CYP1A2	"CP12, P3-450"	ENSG00000140505	"Cytochrome P450 family 1 subfamily A member 2"	P05177	15	74748844-74756202	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Lyase, Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 143.0"	"Cell type enriched"	"Detected in some"	18	"Hepatocytes: 44.0"	"Group enriched"	"Detected in some"	22	"liver cancer: 25.3;urothelial cancer: 6.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB016531	Enhanced					NA	NA					"CAB016531: AB_629359"				"unprognostic (1.54e-4)"			"unprognostic (1.29e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.59e-2)"		"unprognostic (1.76e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.41e-2)"	"unprognostic (2.53e-1)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.7	1.1	4.5	1.2	1.1	0.7	0.3	1.1	0.9	2.7	2.1	0.2	0.0	1.6	0.7	0.0	0.0	0.2	0.6	1.3	2.2	0.5	0.0	1.8	1.2	0.1	0.2	0.1	0.5	1.2	2.8	1.6	0.8	0.1	1.9	1.1	0.4	0.3	0.1	0.0	0.7	0.2	3.9	1.9	4.0	0.0	0.8	2.5	1.3	1.7	0.9	0.6	2.6	2.4	0.9	0.0	2.2	2.2	1.1	2.1	6.0	0.4	2.3	1.6	1.0	0.4	1.1	1.4	1.1	1.2	1.0	0.7	1.6	1.1	2.4	1.2	3.2	1.2	1.2	0.6	0.6	0.5	0.8	0.7	0.5	0.4	1.7	0.7	0.7	4.5	1.1	0.8	1.1	0.4	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	44.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2
CYP1B1	"CP1B, GLC3A"	ENSG00000138061	"Cytochrome P450 family 1 subfamily B member 1"	Q16678	2	38066973-38109902	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism, Steroid metabolism"	"Lyase, Monooxygenase, Oxidoreductase"	"Disease mutation, Glaucoma, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.0;lung: 39.2"	"Cell type enhanced"	"Detected in many"	11	"Glandular cells: 345.6;Leydig cells: 147.9;Peritubular cells: 160.5;Urothelial cells: 295.9"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in some"	6	"classical monocyte: 45.0"	"Lineage enriched"	"Detected in many"	22	"monocytes: 45.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.6;ASC TERT1: 26.4;HSkMC: 105.7;hTERT-RPE1: 24.4;SiHa: 49.2;U-87 MG: 26.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB011705, HPA026863"	Approved		Uncertain	Mitochondria		NA	NA			Mitochondria		"CAB011705: AB_731810, HPA026863: AB_10600900"	"unprognostic (7.25e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (1.87e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (2.76e-4)"	9.1	3.1	0.5	9.4	1.2	0.0	11.4	1.0	1.2	11.4	2.1	0.7	4.5	0.0	12.8	5.9	3.5	15.0	6.9	17.5	1.2		8.8	3.5	39.2	26.3	3.1	1.0	6.1	3.6	0.0	1.3	0.8	3.3	10.7	0.0	19.3	0.0	13.0	4.8	0.5	1.4	10.6	5.1	15.7	0.3	3.9	0.5	5.1	2.5	1.1	4.2	6.9	2.1	0.0	0.4	2.0	45.0	0.0	0.0	16.2	1.2	13.2	0.4	0.0	24.6	26.4	0.0	0.1	0.8	0.2	2.3	0.0	5.5	0.0	3.6	3.2	0.5	10.8	0.0	0.7	0.4	1.0	0.7	0.0	4.0	0.0	6.8	0.0	0.0	105.7	10.3	5.7	0.2	24.4	0.0	0.0	0.1	0.0	0.1	5.2	0.0	4.0	1.4	1.8	2.5	0.0	0.0	0.0	2.5	0.1	0.1	0.4	49.2	7.2	0.0	1.4	9.1	1.9	0.0	0.2	0.0	20.2	0.0	0.0	0.0	0.0	26.8	0.0	2.2	0.4	45.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.0	0.0	5.5	0.2	0.0	16.2											17.9	50.6	0.5	98.2	15.8	0.9	2.7	0.0	12.0	35.2	43.6	0.0	0.4	13.3	5.0	11.7	36.8	0.0	0.0	0.5	0.7	41.1	345.6	3.5	9.7	12.6	0.0	1.7	5.5	116.2	8.6	147.9	28.1	16.9	39.7	0.3	0.5	0.4	0.0	160.5	0.8	0.3	19.4	20.8	1.0	1.8	12.4	0.2	0.0	0.8	295.9
CYP26A1	"CP26, CYP26, P450RAI, P450RAI1"	ENSG00000095596	"Cytochrome P450 family 26 subfamily A member 1"	O43174	10	93073475-93077890	"Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"liver: 23.2;retina: 7.3"	"Cell type enriched"	"Detected in some"	9	"Muller glia cells: 70.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"AF22: 37.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 6.8"							NA	NA						"unprognostic (2.80e-1)"	"unprognostic (4.21e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.90e-1)"	"unprognostic (4.17e-2)"	"unprognostic (6.22e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.04e-11)"	"unprognostic (1.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.11e-1)"	0.1	0.3	0.3	0.0	0.6	0.1	0.3	0.4	1.8	0.3	0.1	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.6	0.3	0.0	23.2	0.1	0.0	0.2	1.4	0.1	0.0	0.0	0.2	0.8	0.3	0.1	0.0	7.3	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.2	1.2	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	37.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.4	1.8	0.6	0.3	0.2	1.4	0.3	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	8.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.5	1.1	0.0	6.4	0.0	0.0	0.0
CYP26B1	P450RAI-2	ENSG00000003137	"Cytochrome P450 family 26 subfamily B member 1"	Q9NR63	2	72129238-72148038	"Disease related genes, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.4"	"Group enriched"	"Detected in many"	8	"Leydig cells: 70.2;Peritubular cells: 216.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 8.2;HaCaT: 12.1;RH-30: 15.6;U-2 OS: 17.3;U-2197: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012567	Uncertain		Approved	Cytosol	"Intracellular and membrane"	No	No			Cytosol		"HPA012567: AB_1847429"	"unprognostic (1.70e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.19e-4)"	"unprognostic (3.46e-2)"	"unprognostic (4.40e-1)"	"unprognostic (2.17e-4)"	"unprognostic (8.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.55e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.04e-2)"	16.6	2.6	8.3	2.1	7.8	0.1	7.7	25.0	23.9	5.8	2.4	1.2	1.6	3.6	1.5	1.6	3.4	2.7	1.2	6.0	2.5	1.5	4.2	0.7	2.7	4.4	3.4	10.0	4.9	0.2	0.9	5.2	3.2	35.4	1.3	1.2	1.2	5.1	7.5	7.6	20.5	2.4	1.5	0.6	1.9	0.5	13.8	1.1	4.9	9.2	2.2	2.8	1.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.9	0.0	0.1	8.2	3.1	4.9	0.7	0.1	0.2	0.2	1.5	0.4	0.0	0.4	0.6	2.4	12.1	6.9	0.0	0.1	0.0	2.2	0.0	4.9	0.6	0.1	0.0	0.2	0.0	0.4	0.0	0.2	2.5	0.9	3.3	0.4	0.1	0.7	2.3	0.0	0.1	0.0	0.1	0.8	0.0	15.6	0.0	0.0	1.2	0.5	0.1	2.7	0.0	2.9	1.0	0.2	0.7	0.0	1.3	17.3	7.6	2.6	0.0	0.9	0.0	5.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	7.8	25.0	23.9	2.5	1.5	3.4	10.0	35.4	1.1	0.0	0.0	2.9	1.1	13.1	0.1	1.1	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.1	1.6	0.0	0.0	0.0	0.7	3.7	0.3	0.0	0.2	0.1	0.0	1.7	17.2	4.5	4.9	70.2	0.0	6.8	0.0	0.0	5.4	0.2	0.0	216.0	0.0	0.0	0.0	5.6	1.4	3.0	8.4	0.1	0.0	0.0	0.1
CYP2A13	"CPAD, CYP2A"	ENSG00000197838	"Cytochrome P450 family 2 subfamily A member 13"	Q16696	19	41088472-41096195	"Enzymes, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 30.7"	"Cell type enriched"	"Detected in single"	7	"Early spermatids: 3.0"	"Cancer enriched"	"Detected in single"	5	"liver cancer: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.1;NTERA-2: 1.6"									"HPA046713, HPA047262"	Supported				"Intracellular and membrane"	NA	NA					"HPA046713: AB_2679767, HPA047262: AB_2680005"	"unprognostic (9.79e-2)"						"unprognostic (1.00e-1)"	"unprognostic (4.51e-3)"		"unprognostic (4.92e-2)"				"unprognostic (1.99e-1)"	"unprognostic (1.49e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	30.7	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0
CYP2A6	"CPA6, CYP2A, CYP2A3"	ENSG00000255974	"Cytochrome P450 family 2 subfamily A member 6"	P11509	19	40843538-40850447	"Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	165	"liver: 199.5"	"Cell type enriched"	"Detected in some"	13	"Hepatocytes: 161.7"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 281.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.3;HL-60: 2.9;K-562: 1.4;RH-30: 4.4;SiHa: 2.2;TIME: 1.0;U-698: 1.0;U-937: 1.0"									"HPA046713, HPA047262"	Supported				"Intracellular and membrane"	NA	NA					"HPA046713: AB_2679767, HPA047262: AB_2680005"	"unprognostic (5.40e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (2.64e-2)"	"prognostic favorable (5.38e-5)"	"unprognostic (4.98e-3)"	"unprognostic (4.86e-2)"	"unprognostic (6.23e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.83e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.55e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	199.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.1	5.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	161.7	0.0	0.0	0.0	12.9	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0
CYP2A7	CYP2A	ENSG00000198077	"Cytochrome P450 family 2 subfamily A member 7"	P20853	19	40875439-40882752	"Enzymes, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	134	"liver: 53.7"	"Cell type enhanced"	"Detected in some"	29	"Hepatocytes: 29.0;Ito cells: 12.3;Kupffer cells: 5.7"	"Group enriched"	"Detected in some"	238	"breast cancer: 9.2;liver cancer: 25.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HL-60: 2.0"									"CAB033510, HPA046713, HPA047262"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB033510: AB_782366, HPA046713: AB_2679767, HPA047262: AB_2680005"	"unprognostic (2.18e-1)"				"unprognostic (3.60e-2)"		"unprognostic (2.65e-3)"	"unprognostic (8.89e-2)"		"unprognostic (1.39e-2)"	"unprognostic (3.95e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.99e-2)"		"unprognostic (1.06e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.7	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.2	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	29.0	0.0	0.0	0.0	12.3	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7
CYP2B6	"CPB6, CYP2B, CYPIIB6"	ENSG00000197408	"Cytochrome P450 family 2 subfamily B member 6"	P20813	19	40991250-41018398	"Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"liver: 137.3"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 326.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 7.0;OE19: 4.9"					"Not detected"	"Not detected"			"CAB033866, HPA048124, HPA062973"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: AB_2684914"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.13e-2)"		"unprognostic (4.59e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.73e-1)"		"unprognostic (5.78e-2)"		"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (9.43e-2)"		"unprognostic (5.44e-1)"	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.9	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.0	3.0	137.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	1.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.9	1.8	3.1	0.8	0.7	0.9	0.1	0.4	0.4	0.5	0.4	0.1	0.0	0.4	0.2	0.3	0.0	0.1	1.5	0.0	0.3	0.3	0.2	0.1	7.0	0.4	0.1	0.1	0.3	0.6	0.4	0.7	0.4	0.4	0.4	0.4	0.0	0.4	0.3	0.1	0.3	0.5	0.7	0.4	0.1	0.2	0.1	0.8	1.8	0.6	4.9	0.4	0.2	0.5	0.4	1.7	0.1	0.9	0.2	0.3	0.1	0.5	0.3	0.7	1.1	0.8	0.6	0.3	0.7	0.5	0.3	0.7	0.9	0.2	1.1	0.3	3.1	0.8	0.4	0.4	0.5	0.4	0.6	0.6	0.4	0.1	1.9	0.5	0.8	2.7	0.7	0.3	1.8	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.2	2.5	1.4	1.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	9.9	46.7	0.2	0.0	0.0	0.1	0.0	326.3	0.0	0.0	0.0	10.4	11.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	7.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.2	0.6
CYP2C18	"CPCI, CYP2C, CYP2C17, P450IIC17"	ENSG00000108242	"Cytochrome P450 family 2 subfamily C member 18"	P33260	10	94683621-94736190	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 62.9;liver: 56.1"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 113.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"basophil: 1.7"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.9;hTCEpi: 2.3;OE19: 4.4"														"Intracellular and membrane"	NA	NA						"unprognostic (2.40e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.10e-2)"		"unprognostic (1.32e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.22e-3)"		"unprognostic (1.62e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"		"unprognostic (6.81e-3)"	0.2	0.0	0.2	0.8	0.2	0.0	0.2	0.2	0.2	2.4	29.2	0.3	0.2	30.2	0.2	0.2	13.5	0.0	6.7	0.2	0.2	0.0	0.2	56.1	0.5	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.5	0.2	0.2	0.5	0.2	2.4	0.2	0.2	1.7	62.9	0.2	0.2	0.2	19.0	0.2	0.2	0.3	0.2	5.0	3.8	0.2	3.7	0.0	0.0	1.7	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.3	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.1	0.0	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	4.4	0.0	0.0	0.0	0.9	0.5	0.2	0.3	0.6	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.2	0.6	0.1	0.5	0.0	0.1	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	3.5	0.0	0.0	0.1	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	14.7	0.0	6.4	0.1	0.0	0.0	0.0	113.1	0.0	0.0	0.0	1.8	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	5.3	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	1.3	0.0	1.5	0.0
CYP2C19	"CPCJ, CYP2C, P450IIC19"	ENSG00000165841	"Cytochrome P450 family 2 subfamily C member 19"	P33261	10	94762681-94853205	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 47.7;liver: 76.4"	"Cell type enriched"	"Detected in single"	31	"Hepatocytes: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.8;RPMI-8226: 1.6"									HPA015066	Supported				"Intracellular and membrane"	NA	NA					"HPA015066: AB_1847433"			"unprognostic (3.15e-2)"			"unprognostic (2.13e-1)"	"unprognostic (2.48e-1)"				"unprognostic (1.83e-2)"			"unprognostic (1.53e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	30.0	0.0	0.0	14.7	0.0	0.0	1.0	0.0	3.7	0.0	0.0	0.0	0.0	76.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	47.7	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CYP2C8	CPC8	ENSG00000138115	"Cytochrome P450 family 2 subfamily C member 8"	P10632	10	95036772-95069497	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	131	"liver: 247.5"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 1616.5"	"Cancer enriched"	"Detected in some"	82	"liver cancer: 102.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"gdT-cell: 1.8"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.8;HL-60: 2.7;SiHa: 3.0;U-266/70: 3.0;U-266/84: 2.3"									"HPA013547, HPA013970, HPA015066"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433"	"unprognostic (3.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (9.82e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.05e-4)"	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.1	0.1	0.2	0.3	247.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.1	1.1	0.2	0.0	0.2	0.0	0.7	1.0	0.0	1.0	0.5	2.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.3	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	3.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	2.3	1.2	0.0	0.9	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	21.0	0.0	0.0	0.9	0.2	155.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.9	0.0	0.0	70.0	0.2	0.0	0.0	0.1	0.0	1616.5	0.0	4.8	1.7	61.4	65.7	5.1	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	1.6	0.0	0.0	2.1	0.6	0.0	0.0	0.0	0.0	0.1
CYP2C9	"CYP2C10, P450IIC9"	ENSG00000138109	"Cytochrome P450 family 2 subfamily C member 9"	P11712	10	94938658-94989391	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 233.0"	"Cell type enriched"	"Detected in some"	48	"Hepatocytes: 1765.4"	"Cancer enriched"	"Detected in some"	41	"liver cancer: 118.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 3.5;NB-4: 1.7;RPMI-8226: 2.5;SiHa: 1.6"									"HPA015066, CAB016123"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB016123: AB_629363, HPA015066: AB_1847433"	"unprognostic (3.37e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.67e-2)"	"unprognostic (4.16e-2)"		"unprognostic (1.83e-2)"	"prognostic favorable (2.83e-6)"	"unprognostic (2.37e-1)"	"unprognostic (2.05e-2)"		"unprognostic (4.93e-2)"		"unprognostic (1.26e-4)"	"unprognostic (7.55e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.24e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	45.8	0.0	0.0	13.6	0.0	0.6	1.1	0.0	1.0	0.0	0.0	0.0	0.5	233.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	43.8	0.0	0.0	0.1	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.7	0.4	0.9	0.0	0.0	0.3	2.5	0.4	0.0	0.1	0.1	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	1.8	0.0	0.0	0.0	4.7	0.0	0.0	4.2	23.3	0.6	0.0	0.0	0.0	0.0	1765.4	0.0	0.0	0.0	36.8	31.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.0
CYP2D6	"CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D"	ENSG00000100197	"Cytochrome P450 family 2 subfamily D member 6"	P10635	22	42126499-42130906	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 78.0"	"Cell type enriched"	"Detected in many"	38	"Hepatocytes: 435.9"	"Cancer enriched"	"Detected in many"	35	"liver cancer: 90.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 4.4;HMC-1: 6.2;Karpas-707: 1.9;REH: 3.6;T-47d: 2.3;U-266/70: 4.3"									HPA045223	Enhanced		Approved	"Golgi apparatus"		No	No			"Golgi apparatus"		"HPA045223: AB_10962927"	"unprognostic (4.40e-3)"	"unprognostic (7.68e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.29e-4)"	"unprognostic (3.83e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.03e-4)"	"unprognostic (2.11e-2)"	"unprognostic (5.61e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.82e-5)"	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.2	0.1	0.1	3.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	78.0	0.1	0.1	0.1	0.1	0.5	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	11.2	0.1	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.9	0.0	0.3	0.2	0.0	0.6	0.0	0.2	3.6	0.0	1.1	0.0	0.0	0.1	0.3	1.2	0.1	0.0	0.0	2.3	0.0	0.0	0.0	1.7	0.0	0.3	4.3	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.5	0.5	6.5	0.3	2.5	1.4	0.0	1.8	2.0	0.1	1.7	0.6	2.9	0.3	3.9	0.0	0.5	0.1	0.2	0.5	0.0	435.9	0.1	11.1	1.2	6.7	6.2	11.4	0.0	0.0	0.0	0.0	1.0	0.9	0.5	2.9	1.4	0.5	2.0	0.0	0.2	0.7	0.3	1.0	0.3	0.5	0.8	0.2
CYP2E1	CYP2E	ENSG00000130649	"Cytochrome P450 family 2 subfamily E member 1"	P05181	10	133520406-133561220	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	87	"liver: 802.4"	"Cell type enriched"	"Detected in many"	65	"Hepatocytes: 5979.1"	"Cancer enriched"	"Detected in some"	278	"liver cancer: 265.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.9;myeloid DC: 9.1"	"Group enriched"	"Detected in many"	17	"dendritic cells: 9.1;T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 9.8;HL-60: 7.6;HMC-1: 8.1;NB-4: 20.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009128, HPA029564"	Enhanced		Approved	"Endoplasmic reticulum,Mitochondria"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum, Mitochondria"		"HPA009128: AB_1078613, HPA029564: AB_10602213"	"unprognostic (6.32e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.83e-5)"	"unprognostic (1.27e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-3)"	"unprognostic (6.36e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-4)"	"unprognostic (1.72e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.78e-1)"	"unprognostic (9.59e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.6	0.3	0.1	0.1	0.2	0.7	0.0	0.1	0.3	0.8	0.2	1.3	0.1	0.1	0.1	0.3	802.4	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.1	0.3	0.1	0.0	0.2	0.1	1.1	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.3	0.1	0.1	0.2	0.2	1.5	0.1	0.1	0.0	9.1	0.0	0.3	0.2	3.9	0.3	0.1	0.0	0.3	0.9	3.2	1.8	0.7	1.4	4.0	0.0	0.3	0.0	2.4	1.3	0.2	0.4	0.0	9.8	0.0	0.2	0.3	0.2	1.4	1.5	0.1	1.1	0.5	7.6	8.1	0.9	0.2	0.0	0.6	1.7	0.0	2.8	0.5	0.4	0.9	0.6	0.5	20.6	5.6	3.7	0.4	0.3	5.5	0.0	1.8	0.0	0.0	0.0	3.7	0.0	0.6	0.1	0.2	0.8	0.0	1.3	0.4	2.0	0.9	2.0	0.8	2.8	1.3	6.4	0.1	0.0	0.0	0.0	0.1	0.0	3.9	0.0	1.7	1.0	9.1	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.3	0.1	0.2	0.6	0.3	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.6	21.0	0.2	2.1	4.5	2.2	50.9	2.7	2.3	0.0	2.0	0.0	0.0	0.3	1.3	0.4	0.0	23.3	1.2	0.1	0.4	0.5	1.1	5979.1	0.0	7.9	0.0	68.2	91.8	1.9	1.4	0.0	0.0	0.0	0.0	1.0	2.6	0.0	2.5	0.0	5.2	0.0	0.5	3.6	2.2	6.6	0.1	8.7	0.0	0.0
CYP2F1	CYP2F	ENSG00000197446	"Cytochrome P450 family 2 subfamily F member 1"	P24903	19	41114432-41128366	"Enzymes, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lung: 10.4;lymphoid tissue: 6.1;pituitary gland: 4.6;testis: 4.9"	"Cell type enhanced"	"Detected in some"	29	"Ciliated cells: 22.7;Club cells: 48.9;Spermatocytes: 9.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.6"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 7.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA						"unprognostic (2.04e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.63e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.29e-3)"		"unprognostic (6.23e-3)"		"unprognostic (2.87e-2)"	"unprognostic (3.91e-2)"		"unprognostic (1.58e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.50e-1)"	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	3.1	6.1	0.0	2.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	22.7	48.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	4.8	0.0	0.0	0.0	0.0	0.0
CYP2J2		ENSG00000134716	"Cytochrome P450 family 2 subfamily J member 2"	P51589	1	59893308-59926790	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 44.9;intestine: 46.6;liver: 74.6"	"Cell type enhanced"	"Detected in many"	15	"Cardiomyocytes: 84.7;Cytotrophoblasts: 107.4;Syncytiotrophoblasts: 201.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 6.0;naive CD8 T-cell: 5.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"OE19: 9.9;RT4: 36.0;SK-BR-3: 9.7"					"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA						"unprognostic (3.53e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.84e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (5.54e-7)"	"unprognostic (4.96e-1)"	"unprognostic (8.45e-2)"	"unprognostic (4.25e-1)"	"unprognostic (9.70e-2)"	0.8	0.9	8.8	1.2	12.0	0.7	5.8	7.9	8.5	1.2	13.1	22.1	0.0	17.9	1.2	1.1	7.2	1.1	1.7	44.9	9.1	6.9	2.2	74.6	1.4	0.8	13.2	6.3	0.7	1.8	0.6	0.7	11.9	12.3	2.4	12.0	0.5	7.2	1.0	12.2	5.3	46.6	1.6	10.1	0.7	3.0	0.9	15.5	0.0	0.7	0.5	2.3	5.8	1.8	1.8	1.2	0.0	0.0	0.7	6.0	1.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.7	0.2	1.6	0.0	0.5	0.0	2.1	0.5	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	1.8	0.0	0.0	0.9	9.9	1.6	0.0	3.8	0.0	2.0	36.0	0.5	2.3	0.0	9.7	0.3	0.1	2.4	0.0	0.0	1.2	1.5	0.0	0.5	1.1	0.1	0.0	0.4	0.0	4.0	0.0	0.0	0.0	0.2	0.0	1.2	1.8	0.7	0.4	0.1	0.9	6.0	5.2	0.0	0.7	0.0	1.2	0.0	1.0	8.8	12.0	7.9	8.5	9.1	6.9	13.2	6.3	12.3	15.5	3.0	2.6	0.5	1.2	0.3	0.0	84.7	12.7	29.4	35.2	0.0	0.0	107.4	0.0	9.1	16.8	0.0	23.8	0.0	0.8	7.3	1.0	0.8	0.0	44.3	6.1	0.0	8.6	0.0	0.6	19.0	0.0	0.0	0.0	1.0	21.4	11.9	1.8	21.0	0.0	2.9	1.0	0.0	0.0	0.3	0.1	1.9	201.5	0.0	23.6	0.9
CYP2S1		ENSG00000167600	"Cytochrome P450 family 2 subfamily S member 1"	Q96SQ9	19	41193049-41207539	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.1;gallbladder: 29.1;intestine: 62.7;stomach 1: 45.9"	"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 16.5;Enterocytes: 23.2;Mucus-secreting cells: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 9.5;myeloid DC: 33.1"	"Group enriched"	"Detected in many"	121	"dendritic cells: 33.1;monocytes: 9.5"	"Cell line enhanced"	"Detected in many"		"A549: 31.3;CACO-2: 16.1;HaCaT: 16.8;NTERA-2: 23.7;OE19: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA049227, HPA069248"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA049227: AB_2680681, HPA069248: AB_2732128"	"unprognostic (1.49e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.45e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.60e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.66e-2)"	1.2	0.8	0.8	2.3	1.0	0.5	0.6	0.1	1.0	1.7	18.3	1.2	0.5	37.6	0.3	0.9	10.1	2.4	29.1	1.0	1.4	1.6	0.9	2.1	3.8	3.3	5.6	0.4	0.8	0.6	0.0	0.9	1.6	4.5	0.9	7.2	1.1	3.8	0.3	0.1	2.0	62.7	0.6	1.1	4.0	45.9	0.5	1.2	2.6	0.4	15.8	21.0	3.2	2.7	0.0	33.1	0.0	9.5	0.0	0.1	3.9	1.2	31.3	0.0	0.0	0.0	0.0	1.5	0.2	0.2	0.3	0.0	16.1	4.5	0.0	3.7	0.2	0.0	16.8	5.5	8.5	0.1	0.0	0.1	4.2	1.7	5.8	6.6	0.0	0.1	0.2	0.4	0.4	0.2	0.0	0.2	1.4	1.9	0.1	0.0	0.6	0.1	0.0	23.7	51.4	4.1	0.0	0.0	0.3	0.5	6.7	0.0	0.2	3.1	0.0	0.0	9.7	4.1	1.6	3.6	0.0	1.3	0.6	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	9.5	0.0	0.0	2.3	0.1	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	3.9	0.8	1.0	0.1	1.0	1.4	1.6	5.6	0.4	4.5	1.2	0.0	8.6	0.0	1.6	2.3	0.0	0.8	0.0	8.1	7.9	1.8	0.0	16.5	0.0	0.8	0.3	0.0	23.2	0.0	0.9	0.6	1.3	0.4	1.1	0.0	12.8	0.0	0.0	0.6	4.7	0.0	0.0	11.5	0.0	8.2	29.0	0.0	13.8	14.8	0.0	0.0	0.0	0.0	0.3	0.1	0.4	2.5	8.6	0.0	13.9	0.1
CYP2U1	SPG49	ENSG00000155016	"Cytochrome P450 family 2 subfamily U member 1"	Q7Z449	4	107931369-107953457	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 122.7"	"Cell type enhanced"	"Detected in many"	4	"Melanocytes: 18.6;Peritubular cells: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041622, HPA046754, HPA064827"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA041622: AB_2677583, HPA046754: AB_2679787, HPA064827: AB_2685362"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.19e-1)"	"unprognostic (8.97e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.02e-1)"	"prognostic favorable (2.75e-5)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	8.6	7.9	7.7	4.4	9.1	0.4	7.3	11.3	9.2	7.8	7.3	7.0	4.1	4.0	9.5	4.6	6.3	9.8	6.6	8.8	7.1	7.9	6.4	6.8	6.6	6.7	8.3	5.2	12.0	2.6	10.3	8.1	2.7	7.8	12.4	4.7	8.6	4.5	11.0	4.3	3.1	6.0	12.3	7.0	8.5	4.6	3.9	7.4	122.7	4.7	3.5	5.4	7.3	5.3	2.6	2.7	0.7	5.9	1.6	1.7	0.4	2.5	1.2	3.4	6.3	18.8	9.0	0.5	10.8	16.3	6.6	10.5	0.0	1.7	6.9	0.8	6.4	5.2	0.1	5.3	4.0	10.4	1.9	1.6	1.4	2.4	0.3	7.5	2.0	0.0	10.1	3.4	3.1	2.1	13.5	2.5	7.8	0.1	3.3	5.5	1.8	7.4	0.0	3.5	0.2	3.0	4.2	4.1	0.0	2.1	4.3	6.7	5.0	2.7	4.7	11.5	3.0	2.3	1.0	6.8	4.3	0.5	6.1	4.3	14.0	13.2	2.2	3.5	0.0	4.8	0.0	0.3	0.7	1.2	1.1	0.9	2.0	0.9	1.0	2.2	2.6	1.7	1.3	0.0	1.6	5.9	2.7	0.0	0.4	7.7	9.1	11.3	6.9	7.1	7.9	8.3	5.2	7.8	7.4	3.0	3.8	3.2	3.2	1.0	4.3	3.4	2.5	13.4	3.4	8.7	3.9	0.4	0.0	0.9	9.6	5.8	2.6	0.0	1.7	0.3	5.1	1.7	4.6	6.8	1.9	1.6	2.9	6.7	6.1	6.1	16.4	4.6	18.6	3.6	1.1	9.9	0.4	0.0	16.6	2.4	3.3	0.0	5.2	0.9	4.3	1.3	0.2	1.3	1.6	0.7
CYP3A4	CYP3A3	ENSG00000160868	"Cytochrome P450 family 3 subfamily A member 4"	P08684	7	99756960-99784265	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	45	"intestine: 145.3;liver: 464.6"	"Cell type enriched"	"Detected in some"	45	"Hepatocytes: 2276.5"	"Cancer enriched"	"Detected in some"	240	"liver cancer: 351.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.2;NB-4: 4.5;RPMI-8226: 6.7;SCLC-21H: 2.6;SH-SY5Y: 5.0"									"CAB033671, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"CAB033671: AB_782375, HPA072245: , HPA075539: "	"unprognostic (4.55e-2)"	"unprognostic (8.95e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.07e-3)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.89e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.82e-2)"	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	145.3	0.1	0.1	56.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	464.6	0.1	0.1	0.1	0.1	0.1	6.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	126.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.2	0.6	0.2	0.6	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.0	1.9	0.4	0.0	1.2	0.0	0.4	0.0	0.0	0.1	0.5	0.0	0.5	0.0	0.1	4.5	0.3	0.0	0.0	0.0	2.2	6.7	0.0	0.5	2.6	5.0	0.5	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.4	0.0	0.7	0.1	0.7	0.1	0.7	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.6	0.6	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	4.3	1.0	0.3	0.0	0.3	40.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	2.6	46.7	0.8	0.0	0.0	0.5	0.0	2276.5	0.0	0.0	0.0	39.3	50.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.4	0.9
CYP3A43		ENSG00000021461	"Cytochrome P450 family 3 subfamily A member 43"	Q9HB55	7	99828013-99866102	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"liver: 32.5"	"Cell type enhanced"	"Detected in some"	15	"Early spermatids: 6.3;granulocytes: 2.3;Hepatocytes: 6.8;Late spermatids: 2.5"	"Cancer enriched"	"Detected in single"	18	"liver cancer: 1.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"											"HPA066463, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA066463: AB_2685670, HPA072245: , HPA075539: "	"unprognostic (1.20e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.64e-3)"		"unprognostic (7.24e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.46e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.37e-4)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	0.9	0.1	0.0	0.1	0.1	0.1	0.0	0.2	32.5	0.1	0.1	0.1	0.1	0.1	8.0	0.0	2.2	0.1	0.1	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.5	1.6	0.6	0.3	0.6	0.2	0.1	0.0	0.9	0.3	1.1	0.2	0.2	0.0	0.2	0.2	0.2	1.2	0.7	1.5	0.3	0.3	0.1	1.3	0.2	0.0	0.7	0.2	0.5	0.9	1.5	1.3	0.3	0.9	1.3	0.0	0.7	0.0	0.0	0.6	0.5	0.1	1.0	1.0	0.0	0.0	0.0	0.6	0.4	0.3	0.0	0.9	0.0	0.2	0.8	1.6	0.5	0.4	0.6	1.7	0.0	0.7	0.5	0.0	1.6	0.5	0.2	1.1	0.7	1.1	1.2	0.1	0.8	0.4	0.2	1.5	0.6	0.4	0.6	0.2	0.3	0.3	0.3	0.2	0.1	0.6	0.5	0.5	1.6	0.3	0.2	0.5	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.3	0.2	0.0	0.0	0.0	0.0	0.0	0.5	2.3	6.8	0.1	1.6	0.0	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.9	0.2	0.3	0.0	0.0	0.0	0.0
CYP3A5	"CP35, P450PCN3, PCN3"	ENSG00000106258	"Cytochrome P450 family 3 subfamily A member 5"	P20815	7	99648194-99680026	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 72.9;liver: 73.4;stomach 1: 21.3"	"Cell type enhanced"	"Detected in many"	11	"Cholangiocytes: 346.5;Enterocytes: 640.5;Hepatocytes: 330.1;Urothelial cells: 352.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 38.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.3;CAPAN-2: 5.6;Hep G2: 5.7;OE19: 23.6"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA072245: , HPA075539: "	"unprognostic (2.13e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.73e-1)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.37e-3)"	"unprognostic (1.21e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.85e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-4)"	"unprognostic (6.58e-3)"	1.0	3.3	0.4	2.0	0.5	0.0	1.3	0.6	0.6	1.9	32.6	0.6	1.0	30.3	0.7	0.5	5.2	0.5	8.2	0.4	0.4	0.0	6.8	73.4	2.4	0.8	0.4	0.4	0.6	12.1	0.0	1.8	0.6	0.8	4.9	5.1	0.4	0.6	1.3	0.4	4.3	72.9	0.6	0.5	0.4	21.3	0.7	0.4	0.5	0.4	2.2	4.0	3.0	2.7	0.0	0.2	0.1	0.6	0.0	0.7	0.2	0.0	2.1	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	8.3	5.6	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.1	0.0	0.3	0.2	23.6	0.0	0.1	0.0	0.6	0.5	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.4	0.5	0.6	0.6	0.4	0.0	0.4	0.4	0.8	0.4	11.9	11.3	11.2	107.3	41.0	13.1	1.0	346.5	14.7	12.5	3.5	11.8	1.3	0.0	58.0	1.7	2.5	640.5	46.7	44.6	1.0	3.8	166.5	9.3	330.1	0.6	7.9	52.5	9.8	8.3	0.0	2.3	4.6	3.3	7.2	117.1	6.0	69.5	210.5	2.5	4.2	20.2	0.0	3.5	6.8	4.2	51.6	1.3	12.9	85.2	352.8
CYP3A7	"CP37, P450-HFLA"	ENSG00000160870	"Cytochrome P450 family 3 subfamily A member 7"	P24462	7	99684957-99735196	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 82.6"	"Cell type enriched"	"Detected in some"	7	"Cholangiocytes: 135.0"	"Cancer enriched"	"Detected in some"	43	"liver cancer: 38.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 1.9;BJ hTERT+: 3.3;Hep G2: 6.4;HHSteC: 3.7;RT4: 1.9"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA072245: , HPA075539: "	"unprognostic (8.10e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.28e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-11)"	"unprognostic (2.02e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.34e-3)"	0.1	0.4	0.1	0.1	0.0	0.0	2.6	0.1	0.1	0.0	0.7	0.0	0.0	0.1	0.3	0.1	0.2	0.0	3.9	0.0	0.1	0.0	2.8	82.6	0.6	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.4	1.9	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.4	3.7	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	135.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	18.4	0.1	0.0	0.0	4.9	3.7	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1
CYP4B1		ENSG00000142973	"Cytochrome P450 family 4 subfamily B member 1"	P13584	1	46757838-46819413	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 92.0"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 1140.4;Ciliated cells: 602.3;Club cells: 304.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 56.9"	"Region enhanced"	"Detected in single"		"midbrain: 1.7"	"Cell type enriched"	"Detected in single"	11	"memory CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Cell line enriched"	"Detected in some"	8	"RT4: 81.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004331	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA004331: AB_1078616"	"unprognostic (2.29e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (7.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.12e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.22e-3)"	"unprognostic (6.69e-3)"	41.6	2.2	0.0	0.6	0.1	0.3	45.5	0.1	0.3	9.5	6.7	0.1	7.2	0.7	2.1	2.8	17.9	18.5	0.8	13.5	0.0	0.0	1.4	0.2	92.0	1.5	1.7	0.1	3.3	0.9	0.5	4.8	0.9	0.8	15.4	0.5	2.8	5.0	6.9	14.4	10.4	3.4	6.8	3.5	0.5	3.0	1.7	0.1	0.7	12.7	4.5	5.7	36.5	18.9	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.5	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.0	1.7	0.1	0.8	0.1	1140.4	70.0	0.0	114.6	0.5	0.0	4.8	0.0	602.3	304.8	0.0	0.0	0.9	0.0	0.0	0.5	2.1	0.0	0.0	0.0	0.2	4.7	3.9	5.8	0.0	0.6	0.0	0.0	2.5	0.0	0.8	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	3.6	0.7	0.0	0.0	142.5
CYP4F11		ENSG00000171903	"Cytochrome P450 family 4 subfamily F member 11"	Q9HBI6	19	15912367-15934867	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 88.6"	"Cell type enhanced"	"Detected in many"	17	"Ductal cells: 13.3;Hepatocytes: 48.8;Urothelial cells: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 7.6;CAPAN-2: 30.3;EFO-21: 11.4;Hep G2: 14.7;RPMI-8226: 7.9;RT4: 9.1"									"HPA017265, CAB033648, HPA058960"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB033648: AB_2088410, HPA017265: AB_1847451, HPA058960: AB_2683862"	"prognostic favorable (4.05e-4)"	"unprognostic (4.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.99e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (4.44e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.78e-2)"	"unprognostic (4.64e-2)"	0.4	2.2	3.6	0.5	4.4	0.5	1.7	1.8	5.4	1.1	2.5	4.4	0.0	7.5	0.5	11.8	7.9	2.2	12.9	0.4	3.9	1.4	4.9	88.6	2.4	0.4	2.1	3.8	0.3	3.5	0.2	0.6	0.2	8.3	2.4	1.9	0.6	2.6	3.4	0.5	0.8	15.7	0.2	9.7	0.9	2.7	1.0	3.0	0.0	2.2	2.8	1.8	4.8	2.0	0.1	0.1	0.8	1.2	0.0	0.2	0.1	7.6	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.1	11.4	0.0	6.5	0.9	0.0	3.9	0.0	0.0	0.0	0.0	2.3	14.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	6.1	0.0	1.1	0.0	0.1	0.0	6.7	0.0	0.0	0.1	7.9	2.1	9.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.1	0.1	0.1	0.1	0.3	0.1	0.2	0.9	0.0	0.8	0.5	0.0	0.1	1.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.7	0.1	0.0	0.1	3.6	4.4	1.8	5.4	3.9	1.4	2.1	3.8	8.3	3.0	0.0	0.0	0.0	7.8	0.1	0.0	0.3	0.0	4.0	1.2	8.7	0.0	0.0	1.7	13.3	0.0	0.0	5.3	0.0	9.9	0.0	0.0	7.8	0.0	48.8	0.0	0.0	1.2	0.0	1.6	0.0	0.3	0.0	0.0	0.0	3.0	2.5	7.5	2.9	0.0	5.4	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	1.7	13.3
CYP4F12		ENSG00000186204	"Cytochrome P450 family 4 subfamily F member 12"		19	15672757-15697174	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"intestine: 53.0;liver: 24.2"	"Cell type enhanced"	"Detected in many"	16	"Enterocytes: 95.3;Paneth cells: 35.4;Undifferentiated cells: 26.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	39	"basophil: 5.3;eosinophil: 13.2"	"Lineage enriched"	"Detected in single"	76	"granulocytes: 13.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.6;HaCaT: 18.7;Hep G2: 5.2;Karpas-707: 12.6;OE19: 27.1"									HPA058960	Approved					NA	NA					"HPA058960: AB_2683862"	"unprognostic (4.30e-4)"	"prognostic favorable (1.21e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.32e-3)"	"unprognostic (1.84e-3)"	"unprognostic (9.13e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-3)"	"unprognostic (6.20e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (2.33e-4)"	1.9	0.7	1.6	6.1	0.9	0.6	3.5	0.0	1.9	3.9	24.6	5.6	1.4	24.6	1.4	1.8	11.5	2.1	10.8	1.7	1.9	0.3	1.1	24.2	0.9	0.3	3.0	3.5	1.9	0.2	0.1	0.3	0.4	2.7	4.4	5.1	1.4	3.0	1.5	0.4	12.9	53.0	5.1	0.8	0.7	8.0	0.4	4.8	0.2	0.6	8.9	6.3	10.1	6.5	0.0	0.0	13.2	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.3	0.0	0.0	0.1	18.7	0.0	0.0	0.0	1.0	0.0	0.0	0.7	5.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.3	0.0	13.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.9	0.0	1.9	1.9	0.3	3.0	3.5	2.7	4.8	0.0	2.6	0.8	10.1	12.5	0.0	1.0	5.1	2.7	0.0	0.0	0.0	0.1	0.0	0.3	1.1	1.5	95.3	0.0	0.0	0.1	3.0	2.8	0.0	24.2	0.4	0.0	7.5	0.6	0.3	2.2	3.7	0.0	1.7	0.0	24.4	2.7	1.1	35.4	1.1	2.1	0.0	0.0	0.8	0.1	0.0	18.4	0.2	0.7	26.0	18.3
CYP4F8		ENSG00000186526	"Cytochrome P450 family 4 subfamily F member 8"	P98187	19	15615218-15630638	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	155	"ductus deferens: 265.6;seminal vesicle: 360.6"	"Cell type enhanced"	"Detected in some"	14	"Glandular cells: 1.7;granulocytes: 1.1;Urothelial cells: 2.4"	"Group enriched"	"Detected in some"	31	"breast cancer: 2.5;prostate cancer: 3.3;urothelial cancer: 10.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"OE19: 2.1;RT4: 1.6;SK-BR-3: 4.4"									HPA058960	Approved					NA	NA					"HPA058960: AB_2683862"	"unprognostic (1.70e-2)"	"unprognostic (5.46e-3)"	"unprognostic (3.21e-2)"	"unprognostic (3.97e-6)"		"unprognostic (3.51e-3)"				"unprognostic (2.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.25e-2)"		"unprognostic (1.15e-2)"			"unprognostic (1.02e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	265.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	360.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.8	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.4
CYP4X1	MGC40051	ENSG00000186377	"Cytochrome P450 family 4 subfamily X member 1"	Q8N118	1	47023568-47050751	"Enzymes, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 38.1"	"Cell type enriched"	"Detected in many"	6	"Ciliated cells: 156.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.7;CACO-2: 6.2;NTERA-2: 2.9;SCLC-21H: 3.8;T-47d: 13.5"	"Low region specificity"	"Detected in all"							HPA017661	Approved					NA	NA					"HPA017661: AB_2669633"	"unprognostic (1.19e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.56e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (8.56e-2)"	"unprognostic (5.03e-2)"	7.9	3.6	9.0	1.1	14.9	0.5	16.0	7.1	16.9	38.1	2.0	1.6	2.5	2.1	3.6	3.2	12.0	9.7	2.0	6.7	4.8	10.6	6.3	10.0	8.9	2.0	3.3	13.5	1.7	2.0	2.0	4.1	1.5	7.8	8.0	2.3	17.6	23.7	3.4	4.5	5.0	1.8	2.4	2.0	1.0	14.3	4.2	0.9	0.0	4.0	6.9	8.8	3.9	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.2	0.1	0.0	0.1	0.0	0.0	6.2	0.0	0.0	0.7	0.0	1.7	0.0	0.0	0.0	0.0	0.5	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.9	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	2.9	1.0	0.0	0.0	0.5	0.0	0.6	0.2	3.8	0.0	0.0	0.3	0.0	0.2	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	14.9	7.1	16.9	4.8	10.6	3.3	13.5	7.8	0.9	20.8	10.5	0.0	23.5	2.3	0.9	1.0	0.0	156.6	27.3	0.0	0.0	0.0	0.0	0.3	6.0	2.3	0.0	0.0	0.6	0.0	1.9	10.7	0.0	2.5	2.9	0.0	0.0	0.6	0.3	5.6	9.8	0.6	5.0	0.0	0.0	0.0	0.2	0.0	19.4	1.3	0.7	0.0	14.5	0.0	1.5	1.3	0.1	0.0	0.6	26.2
CYP4Z1	CYP4A20	ENSG00000186160	"Cytochrome P450 family 4 subfamily Z member 1"	Q86W10	1	47067488-47118319	"Enzymes, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"breast: 23.1"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 1: 8.9"	"Cancer enriched"	"Detected in some"	50	"breast cancer: 42.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	39	"HDLM-2: 13.7;SK-BR-3: 5.9"															NA	NA						"unprognostic (4.11e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.33e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.53e-3)"		"unprognostic (7.76e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.53e-1)"	"unprognostic (6.82e-3)"	"unprognostic (5.09e-3)"	"unprognostic (3.88e-2)"	"unprognostic (6.46e-2)"	"unprognostic (3.49e-3)"	2.5	0.2	0.4	0.4	0.9	0.0	23.1	0.4	2.0	1.0	0.4	0.4	0.4	0.0	0.4	0.8	0.8	0.7	0.4	0.4	0.4	1.8	0.4	1.5	2.1	0.4	0.4	0.4	0.4	0.4	0.3	0.4	0.4	0.7	1.3	0.0	0.4	1.5	0.8	0.5	2.2	0.4	0.4	0.4	0.4	0.2	1.0	0.4	0.6	0.4	0.4	0.5	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.4	2.0	0.4	1.8	0.4	0.4	0.7	0.4	8.9	0.6	0.0	0.4	0.1	0.0	0.2	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6
DAGLA	"C11orf11, DAGLALPHA, KIAA0659, NSDDR"	ENSG00000134780	"Diacylglycerol lipase alpha"	Q9Y4D2	11	61680433-61747001	"Disease related genes, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.0"	"Cell type enhanced"	"Detected in many"	5	"Mucus-secreting cells: 5.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.4;intermediate monocyte: 1.9;non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 11.2;T-47d: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062497, CAB078793"	Approved	Supported				NA	NA					"CAB078793: , HPA062497: AB_2684784"	"unprognostic (2.53e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.13e-7)"	"unprognostic (1.23e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.14e-4)"	"unprognostic (2.22e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.99e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-2)"	3.7	2.5	7.2	2.8	13.3	1.1	3.0	12.0	22.0	3.1	6.0	3.6	3.1	4.4	2.7	3.8	4.7	3.8	2.9	3.8	8.6	6.0	2.3	0.5	3.2	1.3	3.7	7.4	1.2	8.8	1.7	3.3	1.7	4.5	3.5	3.7	2.5	7.9	4.0	3.1	1.1	5.2	3.2	1.4	3.4	2.9	3.3	2.7	0.0	1.6	2.0	1.0	1.7	1.4	0.0	0.8	0.0	1.9	0.0	0.1	0.3	5.4	6.2	4.8	1.0	1.1	1.8	0.8	2.6	0.7	2.9	3.1	3.6	11.2	0.0	2.6	2.3	4.5	3.2	0.8	0.0	1.2	0.0	3.2	0.0	4.6	5.5	1.8	0.0	1.0	0.9	0.3	3.7	0.0	1.7	0.8	0.4	0.0	0.0	1.3	2.6	0.0	0.0	9.9	1.9	6.0	0.0	0.7	0.0	1.0	1.3	10.0	5.5	1.4	2.4	1.7	1.2	12.3	3.1	3.4	1.9	8.7	5.2	3.0	0.0	0.0	0.0	5.2	1.4	3.0	0.0	1.4	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.3	7.2	13.3	12.0	21.5	8.6	6.0	3.7	7.4	4.5	2.7	3.0	0.3	0.0	0.3	0.3	1.1	0.7	0.0	0.0	2.3	3.5	0.0	0.0	0.0	1.5	0.0	0.6	3.1	0.0	1.9	0.1	0.5	0.7	0.0	0.0	2.2	0.0	4.1	2.5	3.3	0.0	1.7	2.7	0.0	0.0	5.6	1.7	2.4	0.0	3.9	0.4	0.3	0.0	0.4	1.2	2.9	0.3	0.0	0.0	4.5	0.0
DAGLB	"DAGLBETA, KCCR13L"	ENSG00000164535	"Diacylglycerol lipase beta"	Q8NCG7	7	6409126-6484190	"Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069377			Supported	"Nucleoplasm,Plasma membrane"		No	No			"Plasma membrane"	Nucleoplasm	"HPA069377: AB_2686132"	"unprognostic (2.39e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (7.18e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-2)"	20.1	28.2	12.6	12.7	20.3	25.8	29.8	18.4	26.1	19.1	18.0	11.4	19.4	15.1	14.3	17.5	16.2	12.5	26.6	18.9	12.4	13.8	24.0	88.0	18.4	25.2	11.6	5.8	22.5	47.0	14.2	19.0	45.7	7.5	14.6	10.6	14.6	34.1	22.3	22.0	22.1	31.3	16.0	13.2	15.1	14.0	27.1	7.9	7.2	23.1	15.1	16.8	15.6	20.8	5.6	18.9	13.6	14.7	2.4	8.4	7.5	10.9	12.5	5.4	7.0	8.2	6.4	4.3	15.4	10.5	13.3	14.4	6.6	12.0	5.9	6.7	7.4	32.5	16.2	8.8	8.1	7.6	2.7	6.1	3.1	14.3	4.5	8.8	8.9	5.0	5.7	13.5	8.9	8.8	5.3	5.7	7.6	8.9	2.9	7.8	7.7	3.1	12.6	19.7	5.4	9.5	27.4	6.2	12.7	8.4	4.0	7.0	4.2	8.7	13.4	2.5	9.0	9.3	16.7	7.0	11.5	21.9	14.4	7.1	3.1	5.6	5.0	5.7	14.0	13.9	6.2	14.7	13.6	4.4	13.9	3.9	5.6	3.5	2.9	18.9	3.6	8.4	4.8	7.3	2.4	12.2	3.2	2.9	7.5	12.6	20.3	18.4	23.4	12.4	13.8	11.6	5.8	7.5	7.9	8.9	13.0	3.9	2.8	14.9	4.2	2.4	2.5	2.7	3.4	5.2	2.0	4.4	0.0	6.2	0.4	6.7	10.9	0.0	5.3	7.7	4.6	4.6	3.5	6.2	14.7	0.0	2.4	8.0	15.4	0.9	5.8	15.3	5.0	11.8	4.7	0.9	9.2	5.8	2.1	1.8	4.5	0.0	5.7	7.2	6.8	11.7	10.4	5.3	6.3	3.2
DGAT1	"ARGP1, DGAT"	ENSG00000185000	"Diacylglycerol O-acyltransferase 1"	O75907	8	144314584-144326910	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"intestine: 161.0"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 291.1;Paneth cells: 112.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 15.8;PC-3: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032853	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoli	"CAB032853: AB_2090798"	"unprognostic (9.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-3)"	11.8	18.5	3.6	5.7	4.7	6.4	6.8	6.6	5.6	3.3	60.2	4.0	6.4	44.7	3.9	3.6	5.5	3.1	7.9	6.3	3.7	2.7	6.7	14.4	3.8	3.1	4.1	2.7	3.3	3.9	5.0	4.0	4.3	3.6	3.4	6.3	4.1	5.9	4.3	10.0	4.8	161.0	3.6	2.6	5.3	5.7	10.7	4.2	5.1	3.8	6.2	5.0	4.7	3.4	0.7	2.2	2.8	2.0	0.3	1.7	0.8	3.8	4.2	2.0	3.6	3.2	1.3	2.3	2.8	2.7	2.6	1.8	9.7	2.6	1.5	10.7	1.7	1.3	3.3	1.6	3.8	0.6	2.8	4.0	2.8	3.4	15.8	2.3	0.7	2.9	1.8	2.9	1.7	1.9	1.8	2.0	4.9	2.2	3.6	1.7	3.2	4.8	3.1	0.9	9.2	17.6	6.3	0.8	2.5	2.4	2.1	2.0	3.4	3.6	4.4	1.8	0.8	2.5	2.7	1.6	1.4	4.9	2.8	2.2	2.1	0.4	0.6	1.5	4.9	2.3	0.0	2.0	2.8	1.2	1.3	1.7	0.7	0.9	1.1	2.2	0.5	0.7	0.3	2.3	0.3	1.7	1.1	0.7	0.8	3.6	4.7	6.6	5.6	3.7	2.7	4.1	2.7	3.6	4.2	14.9	21.3	6.5	9.8	7.1	24.2	17.9	15.3	4.0	7.9	17.4	27.5	10.2	1.7	6.8	13.4	13.5	291.1	0.0	10.4	8.3	7.1	8.8	6.9	49.5	16.5	17.5	22.4	10.4	25.4	16.4	6.4	15.0	5.0	1.0	70.1	18.1	11.4	112.2	6.3	6.8	21.9	0.0	10.5	25.1	15.9	8.2	13.7	8.5	84.8	18.4
DGAT2		ENSG00000062282	"Diacylglycerol O-acyltransferase 2"	Q96PD7	11	75759512-75801535	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 104.3;blood: 68.9;liver: 81.3"	"Cell type enhanced"	"Detected in many"	19	"Early spermatids: 192.0;Hepatocytes: 104.6;Late spermatids: 49.3;Spermatocytes: 45.4;Spermatogonia: 49.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 19.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"eosinophil: 26.3;neutrophil: 68.9"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 68.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 30.3;HDLM-2: 22.0;Hep G2: 22.9;OE19: 44.2"	"Low region specificity"	"Detected in all"							HPA013351			Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA013351: AB_1847630"	"unprognostic (2.28e-1)"	"unprognostic (3.69e-1)"	"unprognostic (9.38e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.59e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.49e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.60e-2)"	104.3	1.3	1.9	12.5	6.8	1.7	30.4	0.1	4.2	1.0	11.8	0.6	0.4	3.6	0.5	0.6	6.3	0.7	6.3	6.0	1.0	1.2	1.0	81.3	1.8	16.1	0.6	1.2	0.6	1.3	0.4	0.6	0.5	1.0	1.0	1.4	1.2	9.9	0.6	1.3	34.1	8.1	0.9	0.6	3.7	3.3	13.6	0.5	1.0	2.4	3.9	4.5	4.0	2.7	1.5	1.1	68.9	4.2	0.0	0.0	0.9	4.6	2.3	0.1	4.0	30.3	2.4	0.3	0.4	0.5	0.6	0.3	16.7	4.9	7.4	6.2	0.1	4.4	0.1	0.6	2.3	1.6	22.0	0.4	0.5	1.6	22.9	0.3	2.6	2.6	10.1	12.4	2.7	3.9	1.6	0.4	7.5	0.4	10.1	0.2	3.0	1.7	5.7	1.3	44.2	10.9	0.0	0.0	8.7	0.4	12.9	8.3	0.5	4.2	0.7	1.0	1.0	1.6	9.3	0.5	5.3	2.6	0.1	3.2	5.9	13.2	9.9	3.8	8.4	9.0	3.0	4.2	26.3	0.0	0.8	0.0	1.5	0.0	0.0	1.1	1.2	0.0	0.0	68.9	0.0	0.8	0.3	0.0	0.9	1.9	6.8	0.1	4.2	1.0	1.2	0.6	1.2	1.0	0.5	6.0	4.8	3.4	0.8	1.0	0.6	3.4	0.0	1.4	1.2	0.0	2.0	0.5	0.0	1.4	192.0	0.3	0.4	0.0	0.4	0.1	0.8	2.0	0.0	104.6	2.3	1.6	1.2	1.3	5.6	49.3	2.0	1.7	1.7	0.0	5.0	0.5	2.1	2.6	0.7	1.7	0.0	6.5	0.3	45.4	49.4	6.9	0.7	0.0	3.4	4.2
DHRS2	"HEP27, SDR25C1"	ENSG00000100867	"Dehydrogenase/reductase 2"	Q13268	14	23630115-23645639	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 79.9;prostate: 40.2;urinary bladder: 120.7;vagina: 47.1"	"Cell type enhanced"	"Detected in some"	11	"Extravillous trophoblasts: 10.3;Spermatogonia: 8.5;Syncytiotrophoblasts: 20.7;Urothelial cells: 11.9"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 141.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 49.9;RT4: 59.8;SK-BR-3: 292.6;U-2 OS: 95.8"	"Region enriched"	"Detected in single"	4	"cerebellum: 2.7"					"HPA053915, HPA069551"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	NA			Mitochondria	Nucleoplasm	"HPA053915: AB_2682307, HPA069551: AB_2686150"	"unprognostic (3.07e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (9.97e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (3.75e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (6.45e-4)"	0.1	0.3	0.3	0.0	0.2	0.0	79.9	0.1	0.2	0.5	0.1	0.1	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.3	0.8	1.8	5.0	0.2	0.0	0.2	0.0	9.0	5.9	0.3	0.5	5.0	0.1	40.2	0.0	0.1	20.1	0.6	0.1	0.7	0.1	23.1	0.3	3.7	0.8	0.9	0.0	0.0	0.1	0.0	0.0	120.7	47.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.4	0.0	0.0	0.2	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.1	20.1	1.5	0.1	0.0	49.9	0.0	0.2	1.8	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.4	2.2	0.1	0.4	0.1	0.0	59.8	0.2	0.3	0.4	292.6	0.3	0.0	0.2	0.0	0.0	0.1	95.8	0.5	0.3	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.2	0.3	0.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	5.9	6.6	0.0	3.4	0.0	0.0	0.0	0.2	10.3	0.3	0.2	0.0	0.8	1.6	0.0	3.4	0.0	0.8	3.0	0.0	0.0	0.0	1.0	0.0	0.0	6.7	0.0	1.1	0.1	1.0	6.5	0.0	0.0	8.5	0.1	20.7	0.0	0.5	11.9
DHRS3	"RDH17, retSDR1, Rsdr1, SDR1, SDR16C1"	ENSG00000162496	"Dehydrogenase/reductase 3"	O75911	1	12567910-12617731	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"gdT-cell: 33.5;MAIT T-cell: 24.2;memory CD4 T-cell: 18.3;memory CD8 T-cell: 15.7;myeloid DC: 8.6;naive CD4 T-cell: 31.6;naive CD8 T-cell: 19.7;NK-cell: 13.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 8.6;NK-cells: 13.8;T-cells: 33.5"	"Cell line enhanced"	"Detected in many"		"A549: 27.6;CAPAN-2: 56.6;hTERT-RPE1: 55.9;SK-BR-3: 30.4;WM-115: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010844	Supported		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA010844: AB_1847653"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (2.65e-4)"	"unprognostic (5.48e-2)"	22.7	4.4	6.3	6.2	8.6	2.5	30.6	4.0	7.9	16.7	16.3	3.4	9.2	13.6	7.6	15.5	19.0	12.2	11.2	16.1	6.8	8.6	12.3	45.6	11.6	8.3	9.0	4.5	11.8	20.3	0.5	8.9	11.5	9.8	16.3	5.6	20.3	11.8	14.3	10.2	5.6	18.9	11.1	9.8	4.2	12.3	5.2	4.2	3.1	40.5	5.4	5.2	21.0	9.4	0.2	8.6	2.1	0.3	13.8	33.5	15.6	4.8	27.6	0.0	12.2	16.0	1.3	3.2	1.6	0.0	0.0	0.1	3.3	56.6	0.0	1.3	16.2	4.9	22.3	6.0	3.1	0.0	0.0	9.9	4.3	2.8	15.4	2.4	0.0	0.0	8.1	3.7	0.0	0.1	55.9	5.2	0.1	6.5	0.0	0.1	0.8	1.1	0.2	1.8	5.2	11.2	0.1	0.0	5.6	0.0	9.5	0.3	0.5	9.3	30.4	1.7	3.9	2.9	1.2	3.8	0.1	0.6	8.5	0.1	0.8	0.0	0.0	6.4	0.3	52.5	2.1	0.2	0.0	33.5	0.1	24.2	0.2	18.3	15.7	8.6	0.2	31.6	19.7	1.7	13.8	0.3	1.0	0.5	15.6	6.3	8.6	4.0	7.9	6.8	8.6	9.0	4.5	9.8	4.2	89.3	49.3	3.7	141.7	22.8	0.8	31.9	38.2	58.9	55.7	19.2	17.7	22.8	19.9	81.6	86.2	36.5	70.9	23.3	142.3	39.4	26.7	66.3	15.1	157.8	60.3	0.0	24.1	62.0	40.2	235.9	21.0	19.3	6.8	17.2	30.8	13.7	112.0	49.1	9.2	39.4	2.0	0.0	30.1	1.4	1.4	23.6	22.0	22.3	29.9	124.6
DHRS4	"FLJ11008, humNRDR, SCAD-SRL, SDR-SRL, SDR25C2"	ENSG00000157326	"Dehydrogenase/reductase 4"	Q9BTZ2	14	23953586-23969279	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023972	Uncertain		Approved	"Nuclear membrane,Vesicles"		NA	NA			Vesicles	"Nuclear membrane"	"HPA023972: AB_1854890"	"unprognostic (1.21e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.65e-2)"	"prognostic favorable (4.55e-6)"	"unprognostic (2.03e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.68e-2)"	15.8	18.5	8.3	10.3	13.7	5.9	15.4	4.4	9.6	11.0	22.2	10.2	12.1	30.3	13.7	11.7	17.2	8.3	16.3	16.3	9.0	6.6	65.8	40.3	12.6	13.6	14.0	7.7	12.6	20.6	7.3	9.7	8.9	9.3	17.0	12.4	12.0	17.5	14.4	25.3	16.6	35.2	14.4	9.6	12.4	12.9	13.5	12.6	6.9	17.1	16.1	11.1	10.0	14.8	9.7	22.0	2.6	25.5	7.9	10.6	14.9	7.7	15.7	5.4	8.8	8.6	9.6	0.1	14.6	7.7	5.8	4.6	3.3	8.3	6.6	7.8	7.2	4.0	9.2	4.3	6.0	5.2	17.8	8.9	4.0	13.2	18.3	5.2	5.7	24.6	9.5	7.5	4.8	10.6	6.6	7.2	9.9	5.9	15.8	7.9	26.3	10.4	5.4	5.3	9.0	15.8	16.9	9.5	21.8	6.0	9.0	10.5	8.8	14.0	9.1	6.9	3.6	8.4	7.7	13.4	7.2	7.6	7.4	4.7	12.1	11.2	1.8	6.3	6.5	7.2	2.4	25.5	2.6	8.9	21.0	10.6	9.7	10.1	8.9	22.0	8.3	10.3	9.9	1.1	7.9	11.1	18.5	8.6	14.9	8.3	13.7	4.4	9.6	9.0	6.6	14.0	7.7	9.3	12.6	14.9	26.2	4.7	9.5	11.1	4.7	30.1	7.6	32.1	31.8	14.0	0.0	8.3	66.3	5.2	39.4	10.8	35.9	0.0	8.6	4.2	11.6	9.3	12.8	64.8	26.6	6.4	18.5	16.0	34.4	43.6	10.3	34.4	5.0	3.6	41.8	12.8	6.6	7.0	16.3	63.7	1.6	6.5	11.3	27.0	2.0	11.7	3.2	14.1	63.5	9.0
DHRS4L2	SDR25C3	ENSG00000187630	"Dehydrogenase/reductase 4 like 2"	Q6PKH6	14	23969874-24006408	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Hepatocytes: 186.0;Proximal tubular cells: 502.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA023972	Uncertain		Approved	"Nuclear membrane,Vesicles"	"Secreted - unknown location"	NA	NA			Vesicles	"Nuclear membrane"	"HPA023972: AB_1854890"	"unprognostic (1.41e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.97e-3)"	"unprognostic (7.34e-2)"	"prognostic favorable (3.21e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.65e-2)"	6.3	11.2	6.9	12.8	7.9	3.0	11.4	14.6	9.6	7.2	9.9	3.4	2.6	12.1	5.6	10.4	25.5	5.4	4.3	8.9	5.0	4.1	42.0	33.0	16.7	7.2	4.6	2.4	7.1	28.4	6.0	5.2	3.1	7.6	8.3	9.5	5.4	14.2	10.9	18.7	9.8	14.9	6.4	5.6	8.1	7.1	28.2	4.5	13.8	5.9	32.8	14.5	5.3	7.1	10.4	22.3	3.2	27.2	7.9	11.5	14.7	8.5	12.9	2.2	11.0	21.4	22.4	0.2	7.7	15.3	11.3	8.4	3.7	10.1	5.6	5.3	15.5	7.3	9.3	9.9	12.9	9.4	18.2	6.0	1.3	11.2	23.0	15.8	7.1	22.2	23.1	16.4	7.3	10.8	7.8	13.2	17.3	4.3	19.9	12.1	26.9	17.7	7.4	4.4	20.1	14.3	28.0	9.1	17.4	16.2	11.3	12.0	7.2	10.6	9.8	6.4	4.9	11.8	10.7	9.3	6.0	6.2	7.0	3.9	11.6	9.2	1.6	5.2	10.3	8.5	2.3	27.2	3.2	10.1	22.5	10.4	10.4	10.8	11.5	22.3	8.2	11.1	10.1	1.3	7.9	13.2	18.3	10.3	14.7	6.9	7.9	14.6	9.6	5.0	4.1	4.6	2.4	7.6	4.5	14.9	23.5	21.4	38.6	24.6	9.7	15.1	17.8	32.1	23.9	24.4	2.0	16.3	107.8	33.6	16.0	33.7	49.1	23.3	48.9	6.2	41.2	29.1	17.3	186.0	120.7	11.1	35.8	45.4	59.2	31.0	40.6	42.6	49.0	45.9	56.0	58.7	33.6	63.1	35.0	502.2	6.9	32.3	38.1	8.9	1.4	35.1	10.9	27.3	69.8	32.0
DHRS9	"3alpha-HSD, RDH15, RDHL, RETSDR8, SDR9C4"	ENSG00000073737	"Dehydrogenase/reductase 9"	Q9BPW9	2	169064789-169096167	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.0;blood: 53.1;heart muscle: 32.2;intestine: 30.9"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 118.1;granulocytes: 85.8;Syncytiotrophoblasts: 223.7;Urothelial cells: 225.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 16.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 53.1;eosinophil: 23.9;neutrophil: 19.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 53.1"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 10.1;HUVEC TERT2: 8.9;NB-4: 14.7;THP-1: 42.9;TIME: 19.1;U-2197: 14.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA036491, HPA036667"	Approved				"Intracellular and membrane"	NA	NA					"HPA036491: AB_10673498, HPA036667: AB_10670237"	"unprognostic (1.15e-1)"	"unprognostic (3.82e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.62e-4)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (2.72e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.41e-1)"	40.0	0.1	1.3	14.9	1.0	3.3	2.2	0.3	1.9	4.0	30.9	1.1	0.8	0.6	1.3	0.9	12.8	0.6	2.3	32.2	1.2	0.8	0.4	1.0	9.6	8.0	2.5	1.1	1.2	1.4	0.0	0.3	4.9	1.1	3.5	20.9	0.6	2.9	0.3	1.0	1.5	2.7	3.5	2.4	4.0	4.6	12.3	0.6	0.9	0.5	23.2	12.0	3.7	4.6	1.7	5.4	53.1	6.1	0.0	0.1	1.3	0.0	0.3	0.0	0.0	1.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.7	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.4	0.2	0.2	0.6	2.7	10.1	8.9	0.0	0.4	0.0	0.0	0.0	0.0	14.7	0.0	0.1	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.9	19.1	0.0	0.1	14.1	0.1	0.0	0.0	0.0	0.3	7.7	0.0	53.1	5.4	23.9	0.0	6.1	0.1	1.7	0.0	0.0	5.4	1.0	0.0	0.0	19.5	0.0	1.2	0.4	0.0	1.3	1.3	1.0	0.3	0.7	1.2	0.8	2.5	1.1	1.1	0.6	0.0	2.2	0.9	6.8	1.4	0.0	26.4	0.0	57.6	10.3	0.0	0.0	1.7	0.0	0.3	118.1	0.6	34.9	0.0	21.0	1.1	1.1	5.5	85.8	0.5	25.7	0.0	1.7	0.0	5.7	33.8	1.1	6.4	0.0	0.0	38.5	3.5	40.1	9.5	0.4	0.0	0.0	6.5	0.1	0.7	0.6	1.3	223.7	0.0	1.3	225.8
GSTM1	"GST1, H-B, MU"	ENSG00000134184	"Glutathione S-transferase mu 1"	P09488	1	109687814-109709039	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 163.2;seminal vesicle: 101.4"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 8.9;Ciliated cells: 9.4;Club cells: 11.4;Ito cells: 8.0;Kupffer cells: 10.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 63.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 26.9;HeLa: 32.1;HHSteC: 25.7;hTEC/SVTERT24-B: 23.2;HUVEC TERT2: 19.7;MOLT-4: 34.6"									"CAB022669, CAB047357, HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Cytokinetic bridge"	"CAB022669: , CAB047357: , HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (2.22e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.72e-3)"	14.5	25.4	15.2	6.9	15.6	2.9	8.2	5.6	19.2	22.0	7.8	16.9	0.0	7.7	9.8	20.2	22.5	13.8	8.2	6.4	14.4	6.8	14.1	163.2	7.7	1.0	7.8	32.1	29.0	18.2	41.4	5.3	2.9	8.2	38.1	6.6	25.7	11.8	101.4	25.1	18.8	17.7	18.2	6.8	21.7	7.5	15.1	11.2	10.9	7.6	1.6	14.5	30.8	19.5	14.6	34.9	14.1	18.9	13.3	17.3	10.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	2.2	8.2	0.0	12.9	0.0	0.4	0.0	0.1	0.2	0.0	0.1	26.9	32.1	0.5	25.7	0.0	0.2	0.0	0.0	23.2	0.1	15.4	19.7	15.8	0.0	18.0	0.8	0.0	34.6	0.2	17.3	0.0	0.0	0.1	0.1	3.4	2.8	0.0	1.7	0.2	0.0	0.1	0.1	0.8	0.3	14.2	0.0	11.5	0.6	0.2	0.0	14.4	19.0	1.1	9.9	0.3	0.6	0.7	12.2	14.1	14.8	18.9	15.7	14.6	15.8	13.7	34.9	14.6	16.5	15.6	1.0	13.3	7.4	19.2	17.3	10.0	15.2	15.6	5.6	19.2	14.4	6.8	7.8	32.1	8.2	11.2	8.9	5.0	0.0	1.0	1.5	0.0	5.6	5.1	9.4	11.4	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	1.7	0.0	2.3	0.6	0.1	0.0	0.0	8.0	10.1	0.0	3.4	0.8	0.0	1.0	0.0	2.3	0.8	0.0	2.1	0.0	0.0	0.0	0.6	0.2	0.2	1.4	0.0	5.3	0.0	0.1
HSD11B1L	"SCDR10, SDR26C2"	ENSG00000167733	"Hydroxysteroid 11-beta dehydrogenase 1 like"	Q7Z5J1	19	5680604-5688523	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 34.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 17.2"					"Low region specificity"	"Detected in all"			HPA049078			Supported	Vesicles	"Secreted in brain"	NA	NA			Vesicles		"HPA049078: AB_2680622"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.73e-3)"	"unprognostic (5.26e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (4.38e-4)"	"unprognostic (4.81e-3)"	"unprognostic (6.63e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (4.52e-1)"	"unprognostic (1.73e-2)"	3.9	8.8	34.4	2.1	19.2	4.7	5.0	10.3	29.7	3.9	2.9	5.4	3.7	2.6	3.6	8.5	2.2	7.6	4.8	3.8	25.4	16.1	6.7	3.5	4.4	2.3	11.7	20.4	6.1	6.2	5.8	8.5	2.5	10.7	4.0	1.9	3.2	9.1	6.9	15.0	6.9	2.9	2.7	6.0	2.6	3.3	4.3	7.5	0.0	6.6	1.3	1.8	2.5	2.2	2.5	4.8	2.5	5.8	1.4	4.5	1.7	2.9	2.8	10.4	1.9	4.9	5.3	2.1	2.2	4.5	1.0	4.5	1.3	2.9	0.7	4.9	1.9	0.8	1.5	1.2	1.6	1.0	2.4	3.1	1.9	2.5	1.8	3.4	0.7	7.1	5.2	3.5	1.6	1.5	9.6	1.6	4.4	1.9	2.8	4.2	0.4	1.8	2.0	2.8	12.5	3.3	3.3	0.4	2.5	8.7	0.7	2.8	17.2	0.5	1.5	11.0	3.8	2.4	0.6	2.8	2.6	4.6	4.4	1.8	6.9	2.3	0.8	7.2	1.1	2.0	1.7	2.5	0.2	1.2	5.8	1.6	1.2	3.2	3.6	2.3	2.5	4.5	3.9	2.5	1.4	2.9	4.8	0.9	1.7	34.4	19.2	10.3	29.7	25.4	16.1	11.7	20.4	10.7	7.5	0.0	1.6	0.8	7.6	7.2	11.2	2.0	5.1	13.4	4.5	22.7	13.7	4.0	13.3	8.9	6.8	3.8	3.8	0.0	4.1	3.9	8.9	8.0	10.3	3.2	4.2	7.9	24.6	8.0	2.8	9.6	6.6	3.6	5.0	2.8	4.3	17.0	4.8	2.8	12.0	23.7	11.7	0.0	9.9	10.3	10.6	8.9	2.4	3.3	3.5	7.5
HSD11B2	SDR9C3	ENSG00000176387	"Hydroxysteroid 11-beta dehydrogenase 2"	P80365	16	67430652-67437553	"Disease related genes, Predicted membrane proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 62.8;kidney: 119.9;salivary gland: 66.0"	"Group enriched"	"Detected in many"	5	"Collecting duct cells: 181.5;Enterocytes: 273.5;Mucus-secreting cells: 229.5;Paneth cells: 137.2;Syncytiotrophoblasts: 95.8;Undifferentiated cells: 114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 8.7;OE19: 21.3;RPMI-8226: 10.2;RT4: 10.3;SCLC-21H: 11.4;SK-BR-3: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB032443, HPA042186, HPA056385"	Enhanced		Approved	"Nucleoplasm,Lipid droplets"		NA	NA			"Lipid droplets"	Nucleoplasm	"CAB032443: AB_2233199, HPA042186: AB_2677888, HPA056385: AB_2683110"	"unprognostic (2.87e-3)"	"unprognostic (5.24e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.55e-2)"	"unprognostic (9.29e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (9.51e-5)"	"unprognostic (7.20e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.84e-1)"	0.4	1.0	0.6	22.2	2.3	0.0	3.2	2.0	1.7	4.8	42.8	0.3	1.3	9.4	3.8	3.6	2.5	2.4	8.3	0.5	0.5	0.1	119.9	1.2	2.3	0.7	0.3	0.8	4.8	2.1	0.0	0.4	42.3	1.1	3.7	24.5	0.4	66.0	1.4	0.4	13.8	62.8	4.3	0.3	1.5	2.1	1.4	1.3	0.5	3.8	3.3	1.6	1.5	4.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.8	0.3	1.1	0.1	1.3	2.8	0.0	0.0	0.1	0.1	4.5	1.0	0.0	2.1	0.0	0.1	5.8	3.9	0.4	0.0	0.0	1.3	0.0	0.5	4.8	0.4	0.5	0.0	1.3	2.3	0.2	0.0	0.0	0.0	3.5	0.3	0.0	0.0	2.8	0.1	0.1	8.7	21.3	0.7	0.0	0.1	10.2	0.4	10.3	11.4	0.7	0.6	10.2	0.4	1.0	4.9	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	2.3	2.0	1.7	0.5	0.1	0.3	0.8	1.1	1.3	0.0	0.3	0.0	8.0	1.3	0.0	0.5	33.1	0.0	1.2	181.5	0.0	0.8	38.1	1.7	0.1	0.0	273.5	0.0	2.7	0.7	3.1	15.6	9.2	1.3	1.3	0.0	25.8	1.3	0.0	0.0	23.6	0.0	1.7	0.0	229.5	0.0	0.8	137.2	6.3	14.6	0.0	12.9	0.4	0.2	1.0	3.0	95.8	0.0	114.3	5.7
HSD17B11	"17-BETA-HSD11, 17-BETA-HSDXI, DHRS8, PAN1B, RetSDR2, SDR16C2"	ENSG00000198189	"Hydroxysteroid 17-beta dehydrogenase 11"	Q8NBQ5	4	87336610-87391386	"Enzymes, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 100.1;intestine: 81.3"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 489.8;Paneth cells: 501.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 100.1"	"Group enriched"	"Detected in all"	4	"granulocytes: 100.1;monocytes: 25.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 68.5"	"Low region specificity"	"Detected in all"							HPA021608	Enhanced		Supported	"Lipid droplets"	"Intracellular and membrane"	NA	NA		14000	"Lipid droplets"		"HPA021608: AB_1847660"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.53e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-2)"	22.0	23.8	11.1	15.5	8.4	23.6	18.9	23.8	12.8	19.6	58.3	7.2	9.5	53.0	19.1	15.7	6.5	14.6	26.3	9.0	10.1	6.4	18.1	57.4	25.3	14.7	14.2	7.9	18.0	24.5	3.0	12.6	11.4	9.7	15.5	36.2	5.7	6.7	9.0	6.4	6.2	81.3	15.2	14.2	12.2	11.6	11.6	10.6	15.8	8.1	8.4	8.2	21.0	15.9	7.7	14.2	100.1	25.8	10.4	10.3	18.7	0.2	10.7	5.2	13.1	16.1	22.2	7.4	5.8	9.1	3.8	7.0	8.9	68.5	0.0	11.2	5.9	3.6	0.2	15.2	1.2	4.2	16.9	3.2	14.7	5.9	30.0	9.1	26.2	27.5	15.7	0.4	5.2	1.8	12.1	7.3	6.4	15.3	7.6	7.0	0.4	5.3	32.1	8.9	33.3	1.8	14.7	4.8	17.3	10.5	16.4	1.7	16.7	11.4	0.3	19.5	7.0	0.0	25.6	6.1	2.6	11.8	10.5	3.0	3.7	1.5	1.6	4.9	18.6	17.8	61.0	25.8	55.9	8.7	18.4	10.3	7.7	8.8	9.0	14.2	6.6	8.1	9.0	100.1	10.4	15.2	4.8	9.9	18.7	11.1	8.4	23.8	12.8	10.1	6.4	14.2	7.9	9.7	10.6	291.8	133.2	72.8	64.6	24.8	1.2	4.4	310.8	75.0	111.5	41.8	2.0	27.4	21.6	38.6	0.9	71.4	489.8	0.0	51.8	45.8	75.4	36.7	98.1	303.2	118.3	17.5	90.0	101.9	213.8	0.9	96.4	169.0	64.1	36.1	155.1	34.2	52.9	501.0	55.9	148.1	3.9	71.1	54.2	2.6	13.1	18.7	12.5	110.7	226.2	80.0
HSD17B14	"DHRS10, retSDR3, SDR47C1"	ENSG00000087076	"Hydroxysteroid 17-beta dehydrogenase 14"	Q9BPX1	19	48813017-48836678	"Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 44.3"	"Cell type enhanced"	"Detected in many"	19	"Distal tubular cells: 66.3;Hofbauer cells: 120.5;Proximal tubular cells: 271.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"B-cells: 5.9;NK-cells: 7.5;T-cells: 4.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 23.0;HHSteC: 21.7;hTERT-RPE1: 16.3;Karpas-707: 24.6;RT4: 17.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA021467	Approved					NA	NA					"HPA021467: AB_1847652"	"unprognostic (2.03e-1)"	"unprognostic (7.94e-3)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (4.32e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.76e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.04e-1)"	"prognostic favorable (2.87e-5)"	"unprognostic (4.56e-1)"	"unprognostic (5.50e-3)"	"unprognostic (9.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.81e-2)"	5.9	25.7	15.5	2.9	16.2	1.4	4.2	20.2	14.1	11.5	4.1	9.7	3.7	3.3	13.2	8.1	3.3	8.3	9.2	4.8	10.5	13.5	44.3	24.0	11.6	5.7	11.9	15.8	32.2	6.0	15.3	9.2	6.5	9.8	8.0	2.1	34.4	2.6	8.1	1.3	3.4	3.7	7.3	9.0	6.7	3.2	4.5	7.1	5.0	16.6	3.2	3.5	7.8	8.0	5.9	0.7	0.0	0.0	7.5	4.8	1.3	0.0	6.0	6.0	1.0	7.1	1.1	0.1	1.1	8.3	0.5	0.5	5.5	0.1	3.7	6.2	0.2	23.0	0.0	0.6	0.0	0.6	0.2	0.4	1.6	0.1	0.8	21.7	0.0	9.7	8.4	0.2	0.6	0.2	16.3	7.8	2.1	0.0	24.6	0.0	0.2	0.5	0.2	0.5	3.5	4.1	3.3	0.0	0.7	0.0	17.6	1.6	4.1	0.0	0.8	4.6	2.6	0.2	0.2	0.0	0.1	2.3	0.2	0.0	4.2	7.8	0.2	5.3	0.6	0.0	0.0	0.0	0.0	1.4	0.0	2.1	5.9	2.6	1.1	0.0	4.5	4.8	3.6	0.0	7.5	0.0	0.7	0.7	1.3	15.5	16.2	20.2	12.8	10.5	13.5	11.9	15.8	9.8	7.1	3.0	8.6	1.5	3.1	2.3	5.0	1.4	0.0	0.0	3.4	7.0	0.0	1.0	66.3	1.4	0.3	3.6	0.0	0.0	1.0	2.1	11.5	3.7	6.9	26.6	120.5	11.1	12.7	21.5	7.6	0.9	3.7	13.5	20.3	13.6	0.0	38.4	4.0	0.0	6.7	271.8	1.4	0.0	4.1	0.9	7.0	1.6	1.8	2.2	0.0	2.3
HSD17B6	"HSE, RODH, SDR9C6"	ENSG00000025423	"Hydroxysteroid 17-beta dehydrogenase 6"	O14756	12	56752161-56787790	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 241.2"	"Cell type enriched"	"Detected in many"	10	"Hepatocytes: 1569.2"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 170.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 11.8;U-266/84: 14.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059141	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA059141: AB_2683922"	"unprognostic (7.70e-2)"	"unprognostic (8.76e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.79e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.74e-2)"	"unprognostic (2.50e-10)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-1)"	1.1	0.5	3.6	1.4	5.2	0.2	0.3	1.2	2.4	9.4	3.3	0.5	2.6	0.6	4.1	0.7	1.6	0.9	2.6	0.4	1.6	1.4	0.5	241.2	8.7	0.3	2.0	2.6	1.1	0.3	0.2	0.0	0.9	0.6	7.9	1.3	1.4	0.2	10.2	0.2	0.2	0.7	11.3	1.0	6.2	0.8	3.2	0.8	0.0	13.3	0.0	0.3	9.9	2.3	2.0	2.0	0.1	1.3	0.1	3.4	0.8	0.3	0.7	1.7	0.3	1.7	1.2	2.0	3.6	3.1	1.7	1.7	0.4	0.4	10.2	1.5	0.4	0.5	0.3	5.3	0.9	1.0	6.5	2.0	3.2	1.0	0.5	1.1	1.6	5.3	0.9	0.3	1.0	0.5	0.5	0.0	9.0	0.9	11.8	0.8	2.1	4.6	1.0	6.6	0.6	0.6	6.3	0.7	2.5	0.2	1.2	9.7	2.0	1.7	3.1	0.8	0.6	0.5	1.3	0.3	0.8	0.8	3.6	0.9	10.3	14.6	6.7	1.2	5.9	0.6	0.0	0.2	0.1	3.0	0.6	3.4	2.0	2.5	2.4	0.6	1.1	3.3	2.2	0.0	0.1	1.3	2.0	2.8	0.8	3.6	5.2	1.2	2.4	1.6	1.4	2.0	2.6	0.6	0.8	160.8	89.7	28.7	2.3	1.1	0.2	0.2	35.7	2.7	17.0	0.0	0.0	1.3	0.0	0.0	2.5	0.4	0.0	23.3	0.0	2.4	4.8	9.9	0.0	1569.2	0.3	0.0	0.0	31.3	41.1	1.5	11.5	0.1	0.0	1.8	0.3	1.0	0.1	0.0	1.4	0.0	0.6	12.9	3.7	13.6	10.6	1.4	0.3	4.4	0.3	0.9
HSD17B8	"D6S2245E, FABGL, H2-KE6, HKE6, KE6, RING2, SDR30C1"	ENSG00000204228	"Hydroxysteroid 17-beta dehydrogenase 8"	Q92506	6	33204642-33206831	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 47.8"	"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 106.1;Proximal tubular cells: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 14.8;T-47d: 9.6;U-266/70: 14.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042132	Enhanced					NA	NA		52000			"HPA042132: AB_10793978"	"prognostic favorable (9.99e-4)"	"unprognostic (4.24e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.11e-2)"	"prognostic favorable (1.90e-5)"	"unprognostic (1.50e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (2.18e-12)"	"unprognostic (2.82e-2)"	"unprognostic (5.57e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.23e-2)"	3.5	11.5	4.1	5.4	4.1	3.0	6.1	3.4	5.9	5.3	12.4	5.3	17.7	6.6	3.2	14.7	11.3	8.1	8.6	11.0	4.1	3.7	13.9	24.0	8.1	7.7	5.3	4.6	3.3	47.8	12.8	6.6	3.5	4.7	4.5	5.6	9.3	16.7	30.1	14.6	10.6	11.2	4.1	5.3	5.4	5.8	5.1	2.4	10.3	11.2	15.5	10.7	5.3	5.2	4.8	4.8	0.4	3.1	4.1	7.8	6.0	1.1	2.1	1.0	1.3	0.3	0.6	0.4	0.1	0.7	0.0	0.0	1.5	2.5	7.0	2.0	0.1	0.3	4.2	1.0	3.2	0.1	1.2	1.2	0.3	2.0	3.8	3.0	0.0	0.5	0.7	4.3	0.0	7.4	0.0	0.3	2.5	0.1	6.8	0.6	2.3	5.2	0.1	0.3	3.3	0.9	3.0	0.1	14.8	4.1	0.1	2.0	1.1	0.4	5.6	1.3	0.7	9.6	0.2	0.1	0.2	1.2	0.0	0.0	14.6	7.0	2.6	0.4	0.1	0.2	0.0	1.4	0.4	4.8	3.1	7.8	4.8	7.2	7.3	2.8	3.1	7.6	7.8	0.1	4.1	3.1	4.8	5.2	6.0	4.1	4.1	3.4	5.9	4.1	3.7	5.3	4.6	4.7	2.4	17.9	16.3	6.7	21.5	26.4	10.3	24.3	38.2	26.8	14.8	21.0	5.9	25.7	106.1	24.6	5.1	8.5	30.9	23.3	28.3	10.1	10.0	13.7	6.9	60.4	14.9	1.6	17.2	6.7	8.9	11.1	6.9	10.0	47.2	10.0	23.7	28.7	19.1	21.0	5.6	106.8	11.8	0.0	5.9	7.5	5.5	32.5	14.5	14.0	43.6	21.3
HSD3B7	"C(27)-3BETA-HSD, SDR11E3"	ENSG00000099377	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7"	Q9H2F3	16	30985207-30989152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	Oxidoreductase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.1"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 52.9;Hofbauer cells: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"basophil: 24.5;eosinophil: 13.5"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 24.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.6;Hep G2: 23.1;HMC-1: 35.9;U-2197: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015965, HPA050521, HPA060847"	Uncertain		Enhanced	"Lipid droplets"		NA	NA			"Lipid droplets"		"HPA015965: , HPA050521: AB_2681155, HPA060847: AB_2684379"	"unprognostic (5.41e-3)"	"unprognostic (4.14e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (1.60e-6)"	"unprognostic (2.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.79e-1)"	21.6	11.2	2.5	7.5	4.7	1.8	7.3	2.7	4.0	4.9	8.3	4.6	2.8	11.2	5.3	6.4	9.4	4.4	7.4	5.2	3.1	1.6	25.6	74.1	6.4	5.6	3.5	1.4	9.3	17.7	5.6	2.6	6.1	3.7	5.9	3.2	2.9	4.5	2.6	5.1	7.8	13.3	6.7	4.8	8.3	4.8	3.6	3.7	1.0	2.9	4.5	4.6	8.0	3.9	0.1	0.8	24.5	0.8	0.2	0.0	0.3	7.0	8.1	0.8	4.1	2.9	10.7	0.5	8.8	14.0	1.7	3.6	0.6	12.3	0.4	2.9	10.8	0.3	2.1	0.8	1.3	0.9	31.6	1.9	0.5	6.4	23.1	2.7	0.1	35.9	5.1	2.2	8.4	1.7	4.1	0.8	0.4	1.6	0.3	6.6	15.1	0.2	5.0	0.6	3.0	1.1	0.8	2.8	7.8	5.4	0.4	3.0	1.5	1.1	5.8	0.8	0.4	11.2	0.5	4.1	3.7	1.0	34.9	0.9	0.6	5.1	0.4	14.3	0.9	0.3	24.5	0.8	13.5	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.6	0.2	0.0	0.3	0.0	0.3	2.5	4.7	2.7	4.0	3.1	1.6	3.5	1.4	3.7	3.7	3.0	6.2	2.7	2.2	7.0	0.7	1.6	25.5	1.4	0.0	14.0	0.0	1.7	13.3	34.6	37.8	6.5	20.6	0.0	26.8	2.6	9.0	2.5	9.2	52.9	55.1	1.6	7.5	6.7	7.9	1.1	6.1	14.8	13.5	21.6	7.2	1.9	19.4	11.2	4.9	33.2	0.4	12.9	9.0	0.6	1.1	11.0	1.1	1.0	15.7	2.4
HTATIP2	"CC3, FLJ26963, SDR44U1, TIP30"	ENSG00000109854	"HIV-1 Tat interactive protein 2"	Q9BUP3	11	20363685-20383783	"Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Differentiation, Host-virus interaction"	"Developmental protein, Oxidoreductase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 60.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA006417, HPA024321"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA006417: AB_1079091, HPA024321: AB_1851288"	"unprognostic (8.05e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.79e-3)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (1.20e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (8.01e-4)"	"unprognostic (1.20e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	16.3	28.1	8.5	11.9	16.3	6.3	26.3	3.2	10.6	9.4	50.4	16.2	10.8	52.2	6.8	13.0	23.1	5.7	17.6	9.5	10.8	9.9	21.5	41.8	19.5	16.2	24.3	8.0	6.8	11.9	17.9	27.4	22.9	12.4	13.9	32.2	3.3	16.5	9.2	19.4	14.8	74.6	12.1	15.0	19.6	29.4	10.6	14.6	6.6	23.9	17.2	12.1	17.8	26.7	16.4	17.4	69.4	30.6	13.5	30.6	23.8	23.1	38.5	0.8	0.0	11.8	9.0	8.6	10.1	10.0	7.8	9.4	22.2	20.4	5.3	20.8	12.6	30.4	32.6	0.0	6.1	7.6	60.3	4.7	6.5	38.0	0.0	28.5	2.4	31.1	12.9	43.5	6.3	9.9	0.0	22.3	0.0	16.0	7.0	14.5	21.7	0.0	1.5	12.5	40.7	19.2	4.9	0.0	19.0	10.6	12.9	10.5	0.1	32.8	13.0	15.4	4.2	27.2	12.2	27.1	5.6	12.3	11.3	0.2	7.5	9.2	0.1	0.0	16.5	24.1	43.7	30.6	37.3	15.5	27.5	17.5	14.9	18.0	16.5	17.4	16.4	15.8	15.5	69.4	13.5	28.3	5.1	30.6	23.8	8.5	16.3	3.2	10.6	10.8	9.9	24.3	8.0	12.4	14.6	23.8	8.1	24.1	49.8	32.3	0.3	9.7	117.2	8.1	10.3	45.4	0.0	50.0	26.6	84.2	36.1	22.9	185.2	0.0	63.6	102.1	14.2	53.7	23.0	69.2	75.1	3.2	23.2	28.8	55.0	45.4	18.4	40.5	42.2	143.3	93.7	9.4	88.6	161.4	8.9	60.3	1.7	12.9	29.5	27.3	17.2	36.8	51.5	35.8	83.1	52.5
LIPC	"HL, HTGL"	ENSG00000166035	"Lipase C, hepatic type"	P11150	15	58410569-58569843	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 91.7"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 125.3"	"Group enriched"	"Detected in some"	14	"liver cancer: 20.4;renal cancer: 10.4"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"granulocytes: 3.7;NK-cells: 3.0;T-cells: 4.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 7.0;EFO-21: 5.3;Hep G2: 20.0;HMC-1: 5.9;MOLT-4: 4.5;U-2197: 15.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		3200000				"unprognostic (1.76e-2)"	"unprognostic (9.15e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.15e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.93e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.27e-2)"	0.2	0.1	0.4	1.1	0.7	0.0	0.7	0.1	0.4	0.3	0.2	0.6	0.0	0.7	0.1	0.4	0.2	0.4	0.3	0.3	0.4	0.2	3.0	91.7	0.3	0.2	1.2	0.2	0.3	1.0	0.0	1.0	0.1	1.5	0.3	0.3	0.5	0.1	1.5	0.1	0.3	0.3	0.1	1.2	0.4	0.2	0.1	0.5	2.7	0.5	0.0	0.1	1.1	0.2	0.1	0.2	3.7	0.4	3.0	4.5	2.5	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.7	0.0	0.0	7.0	0.0	0.0	5.3	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	2.5	0.0	20.0	0.4	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.1	4.5	0.6	0.0	0.0	0.0	0.9	0.3	0.0	2.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	15.8	0.0	0.0	0.0	0.1	0.1	0.4	0.0	3.7	0.3	0.0	3.0	0.2	4.5	0.0	0.8	2.2	0.2	0.1	1.0	3.2	0.4	3.0	0.4	0.1	2.1	2.5	0.4	0.7	0.1	0.4	0.4	0.2	1.2	0.2	1.5	0.5	0.0	0.0	5.1	0.0	0.2	0.0	0.8	12.7	0.0	1.2	3.5	0.0	0.0	5.0	3.7	0.0	0.0	0.0	0.0	3.3	0.0	1.2	0.2	0.0	125.3	0.1	0.0	0.0	5.5	4.0	0.0	0.3	0.0	1.7	1.0	0.0	0.0	0.3	0.0	0.0	9.6	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0
LIPE	HSL	ENSG00000079435	"Lipase E, hormone sensitive type"	Q05469	19	42401507-42427426	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid degradation, Lipid metabolism, Steroid metabolism, Sterol metabolism"	Hydrolase	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 207.4;breast: 65.1"	"Group enriched"	"Detected in many"	6	"Early spermatids: 123.5;Late spermatids: 188.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"ASC diff: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA006567, CAB017700"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"CAB017700: AB_2135504, HPA006567: AB_2667618"	"unprognostic (4.24e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.11e-1)"	"unprognostic (9.44e-2)"	"prognostic favorable (1.15e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.63e-10)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.34e-3)"	207.4	6.0	3.2	2.9	9.4	2.1	65.1	2.0	6.8	1.2	6.7	19.6	0.8	2.4	1.7	1.3	2.2	1.6	3.6	4.8	6.2	4.2	1.5	1.1	1.4	2.7	18.0	2.3	1.5	2.2	2.2	0.8	1.7	9.9	1.7	1.3	3.7	5.4	1.7	3.7	2.9	3.4	1.7	19.2	3.1	1.6	9.0	10.8	1.7	1.5	1.8	1.9	2.0	3.7	6.1	4.8	10.8	12.1	4.1	5.2	4.0	4.9	3.8	2.5	0.9	57.3	0.5	0.0	2.3	1.3	3.7	3.5	0.9	1.9	8.2	2.6	0.7	1.8	2.2	1.5	4.6	0.4	1.5	2.4	2.3	1.8	0.1	1.1	0.0	5.6	0.5	4.4	0.6	0.8	0.5	1.0	3.4	1.0	5.2	0.5	0.0	5.7	0.2	0.3	3.8	1.1	4.7	0.4	2.7	1.0	5.2	3.5	3.6	2.0	2.3	2.1	0.1	0.6	3.0	1.9	1.0	3.2	0.4	2.1	3.9	3.2	6.1	2.6	0.2	3.5	10.8	12.1	4.7	3.6	6.0	3.3	4.8	4.6	5.2	4.8	6.1	4.1	3.7	2.0	4.1	3.3	3.9	3.9	4.0	3.2	9.4	2.0	6.8	6.2	4.2	18.0	2.3	9.9	10.8	0.0	3.5	1.3	10.1	3.7	8.1	2.2	0.0	0.0	0.0	1.8	9.8	0.0	1.7	6.4	123.5	4.5	3.2	23.3	2.4	0.1	1.7	5.2	0.0	0.0	0.6	7.9	0.0	17.8	1.8	188.1	2.8	1.2	5.0	0.0	1.1	3.3	1.4	0.0	1.4	1.1	12.3	0.0	1.0	26.8	12.4	2.0	0.0	6.9	2.7	9.0
LIPF	"HGL, HLAL"	ENSG00000182333	"Lipase F, gastric type"	P07098	10	88664441-88678814	"Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"stomach 1: 762.9"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	75	"stomach cancer: 278.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.9"	"Cell type enriched"	"Detected in single"	16	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 6.4;MOLT-4: 5.0;NTERA-2: 5.3;REH: 3.1;THP-1: 10.0;U-2 OS: 3.6;U-266/70: 4.9"	"Region enriched"	"Detected in single"	51	"olfactory region: 9.9"					HPA045930	Enhanced				"Secreted to digestive system"	NA	NA					"HPA045930: AB_10959518"										"unprognostic (1.53e-1)"				"unprognostic (1.83e-1)"				0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.1	1.9	0.1	0.2	28.2	0.1	8.2	0.1	0.1	31.6	0.1	0.6	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	9.9	0.1	0.1	0.0	0.1	0.1	0.1	0.1	762.9	0.1	0.1	0.2	0.1	1.1	0.1	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.1	5.3	0.0	0.0	3.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	3.6	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	1.9	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
LIPG	EDL	ENSG00000101670	"Lipase G, endothelial type"	Q9Y5X9	18	49560699-49599182	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.0;placenta: 44.7;thyroid gland: 84.3"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 56.9;Extravillous trophoblasts: 60.0;Hepatocytes: 66.8"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 20.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 31.4;HaCaT: 48.1;RPTEC TERT1: 32.0;TIME: 62.4"	"Group enriched"	"Detected in many"	5	"amygdala: 3.7;basal ganglia: 2.1;cerebral cortex: 2.9;hippocampal formation: 1.8;olfactory region: 1.9"	"Low region specificity"	"Detected in many"			HPA016966	Uncertain				"Secreted to blood"	NA	NA	657000000	170000			"HPA016966: AB_1852893"	"unprognostic (2.20e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.25e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.35e-1)"	1.5	0.4	0.8	4.7	0.7	0.1	0.8	2.0	0.7	0.4	5.6	3.9	15.0	1.9	0.4	3.1	1.0	0.5	4.3	1.2	1.1	0.9	5.2	37.0	4.4	0.7	1.1	0.1	0.5	1.0	0.0	0.6	44.7	1.4	1.0	2.2	8.3	0.6	24.6	2.6	1.1	7.6	2.2	1.4	0.4	1.4	5.8	0.4	0.3	84.3	2.1	0.5	2.0	0.6	1.2	0.6	2.1	0.6	1.7	0.8	0.1	0.5	0.0	13.8	31.4	0.1	0.0	0.2	0.1	1.4	0.0	0.0	13.6	4.9	0.0	7.6	0.0	9.6	48.1	2.0	9.8	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.2	1.4	11.1	4.9	9.6	0.1	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.1	0.0	0.0	0.7	32.0	3.7	0.2	0.0	0.2	0.3	0.0	1.8	0.0	0.0	62.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.4	0.7	0.4	0.4	0.8	0.5	0.5	0.2	1.2	0.8	0.7	2.1	1.7	0.4	0.6	0.4	0.1	0.8	0.7	2.0	0.5	1.1	0.9	1.1	0.1	1.4	0.4	0.0	1.4	0.0	4.8	1.5	0.8	1.7	25.5	0.0	3.4	14.0	56.9	4.7	0.0	3.2	8.0	1.4	9.5	0.0	1.2	60.0	1.0	8.4	0.0	66.8	1.6	0.0	13.3	4.9	1.9	6.0	0.3	0.0	1.7	1.0	3.4	1.0	7.7	2.9	0.0	1.0	2.4	0.0	0.7	1.0	0.8	2.3	16.2	0.7	6.2	9.9
LRAT	LCA14	ENSG00000121207	"Lecithin retinol acyltransferase"	O95237	4	154626945-154753118	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction, Vision"	"Acyltransferase, Transferase"	"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 82.4"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 7.6;Early spermatids: 7.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"NTERA-2: 16.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA070726			Uncertain	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Endoplasmic reticulum"	"HPA070726: "	"unprognostic (3.64e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-4)"	"unprognostic (4.49e-6)"	"unprognostic (6.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.98e-1)"	0.9	0.8	2.2	0.8	3.2	1.8	1.4	0.7	1.1	0.9	4.2	3.0	0.8	3.7	0.5	1.2	0.5	0.9	2.3	0.6	3.1	4.2	0.6	3.3	1.0	0.5	2.9	2.4	1.0	2.9	0.3	1.0	0.3	8.9	1.6	0.4	82.4	0.5	1.6	2.3	1.4	11.1	0.3	7.0	0.7	0.9	2.9	3.1	0.0	4.9	0.2	0.6	0.5	0.7	0.9	3.7	2.0	4.5	0.6	0.3	3.9	0.7	0.5	0.4	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.3	0.0	0.2	0.0	0.0	0.1	0.8	0.6	0.1	0.1	0.2	0.5	0.4	0.3	0.1	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.3	16.5	0.0	0.0	0.1	0.0	0.1	2.0	0.5	0.1	0.0	0.2	0.1	0.2	0.3	0.1	0.0	0.0	0.4	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.2	0.5	1.0	4.5	0.4	0.3	1.6	0.3	0.5	0.3	0.3	3.7	0.9	0.3	0.3	2.0	0.6	0.5	0.5	0.2	3.9	2.2	3.2	0.7	1.1	3.1	4.2	2.9	2.4	8.9	3.1	0.0	4.1	0.0	4.2	1.0	0.8	0.2	7.6	0.0	1.2	0.0	0.0	0.1	3.3	0.8	7.2	0.2	2.0	0.0	0.7	0.1	0.3	2.4	0.0	2.0	0.1	0.0	0.0	1.8	0.0	1.6	0.0	0.0	5.0	0.0	0.7	3.7	1.4	0.0	0.0	0.3	0.9	0.0	0.1	4.8	4.5	1.0	0.2	0.7	0.3	0.6
MDH1B	"FLJ25341, RP11-95H11"	ENSG00000138400	"Malate dehydrogenase 1B"	Q5I0G3	2	206737763-206765547	"Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 26.7;testis: 27.6"	"Group enriched"	"Detected in many"	6	"Ciliated cells: 121.8;Early spermatids: 123.3;Spermatocytes: 50.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 7.2;SCLC-21H: 6.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073761	Approved					NA	NA					"HPA073761: AB_2732241"	"unprognostic (1.03e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.23e-3)"	"unprognostic (3.08e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.09e-2)"	"unprognostic (7.84e-3)"	"unprognostic (3.01e-1)"	0.9	2.3	3.1	0.7	9.0	0.6	1.9	1.5	5.7	2.0	1.1	5.0	3.6	0.5	2.5	6.6	1.1	26.7	1.5	1.9	3.4	4.2	4.2	0.6	3.6	0.8	2.4	3.5	4.5	1.1	6.3	15.1	0.5	9.5	1.3	1.1	2.8	1.7	2.2	0.9	1.0	0.6	1.5	1.6	0.6	1.1	27.6	1.8	0.1	5.2	0.0	0.7	0.9	0.5	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.7	2.4	1.8	4.9	0.4	2.3	0.7	0.0	0.9	1.0	0.7	0.2	1.6	1.1	1.1	0.2	2.2	1.1	0.1	1.4	1.0	0.1	0.1	0.5	0.4	1.5	1.1	0.8	2.5	1.4	0.5	0.1	0.3	1.1	1.4	2.3	0.1	1.4	0.7	2.9	1.5	0.6	3.2	0.3	2.9	3.1	1.8	0.1	7.2	0.3	6.9	1.5	2.2	1.1	0.6	1.1	2.2	0.0	0.1	1.2	1.2	0.3	0.6	0.7	2.9	0.4	2.6	0.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	3.1	9.0	1.5	5.7	3.4	4.2	2.4	3.5	9.5	1.8	6.0	1.0	0.0	1.2	0.7	3.0	1.2	2.5	121.8	6.8	0.0	0.0	0.1	11.6	0.7	123.3	0.2	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	0.1	3.2	1.2	0.0	0.0	17.1	1.7	0.2	1.7	0.0	0.0	7.7	0.1	0.0	2.8	5.1	9.9	0.0	1.0	50.4	4.0	0.3	0.0	0.0	0.0	0.4
PNLIP	PL	ENSG00000175535	"Pancreatic lipase"	P16233	10	116545931-116567855	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1895	"pancreas: 3207.8"	"Cell type enriched"	"Detected in some"	4	"Exocrine glandular cells: 3478.1"	"Cancer enriched"	"Detected in some"	4854	"pancreatic cancer: 2731.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.1;HDLM-2: 2.8;U-2 OS: 4.6;U-251 MG: 1.1;U-266/84: 1.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA062430, HPA062494"	Enhanced				"Secreted to digestive system"	NA	NA		13000000			"HPA062430: AB_2684761, HPA062494: AB_2684782"											"unprognostic (2.05e-2)"	"unprognostic (4.46e-2)"						0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	3207.8	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	1.1	0.0	1.5	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.5	0.0	0.0	0.0	3478.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	25.2	0.0	0.0	826.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PNLIPRP1	PLRP1	ENSG00000187021	"Pancreatic lipase related protein 1"	P54315	10	116590385-116609175	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2629	"pancreas: 516.5"	"Cell type enriched"	"Detected in some"	5	"Exocrine glandular cells: 576.9"	"Cancer enriched"	"Detected in single"	475	"pancreatic cancer: 32.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"EFO-21: 1.1;U-2 OS: 1.8;U-266/84: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to digestive system"	NA	NA		210000						"unprognostic (1.21e-1)"	"unprognostic (4.08e-3)"						"unprognostic (1.40e-1)"	"unprognostic (1.80e-1)"		"unprognostic (2.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.49e-1)"		0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	516.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	0.0	576.9	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	3.6	0.1	0.0	108.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.2
PNLIPRP3		ENSG00000203837	"Pancreatic lipase related protein 3"	Q17RR3	10	116427867-116477957	"Enzymes, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 8.5;breast: 15.9;esophagus: 12.0;skin 1: 15.5"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 1.0;Late spermatids: 1.6;Melanocytes: 1.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"hTCEpi: 86.9"					"Not detected"	"Not detected"			"HPA046202, HPA052009"	Uncertain				"Secreted - unknown location"	NA	NA					"HPA046202: AB_10959739, HPA052009: AB_2681692"					"unprognostic (2.62e-4)"	"unprognostic (1.60e-1)"			"unprognostic (6.97e-2)"									8.5	0.1	0.0	0.0	0.2	0.0	15.9	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.0	0.4	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	15.5	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.3	0.0	8.1	1.9	0.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0
PNPLA2	"ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2"	ENSG00000177666	"Patatin like phospholipase domain containing 2"	Q96AD5	11	818902-825573	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adipose tissue: 158.1;breast: 155.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055173, HPA062602, HPA075175"	Approved		Enhanced	"Nucleoplasm,Lipid droplets"		NA	NA			"Lipid droplets"	Nucleoplasm	"HPA055173: AB_2682725, HPA062602: AB_2684804, HPA075175: "	"unprognostic (2.11e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.68e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.46e-1)"	"unprognostic (4.09e-1)"	"unprognostic (2.07e-2)"	158.1	7.2	1.6	9.4	1.8	11.2	155.2	2.7	2.3	4.1	35.9	1.5	3.8	5.6	4.5	7.8	8.6	4.3	7.2	12.6	1.7	1.1	15.6	7.4	11.3	4.5	1.6	1.6	4.9	11.8	2.5	4.2	11.6	1.8	5.2	1.5	1.9	8.1	8.1	25.0	6.1	23.1	3.0	2.1	4.9	8.2	4.0	1.5	1.5	11.3	4.8	5.1	13.0	18.6	4.2	6.5	18.7	8.5	3.6	5.3	3.6	10.5	8.3	1.7	4.5	65.2	5.8	11.2	11.3	9.1	7.1	6.3	7.1	10.7	6.3	6.7	8.5	4.4	9.5	2.6	4.7	2.2	8.1	23.1	8.7	3.7	11.3	21.4	6.0	11.0	11.4	6.1	4.7	5.5	7.3	5.8	4.7	7.4	6.4	6.3	6.2	8.0	13.1	5.0	10.8	17.9	7.7	3.8	14.1	7.0	2.4	6.4	8.5	21.0	17.9	6.5	1.1	7.7	6.9	10.4	6.4	5.0	4.1	5.1	24.7	15.2	5.3	16.1	8.5	4.4	9.3	8.5	18.7	3.6	5.5	3.5	4.2	4.6	5.2	5.7	3.6	5.3	4.3	7.7	3.6	6.0	6.5	3.9	3.6	1.6	1.8	2.7	1.9	1.7	1.1	1.6	1.6	1.8	1.5	6.0	16.9	27.0	63.2	39.3	8.8	42.3	63.7	5.3	13.6	48.8	7.9	56.2	28.2	55.9	14.2	38.0	114.0	23.3	57.3	27.0	25.2	72.1	11.5	41.9	27.6	11.1	49.4	84.1	28.5	4.2	44.8	24.9	40.5	27.9	80.0	34.7	98.9	112.2	36.7	37.9	7.5	64.7	32.2	42.2	28.2	36.0	141.7	36.2	41.4	167.2
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923739-43964488	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 31.1;retina: 39.3"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 37.1;Cholangiocytes: 15.3;Cone photoreceptor cells: 17.7;Hepatocytes: 42.7;Rod photoreceptor cells: 34.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 13.5;LHCN-M2: 15.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA			Nucleoli	"Mitochondria, Cytosol"	"HPA058058: AB_2683590"	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	2.8	0.4	0.5	0.7	1.0	0.3	4.0	0.3	2.4	0.8	1.3	0.4	0.0	1.0	0.5	1.9	0.4	1.1	0.5	0.9	0.8	0.6	4.6	31.1	1.4	0.4	0.3	1.8	0.5	0.2	0.6	0.2	0.4	2.2	0.2	0.2	39.3	0.9	0.2	2.2	5.3	0.6	0.2	0.5	0.6	0.3	0.5	0.3	0.0	0.2	0.0	0.3	0.2	0.4	1.2	0.7	1.8	0.6	0.9	0.8	0.0	3.9	1.3	13.5	5.5	3.8	4.3	0.4	2.4	1.4	3.3	7.2	3.9	7.1	0.0	2.1	4.0	1.9	3.4	8.4	3.9	2.8	0.0	0.7	0.2	3.2	7.2	6.2	0.0	0.2	4.9	3.1	10.6	0.5	5.7	0.4	0.1	0.0	0.0	15.3	0.6	0.2	0.0	9.2	0.4	0.0	0.0	7.3	0.1	1.5	0.2	1.2	0.1	2.7	1.1	3.8	2.4	4.2	4.6	0.4	1.3	4.1	0.1	0.1	0.0	0.0	0.0	11.6	0.0	4.8	1.5	0.6	0.4	0.5	0.4	0.3	0.7	0.4	0.3	0.2	1.2	0.6	0.8	1.8	0.9	0.3	0.7	0.2	0.0	0.5	1.0	0.3	2.4	0.8	0.6	0.3	1.8	2.2	0.3	0.0	0.0	0.0	0.5	0.3	37.1	1.1	15.3	0.0	0.0	0.0	17.7	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.4	0.0	42.7	0.6	0.0	1.7	0.6	2.6	0.0	0.3	0.0	1.7	0.0	0.5	1.3	1.5	0.0	0.7	5.0	34.3	0.0	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.4
PNPLA4	"DXS1283E, GS2, iPLA2eta"	ENSG00000006757	"Patatin like phospholipase domain containing 4"	P41247	X	7898247-7927739	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 81.2;Proximal tubular cells: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA003656	Approved				"Intracellular and membrane"	NA	NA					"HPA003656: AB_1079033"	"unprognostic (2.97e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.17e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (5.29e-4)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.42e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.27e-1)"	"prognostic favorable (2.23e-12)"	"unprognostic (5.23e-2)"	"unprognostic (6.71e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.12e-1)"	11.3	18.1	12.6	6.0	18.8	4.7	13.9	5.0	11.5	8.9	8.9	8.5	13.3	11.2	9.2	11.4	13.2	15.0	6.2	24.0	10.9	11.9	26.5	39.8	5.8	6.3	12.0	8.7	14.0	21.0	13.3	17.0	4.7	12.2	8.0	7.5	13.1	18.9	10.7	40.9	10.8	10.5	7.4	11.2	5.4	11.5	7.8	10.6	7.2	23.6	21.1	8.9	6.6	9.5	13.2	18.3	7.6	10.4	9.0	10.3	8.4	18.4	7.6	1.2	19.0	0.4	0.2	5.1	5.7	0.6	10.0	6.2	7.6	6.8	5.8	0.0	1.8	0.1	10.9	0.0	19.3	17.1	0.2	13.5	4.1	14.7	15.9	12.7	7.2	6.1	13.0	19.8	5.1	11.9	2.4	6.9	0.2	16.2	0.2	0.1	4.8	0.1	7.2	20.1	12.8	16.1	0.1	0.1	6.4	13.2	8.4	11.0	5.5	17.4	7.2	9.8	22.6	11.2	5.4	3.9	0.1	5.0	15.3	0.1	8.8	0.1	11.0	0.1	0.0	1.6	5.2	9.8	7.6	5.4	10.4	6.2	12.3	7.8	5.9	18.3	13.2	10.3	9.8	0.7	9.0	9.7	13.5	4.8	8.4	12.6	18.8	5.0	11.5	10.9	11.9	12.0	8.7	12.2	10.6	8.9	12.2	10.2	12.9	10.5	11.3	43.9	22.9	26.8	9.1	19.2	0.0	24.2	81.2	29.5	2.3	11.6	26.5	0.0	42.6	18.0	10.3	13.5	8.1	58.6	26.3	9.5	19.0	13.5	7.2	2.2	15.3	11.0	16.9	17.2	30.1	29.0	29.8	28.1	19.1	97.0	12.8	6.5	11.3	15.9	21.3	14.6	11.7	5.2	34.5	13.7
RBP1	"CRABP-I, CRBP, CRBP1, CRBPI, RBPC"	ENSG00000114115	"Retinol binding protein 1"	P09455	3	139517434-139539829	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 161.0;pancreas: 107.4;retina: 85.3"	"Group enriched"	"Detected in many"	7	"Ductal cells: 920.8;Exocrine glandular cells: 932.2;Ito cells: 319.8;Pancreatic endocrine cells: 450.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 136.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"basal ganglia: 56.8"	"HPA007338, CAB018603, CAB019276"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB018603: AB_2060572, CAB019276: , HPA007338: AB_2667814"	"unprognostic (9.62e-3)"	"unprognostic (7.67e-2)"	"unprognostic (9.53e-3)"	"unprognostic (5.17e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.27e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.28e-3)"	1.9	43.1	6.5	3.3	11.3	0.1	7.5	5.1	7.8	7.8	3.2	11.5	8.4	4.5	26.8	11.3	3.3	58.4	42.7	7.5	7.7	8.1	3.7	20.1	4.9	6.5	10.4	4.9	161.0	107.4	4.3	26.2	20.6	31.5	9.8	2.1	85.3	4.7	6.4	1.8	2.9	4.8	17.5	8.7	4.7	2.8	12.9	4.3	0.9	3.3	2.6	2.0	7.7	7.2	0.5	0.5	2.1	0.9	0.7	0.4	0.2	1.2	0.3	1.1	26.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.2	0.0	8.7	0.0	0.4	0.0	6.1	0.1	0.0	0.0	0.7	0.0	0.4	11.2	25.8	0.0	0.0	0.4	0.0	0.0	0.0	26.4	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	5.2	0.0	0.0	0.0	3.2	136.6	5.6	0.0	0.0	2.3	0.5	0.1	0.0	0.0	20.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	1.2	0.9	0.8	0.4	0.8	0.1	0.4	0.2	0.1	0.0	0.5	0.3	0.2	2.1	0.7	0.5	0.5	0.1	0.2	6.5	11.3	5.1	7.8	7.7	8.1	10.4	4.9	31.5	4.3	29.8	5.1	10.5	43.6	15.7	12.3	15.5	63.7	5.3	12.5	22.7	2.0	2.6	11.6	920.8	3.9	54.2	0.0	0.0	932.2	6.9	95.1	21.2	0.0	6.6	16.2	3.2	41.3	319.8	11.5	8.3	25.0	2.8	8.5	23.4	0.5	79.7	450.0	0.0	4.2	2.7	7.0	25.8	22.5	2.3	4.1	30.6	3.2	2.5	0.8	27.7
RBP2	"CRABP-II, CRBP2, CRBPII, RBPC2"	ENSG00000114113	"Retinol binding protein 2"	P50120	3	139452884-139480747	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	198	"intestine: 333.2"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 8.9;Collecting duct cells: 12.2;Cone photoreceptor cells: 7.9;Enterocytes: 17.1;Pancreatic endocrine cells: 9.4;Paneth cells: 14.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"CACO-2: 41.9"	"Region enriched"	"Detected in single"	4	"basal ganglia: 4.6"	"Not detected"	"Not detected"			HPA035866	Enhanced		Approved	"Golgi apparatus"		NA	NA		96000	"Golgi apparatus"		"HPA035866: AB_10672232"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.72e-6)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.51e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.24e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	130.1	0.0	0.0	221.8	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.1	1.6	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	333.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	41.9	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.1	0.0	0.1	0.0	0.0	0.0	5.9	0.0	0.0	2.2	5.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	8.9	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	12.2	7.9	0.0	0.0	0.5	0.0	0.0	17.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	9.4	14.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0
RBP3	"D10S64, D10S65, D10S66, RP66"	ENSG00000265203	"Retinol binding protein 3"	P10745	10	47348371-47357875	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	Transport		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"retina: 135.2"	"Group enriched"	"Detected in some"	12	"Cone photoreceptor cells: 1949.7;Rod photoreceptor cells: 1076.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 2.7;HDLM-2: 2.5;SH-SY5Y: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041301, HPA044239"	Enhanced				"Secreted in other tissues"	NA	NA					"HPA041301: AB_2677398, HPA044239: AB_2678868"	"unprognostic (3.48e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.36e-2)"		"unprognostic (4.02e-2)"	"unprognostic (1.40e-1)"		"unprognostic (1.58e-2)"		"unprognostic (5.09e-2)"	"unprognostic (5.14e-3)"			"unprognostic (7.44e-2)"	"unprognostic (1.23e-1)"		"unprognostic (4.68e-3)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	135.2	0.0	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	125.3	0.3	0.0	0.0	0.0	0.0	1949.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.8	0.0	0.0	0.0	0.0	1076.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RBP4		ENSG00000138207	"Retinol binding protein 4"	P02753	10	93591687-93601744	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Transport, Vision"		"Cancer-related genes, Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"liver: 897.1"	"Cell type enriched"	"Detected in many"	13	"Hepatocytes: 11448.6"	"Cancer enriched"	"Detected in all"	27	"liver cancer: 3135.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	14	"classical monocyte: 1.2;myeloid DC: 1.5"	"Group enriched"	"Detected in many"	14	"dendritic cells: 1.5;monocytes: 1.2"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 155.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001641, CAB004555"	Supported				"Secreted to blood"	NA	NA	46100000000	420000000000			"CAB004555: AB_670938, HPA001641: AB_1079795"	"unprognostic (9.42e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.69e-4)"	"prognostic favorable (1.74e-8)"	"unprognostic (2.39e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.14e-3)"	"unprognostic (9.88e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.60e-2)"	39.0	2.0	1.4	2.4	3.1	0.3	27.0	0.0	2.1	0.3	1.8	0.0	0.1	0.5	0.4	0.4	0.3	0.4	2.1	1.2	1.4	2.2	7.9	897.1	1.5	1.0	0.2	1.1	0.5	4.7	0.3	28.3	1.8	0.4	0.9	0.6	5.6	1.8	0.5	0.4	0.4	0.6	0.3	0.1	0.3	0.7	0.4	0.0	0.0	0.3	0.5	0.2	0.6	1.6	0.0	1.5	0.0	1.2	0.0	0.0	0.4	0.0	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	37.5	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	155.4	0.0	1.2	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.2	0.3	17.6	0.0	1.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.5	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	3.1	0.0	2.1	1.4	2.2	0.2	1.1	0.4	0.0	0.0	3.4	60.7	0.2	0.7	0.0	0.4	853.5	1.4	1.2	22.7	5.9	0.2	82.9	7.1	2.2	0.7	2.1	46.7	0.2	11.9	6.8	1.7	0.0	11448.6	18.7	0.0	60.0	171.2	183.3	1.9	2.8	2.0	1.7	0.0	33.0	0.7	46.4	10.5	5.3	393.5	0.2	0.0	0.8	2.8	13.4	0.6	1.1	19.1	1.1	0.9
RDH10	SDR16C4	ENSG00000121039	"Retinol dehydrogenase 10"	Q8IZV5	8	73294612-73325281	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 134.3"	"Group enriched"	"Detected in many"	5	"Collecting duct cells: 193.7;Muller glia cells: 296.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 4.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.4;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 46.8;BJ: 33.5;CACO-2: 29.9;HDLM-2: 33.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049199			Supported	"Lipid droplets"		NA	NA			"Lipid droplets"		"HPA049199: AB_2680673"	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.18e-3)"	"unprognostic (8.88e-3)"	"unprognostic (1.13e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.23e-2)"	18.3	3.2	2.7	9.5	3.3	0.7	11.8	1.7	2.8	8.2	18.7	2.9	10.0	13.6	5.9	5.8	9.4	4.4	21.9	9.6	2.3	2.4	19.6	37.5	8.7	4.8	4.1	1.7	4.9	14.8	3.7	17.9	20.9	8.7	12.4	6.4	134.3	22.6	5.7	3.4	4.4	34.1	14.0	6.9	5.6	15.3	8.0	2.1	2.0	3.5	7.3	6.5	12.8	6.5	0.6	0.7	4.4	0.6	0.2	2.3	0.5	4.2	12.2	1.3	5.6	46.8	3.4	12.4	33.5	5.4	1.3	2.2	29.9	12.1	2.9	4.4	18.7	2.0	11.1	6.1	4.8	2.7	33.6	15.4	5.2	12.0	9.2	1.8	2.4	5.7	2.0	6.2	5.2	4.9	5.9	4.9	2.9	5.9	4.3	2.2	1.8	2.5	1.0	1.6	25.8	6.0	2.2	1.4	1.7	9.1	6.0	0.8	1.0	2.8	20.9	1.7	1.8	4.1	1.3	7.4	2.0	3.4	9.2	2.5	2.8	2.9	2.4	1.6	2.2	4.6	4.4	0.6	1.1	1.2	0.3	0.7	0.6	1.3	1.4	0.7	0.1	2.3	1.2	0.8	0.2	0.5	0.2	0.7	0.5	2.7	3.3	1.7	1.8	2.3	2.4	4.1	1.7	8.7	2.1	11.9	28.0	0.0	8.6	11.9	3.0	8.1	30.6	20.1	18.2	193.7	21.6	15.7	3.3	12.8	53.9	10.3	25.7	0.0	15.2	16.8	18.4	19.0	2.3	35.0	16.7	3.2	4.1	1.8	4.0	5.2	2.6	6.0	16.9	0.0	13.1	296.7	39.0	25.9	3.5	18.6	10.4	0.0	8.2	9.3	5.3	12.2	35.1	2.2	14.1	16.0
RDH11	"ARSDR1, MDT1, SDR7C1"	ENSG00000072042	"Retinol dehydrogenase 11 (all-trans/9-cis/11-cis)"	Q8TC12	14	67676801-67695814	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Cataract, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 204.2"	"Cell type enhanced"	"Detected in all"	7	"Glandular cells: 335.2;Muller glia cells: 352.2"	"Cancer enriched"	"Detected in all"	13	"prostate cancer: 286.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB046011	Enhanced				"Intracellular and membrane"	NA	NA		9100000			"CAB046011: AB_11129613"	"unprognostic (1.38e-1)"	"unprognostic (6.86e-3)"	"unprognostic (1.77e-1)"	"prognostic favorable (2.62e-4)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (9.29e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (1.30e-7)"	"unprognostic (1.65e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.74e-2)"	8.8	24.9	18.3	8.9	19.0	5.1	10.8	15.7	25.3	13.0	10.8	24.3	16.1	12.3	13.0	31.4	13.6	9.3	15.6	7.2	18.5	19.9	40.7	51.6	12.6	7.2	21.8	16.6	11.4	15.3	28.7	13.1	8.3	31.1	204.2	12.0	40.4	16.2	13.5	3.6	11.2	10.2	15.8	32.5	10.8	11.6	10.3	15.8	12.5	24.2	8.1	9.5	14.8	11.4	11.5	17.0	62.4	19.7	14.4	20.8	28.2	47.8	21.8	19.4	22.0	31.0	28.2	16.2	18.2	36.1	22.9	41.6	18.1	58.3	8.3	14.1	17.1	28.6	38.4	27.9	40.2	31.3	16.7	11.3	17.2	11.6	17.9	29.9	6.3	12.6	26.3	26.7	29.8	25.3	17.5	26.1	23.1	13.4	27.5	20.8	25.4	18.5	9.9	10.9	13.0	25.1	14.1	24.0	11.9	52.4	24.7	20.2	16.9	19.2	24.3	25.4	16.5	27.2	10.0	20.1	24.7	28.2	10.5	13.0	13.0	10.3	10.8	32.1	17.7	20.0	62.4	19.7	28.2	18.7	16.1	20.4	11.3	20.5	18.5	14.5	11.5	20.8	20.1	3.3	14.4	16.9	17.0	17.6	28.2	18.3	19.0	15.7	25.3	18.5	19.9	21.8	16.6	31.1	15.8	23.8	57.7	45.5	30.5	10.2	50.0	15.5	73.9	22.7	28.4	45.4	47.1	23.0	6.6	75.7	1.9	38.4	22.6	46.7	73.5	33.5	32.0	335.2	28.8	124.8	32.2	74.7	41.6	54.0	39.8	5.1	40.0	33.9	33.7	38.7	21.8	352.2	48.1	34.5	52.6	56.8	94.6	45.3	30.9	19.1	14.3	16.8	53.1	30.8	15.7	29.3
RDH12	"FLJ30273, LCA13, RP53, SDR7C2"	ENSG00000139988	"Retinol dehydrogenase 12 (all-trans/9-cis/11-cis)"	Q96NR8	14	67701886-67734452	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Oxidoreductase	"Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 29.3"	"Group enriched"	"Detected in some"	7	"Cone photoreceptor cells: 137.4;Rod photoreceptor cells: 371.5"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.7;K-562: 1.9;SK-MEL-30: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA						"unprognostic (4.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.72e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.83e-2)"	"unprognostic (3.58e-1)"	"unprognostic (3.92e-1)"	0.0	1.9	0.0	0.0	0.5	0.0	1.2	0.3	0.5	4.9	0.0			0.0	0.0	5.3	9.9	0.1	10.6	0.0	0.1	0.3	7.7	1.9	0.0	0.0	1.3		0.0	1.7	0.0	0.1	0.0		0.0	0.0		0.6	0.0	0.0	29.3	0.0	0.0	0.0	0.0	6.9	0.0			0.4		0.6	0.0	9.7	0.2	0.6	0.0	0.9	0.5	0.6	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.3	1.5	0.0	2.7	0.7	0.2	0.6	0.0	0.0	0.6	0.4	0.0	0.9	0.1	0.0	0.2	0.0	1.0	0.1	0.2	0.0	0.7	0.2	1.9	0.7	0.1	0.7	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.1	0.0	0.3	1.2	0.0	0.0	1.0	2.3	0.1	0.7	0.1	0.0	0.3	1.3	0.4	0.0	1.6	0.7	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.1	0.9	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.5	0.0	0.6	0.6	0.1											0.0	0.0	0.0	0.2	4.1	37.5	0.0	20.4	0.0	0.0	1.8	137.4	0.0	0.0	0.7	0.1	0.1	0.0	0.0	1.6	0.0	0.9	0.4	0.0	4.2	0.2	19.1	0.0	0.0	0.3	0.0	0.3	0.0	1.7	0.0	0.0	29.8	1.0	0.2	0.0	6.5	371.5	0.0	0.1	0.0	0.0	33.8	0.0	0.0	0.0	0.3
RDH13	SDR7C3	ENSG00000160439	"Retinol dehydrogenase 13"	Q8NBN7	19	55039108-55071291	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Syncytiotrophoblasts: 175.4;Urothelial cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042006	Approved		Supported	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			"Mitochondria, Cytosol"		"HPA042006: AB_10960270"	"unprognostic (9.26e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.42e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.45e-3)"	"prognostic favorable (2.09e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.66e-3)"	4.4	6.8	4.0	6.0	6.6	5.5	4.2	8.7	9.4	7.5	8.3	3.5	9.0	5.1	5.0	5.0	17.6	4.2	7.1	11.4	3.0	5.4	8.8	7.5	5.6	5.1	4.7	5.2	3.8	10.7	8.8	6.1	34.0	10.0	5.7	4.0	6.4	11.6	13.1	9.4	18.0	6.9	5.2	2.2	6.8	9.5	4.4	3.0	2.1	7.2	8.6	8.9	8.5	10.2	7.4	6.0	5.4	6.7	6.1	8.5	3.5	3.1	3.6	0.6	1.9	0.4	0.4	5.8	2.9	0.3	2.1	1.5	5.4	3.6	1.8	2.4	0.7	0.4	3.2	3.8	2.3	0.2	1.6	10.1	2.0	4.7	3.7	0.9	4.8	1.4	1.3	0.9	1.9	1.4	0.7	2.8	1.6	4.0	1.0	0.7	5.2	0.8	3.1	0.8	6.9	4.7	2.5	1.0	10.0	1.3	5.5	2.2	2.7	2.8	8.0	3.6	0.6	3.9	4.7	2.9	0.3	1.1	0.2	3.9	2.0	3.6	2.2	1.5	3.4	2.0	4.1	4.1	5.4	8.5	6.7	7.7	6.1	7.0	7.7	4.5	7.4	8.4	6.8	2.6	6.1	5.9	6.0	5.7	3.5	4.0	6.6	8.7	9.4	3.0	5.4	4.7	5.2	10.0	3.0	14.9	16.2	5.1	19.9	9.5	17.3	22.2	28.1	6.7	11.4	14.0	39.3	30.2	10.0	12.3	18.5	6.5	27.1	0.0	5.7	26.9	6.0	23.1	8.1	6.0	9.9	23.8	11.5	16.5	4.1	11.2	3.4	5.0	6.8	1.8	19.8	10.0	11.4	26.2	3.2	3.4	27.0	6.5	5.1	1.4	9.6	15.3	175.4	8.7	21.9	72.9
RDH14	"PAN2, SDR7C4"	ENSG00000240857	"Retinol dehydrogenase 14"	Q9HBH5	2	18554723-18560680	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056686, HPA078577"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA056686: AB_2683209, HPA078577: "	"unprognostic (5.79e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.83e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.69e-2)"	13.8	16.2	10.7	8.7	14.3	5.1	14.0	14.2	15.4	11.3	14.1	11.0	9.6	12.7	16.2	14.3	16.0	12.7	11.0	29.0	12.2	10.4	23.0	22.1	12.5	14.6	11.7	9.0	11.7	21.0	23.5	13.5	14.2	13.2	20.7	12.0	10.6	13.8	13.1	27.8	9.9	16.3	22.9	10.3	15.4	15.9	11.1	8.8	17.4	18.1	13.6	10.7	18.1	17.9	9.9	7.6	7.2	2.0	3.7	7.6	1.6	18.6	5.9	5.0	4.1	15.1	16.1	16.8	11.4	11.7	10.3	10.3	4.6	9.7	18.4	6.8	6.8	13.4	10.2	7.2	13.3	12.1	10.2	19.8	7.2	6.5	13.8	12.9	8.7	9.8	12.2	13.6	10.0	15.7	14.5	9.5	7.5	12.8	6.3	16.9	6.0	7.5	15.4	13.5	14.3	16.9	11.0	13.6	7.9	20.2	12.2	7.7	13.4	6.2	13.7	16.2	10.9	6.8	5.0	9.5	14.7	9.1	11.6	13.5	17.9	14.7	13.7	10.5	6.0	11.5	1.7	1.8	7.2	4.4	2.0	7.6	7.4	5.1	6.3	2.3	9.9	7.3	6.0	0.8	3.7	1.9	7.6	5.8	1.6	10.7	14.3	14.2	15.4	12.2	10.4	11.7	9.0	13.2	8.8	14.9	10.9	21.4	26.0	21.8	22.4	43.0	22.9	2.7	6.8	15.7	5.9	40.0	26.6	32.8	16.1	17.9	14.0	0.0	30.8	42.8	33.7	31.0	12.7	26.8	21.0	14.3	12.7	17.2	15.1	9.4	61.9	14.8	21.9	22.6	27.1	25.0	23.9	32.3	42.1	30.5	18.0	32.3	30.7	71.9	28.2	16.3	38.2	17.5	29.8	23.7
RDH16	"RODH-4, SDR9C8"	ENSG00000139547	"Retinol dehydrogenase 16 (all-trans)"	O75452	12	56951431-56959374	"Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	59	"liver: 114.6"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 276.0"	"Cancer enriched"	"Detected in many"	20	"liver cancer: 44.0"					"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.4;hTCEpi: 7.7;OE19: 1.8"					"Low region specificity"	"Detected in single"			HPA038518	Enhanced					NA	NA					"HPA038518: AB_10672713"	"unprognostic (5.42e-3)"	"unprognostic (4.20e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (2.16e-5)"	"unprognostic (8.83e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.10e-1)"	"unprognostic (7.99e-12)"	"unprognostic (2.24e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	114.6	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.8	0.0		0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0			0.0		0.1	0.0	0.1	0.2	0.0	0.0	0.8	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.6	0.1	0.0	7.7	0.0	0.8	0.0	0.0	0.1	0.1	0.2	0.0	0.4	0.0	0.2	0.0	1.8	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.3	0.2	0.2	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.8	0.0	0.0	0.2											0.0	0.0	4.5	1.0	0.0	2.2	2.0	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.3	0.1	0.0	23.3	0.3	0.0	0.1	4.2	0.0	276.0	0.2	1.6	0.0	3.1	5.1	4.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.9	0.4	0.3	0.0	0.0	0.0	0.4
RDH5	"HSD17B9, RDH1, SDR9C5"	ENSG00000135437	"Retinol dehydrogenase 5"	Q92781	12	55720367-55724705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sensory transduction, Steroid metabolism, Vision"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 39.4;retina: 127.9"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 58.9;Rod photoreceptor cells: 68.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 19.0;ASC TERT1: 16.4;hTEC/SVTERT24-B: 9.9;hTERT-RPE1: 16.2;LHCN-M2: 9.9;U-87 MG: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063345			Uncertain	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA063345: AB_2684992"	"unprognostic (1.04e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.63e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.12e-3)"	"unprognostic (3.27e-2)"	39.4	0.7	0.6	2.8	0.8	0.2	14.9	0.5	0.8	1.0	7.6	1.0	1.5	8.6	1.9	4.5	2.4	2.2	4.8	3.9	1.0	0.5	3.7	27.2	0.7	1.6	0.8	0.8	1.4	1.5	0.0	0.6	0.4	1.5	1.8	1.9	127.9	3.2	1.0	3.1	1.0	9.4	8.8	1.1	0.9	2.7	0.9	1.0	0.3	1.1	2.6	0.7	2.0	2.5	0.4	2.3	2.1	0.9	1.5	2.6	0.4	0.4	0.9	0.5	0.3	19.0	16.4	0.3	2.4	2.7	0.5	0.9	0.3	5.1	0.6	0.4	1.3	0.1	0.2	0.2	0.0	0.4	0.6	0.8	0.1	1.0	1.3	0.5	0.0	0.2	7.0	0.6	9.9	0.0	16.2	0.2	0.3	0.1	0.8	9.9	0.4	0.2	0.1	0.2	2.3	1.4	0.3	0.3	0.3	0.1	0.5	0.1	0.7	0.1	0.3	2.2	0.1	0.4	0.3	0.3	1.0	1.0	0.7	0.6	0.7	0.3	0.1	17.7	0.2	0.2	0.3	0.6	2.1	0.4	0.9	0.2	0.4	1.2	2.6	1.2	0.3	1.0	0.4	0.9	1.5	0.9	2.3	0.2	0.4	0.6	0.8	0.5	0.8	1.0	0.5	0.8	0.8	1.5	1.0	8.9	2.1	6.7	4.2	1.6	22.6	2.1	5.1	5.3	1.2	1.8	58.9	1.6	1.7	1.6	0.6	4.2	28.4	0.0	2.3	1.0	3.3	2.8	0.0	17.9	0.5	15.9	11.1	1.8	2.2	1.8	12.4	4.0	5.0	4.6	8.7	10.9	2.8	17.6	6.3	8.4	68.6	12.9	4.7	3.5	6.3	1.5	1.3	10.0	11.8	2.7
RDH8	"PRRDH, SDR28C2"	ENSG00000080511	"Retinol dehydrogenase 8 (all-trans)"		19	10013249-10022279	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	5	"retina: 29.4"	"Cell type enhanced"	"Detected in some"	28	"Bipolar cells: 33.9;Cone photoreceptor cells: 51.1;Early spermatids: 58.4;Rod photoreceptor cells: 203.6"	"Group enriched"	"Detected in some"	8	"melanoma: 2.2;stomach cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.9;SK-MEL-30: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064473			Approved	"Nucleoplasm,Midbody ring,Cytosol"		NA	NA			Nucleoplasm	"Midbody ring, Cytosol"	"HPA064473: "			"unprognostic (4.12e-1)"		"unprognostic (2.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.98e-3)"		"unprognostic (4.58e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.45e-1)"			"unprognostic (1.02e-1)"	"unprognostic (3.86e-1)"		"unprognostic (2.63e-1)"	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	2.9	0.8	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.9	0.3	0.0	0.0	0.0	0.0	51.1	0.0	0.0	0.0	58.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.4	0.0	203.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0
RLBP1	CRALBP	ENSG00000140522	"Retinaldehyde binding protein 1"	P12271	15	89209869-89221751	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction, Transport, Vision"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"retina: 164.1"	"Cell type enriched"	"Detected in some"	43	"Muller glia cells: 2424.2"	"Group enriched"	"Detected in some"	30	"glioma: 3.7;melanoma: 7.4"	"Group enriched"	"Detected in many"	4	"amygdala: 6.9;basal ganglia: 10.6;cerebral cortex: 7.0;hippocampal formation: 3.7"	"Group enriched"	"Detected in some"	7	"basophil: 3.3;neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.3"	"Cell line enriched"	"Detected in single"	48	"SK-MEL-30: 21.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042051, HPA044083"	Enhanced	Approved	Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Centrosome"	"HPA042051: AB_2732495, HPA044083: AB_2678802"	"unprognostic (3.19e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.76e-1)"		"unprognostic (8.24e-3)"	"unprognostic (5.21e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.76e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.13e-1)"		"unprognostic (8.42e-2)"	0.2	0.7	6.9	0.6	10.6	0.6	0.2	0.6	11.5	0.2	0.8	0.3	0.1	0.9	0.2	1.0	0.3	0.2	0.3	0.2	3.7	1.3	0.2	0.2	0.3	0.3	1.6	0.6	0.2	0.2	0.2	1.7	0.3	0.4	0.2	0.8	164.1	0.2	0.2	0.5	0.3	0.6	0.5	0.5	0.3	0.2	1.1	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.0	3.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	6.9	10.6	0.6	7.0	3.7	1.3	1.6	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	17.2	0.3	0.0	0.0	0.0	0.0	37.3	3.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	2424.2	0.0	0.0	0.0	0.0	56.9	0.0	0.0	0.1	0.0	0.0	16.7	0.0	0.0	0.0
RPE65	"BCO3, LCA2, rd12, RP20"	ENSG00000116745	"RPE65, retinoid isomerohydrolase"	Q16518	1	68428822-68449959	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Hydrolase, Isomerase"	"Disease mutation, FDA approved drug targets, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"retina: 268.3"	"Group enriched"	"Detected in some"	12	"Cone photoreceptor cells: 9.8;Rod photoreceptor cells: 17.3"	"Group enriched"	"Detected in some"	10	"glioma: 5.8;head and neck cancer: 1.5"	"Group enriched"	"Detected in many"	5	"hypothalamus: 6.0;midbrain: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.2;PC-3: 10.6;U-2 OS: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.59e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.15e-1)"		"prognostic favorable (9.75e-4)"	"unprognostic (4.55e-2)"		"unprognostic (5.91e-2)"	"unprognostic (6.59e-4)"	"unprognostic (2.98e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.24e-2)"	"unprognostic (3.21e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.05e-1)"	"unprognostic (3.48e-2)"	"unprognostic (8.40e-3)"	0.0	0.0	0.9	0.1	0.7	0.0	1.0	0.1	3.8	0.2	0.1	1.3	1.4	0.4	1.4	0.7	0.8	0.6	0.2	0.0	1.5	6.0	0.0	0.0	0.0	0.1	8.8	0.1	0.1	0.0	0.0	0.0	0.0	1.2	4.2	0.2	268.3	0.2	10.5	0.0	0.0	0.1	0.5	1.4	0.2	0.6	0.2	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.1	0.6	1.5	6.0	8.8	0.1	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	17.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
RPP14	P14	ENSG00000163684	"Ribonuclease P/MRP subunit p14"	O95059	3	58306247-58324695	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 53.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036194	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA036194: AB_10672082"	"unprognostic (6.05e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-3)"	"unprognostic (3.76e-2)"	"prognostic favorable (3.07e-10)"	"unprognostic (5.19e-3)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (5.78e-2)"	7.1	8.5	8.3	5.7	12.9	5.3	7.1	15.8	10.7	6.6	8.6	5.9	6.6	10.2	8.2	7.8	8.5	7.4	6.2	11.8	7.2	6.8	11.2	15.0	5.6	7.6	6.5	9.9	8.4	11.9	10.8	9.4	6.0	7.2	7.4	8.2	9.0	8.5	7.0	53.5	7.4	9.1	11.7	5.5	7.7	7.7	9.1	5.9	6.3	8.1	18.5	8.5	7.2	7.0	4.6	6.6	4.7	9.8	9.8	6.4	3.5	10.1	8.1	9.4	7.5	7.9	8.5	10.4	8.6	9.3	12.4	14.0	12.3	6.7	12.2	2.0	11.5	10.8	6.2	14.1	12.8	12.1	8.5	7.4	11.6	9.7	6.7	7.7	19.9	9.7	9.3	12.4	14.7	14.1	6.2	9.7	15.0	9.9	8.7	12.0	5.5	13.5	7.0	12.3	8.4	15.4	5.5	7.4	11.8	9.0	14.6	5.9	10.5	8.1	9.7	11.6	6.8	9.3	9.6	8.8	9.4	10.5	9.9	16.3	13.0	22.3	17.6	10.7	14.0	6.6	3.0	5.7	4.7	4.2	4.9	5.6	4.1	5.5	5.8	6.6	4.6	6.4	6.2	2.6	9.8	9.8	6.2	3.0	3.5	8.3	12.9	15.8	10.7	7.2	6.8	6.5	9.9	7.2	5.9	8.9	11.0	7.0	7.1	27.7	24.7	26.6	5.1	8.1	5.7	3.5	23.6	7.2	10.0	5.3	0.7	7.2	11.7	0.0	5.3	5.2	8.4	6.9	3.5	17.9	5.4	17.5	9.2	12.3	11.4	0.9	11.5	9.5	21.9	8.2	12.5	12.9	6.2	3.5	9.2	10.1	28.1	0.0	20.5	8.6	13.5	37.6	8.6	7.0	13.4	6.2
SCARF2	"HUMZD58C02, SREC-II, SREC2"	ENSG00000244486	"Scavenger receptor class F member 2"	Q96GP6	22	20424815-20437826	"Disease related genes, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 28.8;Fibroblasts: 17.0;Leydig cells: 12.4;Peritubular cells: 16.6;Sertoli cells: 12.9;Smooth muscle cells: 14.4"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"T-reg: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 14.2;SH-SY5Y: 15.8;SK-MEL-30: 15.7;U-138 MG: 21.8;U-2 OS: 22.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035079	Approved		Uncertain	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		360000	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA035079: AB_10670287"	"unprognostic (2.12e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.92e-1)"	"unprognostic (7.68e-2)"	"unprognostic (7.87e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (4.38e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (4.28e-4)"	6.5	2.4	0.0	4.1	0.3	0.1	9.2	0.0	1.2	10.6	3.2	0.4	2.9	1.4	8.1	6.6	1.8	2.6	11.3	3.4	0.6		3.2	1.1	5.9	5.1	0.8	0.4	12.6	1.6	0.0	0.6	5.6	0.9	5.5	0.0	9.2	1.1	6.8	1.8	2.2	1.9	9.9	0.5	5.3	1.4	2.5	0.0	0.0	5.4	3.3	1.4	7.1	10.9	0.1	0.1	0.9	0.0	0.0	1.8	0.0	0.4	0.2	3.2	5.5	1.9	2.7	1.3	14.2	5.9	3.4	1.8	0.0	0.0	0.2	8.3	6.8	0.2	0.1	1.8	0.0	0.4	0.4	11.9	1.1	0.2	2.5	11.8	0.0	0.6	4.6	0.0	1.7	0.8	1.6	1.7	0.0	0.1	0.1	1.2	0.6	0.0	0.2	4.3	0.0	1.8	0.3	9.0	0.0	0.0	0.0	1.4	15.8	0.1	0.0	15.7	0.6	0.5	0.0	2.1	21.8	22.9	0.5	3.2	0.6	0.2	0.2	0.1	0.3	10.8	0.0	0.0	0.9	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	1.8	0.0											0.0	0.0	0.0	1.7	2.5	3.0	28.8	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.0	0.2	3.3	0.0	0.0	0.0	1.2	17.0	2.2	0.0	0.0	0.5	0.0	0.0	2.5	0.6	0.0	12.4	0.6	3.3	0.0	0.0	0.5	0.0	0.0	16.6	0.0	0.4	12.9	14.4	0.5	0.2	2.4	0.3	0.0	0.0	0.5
SDR16C5	"EPHD-2, RDH-E2, RDHE2"	ENSG00000170786	"Short chain dehydrogenase/reductase family 16C member 5"	Q8N3Y7	8	56300010-56320776	"Enzymes, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 27.5;lung: 34.0;skin 1: 35.9;tongue: 25.8"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 44.7;Alveolar cells type 2: 125.1;Basal keratinocytes: 45.3;Ciliated cells: 48.2;Pancreatic endocrine cells: 58.7;Suprabasal keratinocytes: 63.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	36	"memory B-cell: 9.1;naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	56	"B-cells: 9.1"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 18.0;HaCaT: 9.0;hTCEpi: 14.9;OE19: 21.3;T-47d: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025224	Enhanced					NA	NA					"HPA025224: AB_1856163"	"unprognostic (1.66e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.46e-2)"	"unprognostic (4.18e-4)"	"unprognostic (8.83e-3)"	"prognostic favorable (7.88e-4)"		"unprognostic (1.66e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.48e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.71e-1)"	0.3	0.2	2.0	2.0	1.9	0.0	7.4	0.9	6.2	8.1	5.9	0.2	0.0	1.7	0.2	0.0	27.5	0.2	1.5	0.2	0.6	1.2	0.2	0.2	34.0	0.3	1.4	2.9	0.2	0.3	0.0	0.5	0.0	10.6	0.3	3.0	0.2	9.2	0.0	0.3	35.9	16.9	0.2	0.4	0.2	12.9	0.5	0.2	0.0	0.2	25.8	21.1	1.0	11.5	9.1	0.0	0.0	0.0	0.0	0.1	0.1	3.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	9.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	21.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	1.9	0.9	6.2	0.6	1.2	1.4	2.9	10.6	0.2	44.7	125.1	0.0	5.5	45.3	0.2	0.1	10.2	48.2	36.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.1	0.0	1.2	0.0	1.5	5.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	3.3	1.0	7.1	9.9	58.7	3.2	0.0	0.0	1.4	0.0	0.3	0.2	4.1	63.1	0.0	0.0	4.5	19.5
SDR42E1	HSPC105	ENSG00000184860	"Short chain dehydrogenase/reductase family 42E, member 1"	Q8WUS8	16	81988855-82011488	"Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 8.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 4.0;NK-cells: 3.6;T-cells: 4.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 7.5;hTCEpi: 10.8;MCF7: 7.1;RT4: 17.4;SCLC-21H: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014388	Uncertain					NA	NA					"HPA014388: AB_1851226"	"unprognostic (2.09e-1)"	"unprognostic (4.90e-1)"	"unprognostic (9.52e-3)"	"unprognostic (3.81e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.93e-4)"	"unprognostic (4.90e-7)"	"unprognostic (2.18e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.21e-2)"	"unprognostic (8.27e-2)"	1.3	0.3	0.2	6.5	0.5	0.3	5.8	0.2	0.2	3.5	12.2	0.0	4.1	7.9	4.6	3.9	11.5	2.1	2.6	2.2	0.2	0.4	7.4	8.3	4.1	3.6	0.2	0.1	0.6	14.3	3.8	14.9	0.3	0.2	3.1	2.2	1.4	18.8	3.4	0.7	16.7	21.3	1.5	0.3	3.8	3.6	7.3	0.1	8.2	6.1	7.3	13.7	4.3	4.7	4.0	0.4	0.8	0.0	3.6	4.6	2.0	3.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	4.5	0.0	1.5	0.0	0.3	7.5	0.0	5.8	0.0	0.0	0.5	0.0	1.5	0.0	0.1	0.0	0.0	0.3	10.8	1.4	5.5	0.0	0.0	0.0	1.2	0.0	0.8	7.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	2.3	17.4	7.5	0.0	0.2	3.6	0.0	0.2	0.1	0.0	0.2	0.0	4.0	0.0	0.0	3.7	5.0	0.4	0.0	0.0	0.0	0.1	0.0	0.8	1.8	0.0	2.4	4.0	1.5	2.5	0.3	2.1	4.6	3.6	0.1	3.6	0.0	0.4	3.0	2.0	0.2	0.5	0.2	0.2	0.2	0.4	0.2	0.1	0.2	0.1	0.0	0.6	1.7	3.5	5.3	0.0	2.4	2.5	4.0	2.3	1.8	0.0	0.4	3.3	8.0	0.9	0.3	3.1	0.0	6.5	0.1	0.5	3.2	0.0	3.0	0.0	0.0	2.4	0.0	0.0	0.8	0.0	0.0	1.7	0.0	4.9	0.0	4.9	3.5	0.0	2.1	0.0	0.0	0.3	8.2	3.4	8.0	0.2	1.0	3.3	4.1
SDR42E2		ENSG00000183921	"Short chain dehydrogenase/reductase family 42E, member 2"	A6NKP2	16	22165583-22191754	"Predicted membrane proteins"		Oxidoreductase		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 6.0;fallopian tube: 5.0;testis: 3.3"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 22.2;Erythroid cells: 23.3;Muller glia cells: 18.4"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	7	"neutrophil: 6.0"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.0"	"Cell line enriched"	"Detected in single"	5	"RPMI-8226: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.03e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.72e-4)"	"unprognostic (1.85e-1)"	"unprognostic (7.07e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.72e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.32e-3)"	"unprognostic (2.01e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.61e-2)"	0.1	0.1	1.0	0.2	2.1	0.1	0.0	0.0	1.1	0.5	0.0			0.6	0.1	0.1	0.0	5.0	0.2	0.0	1.7	2.4	0.2	0.0	0.4	0.3	0.0		0.3	0.5	0.1	2.2	0.2		0.2	0.1		0.2	0.0	1.5	0.6	0.2	0.0	0.3	0.5	0.1	3.3			0.1		0.0	0.1	0.0	0.8	0.3	6.0	0.8	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.3	0.3	0.4	0.5	0.3	0.4	0.1	0.8	0.3	0.4	6.0	0.3	0.1	0.3	0.3	0.2											0.0	3.7	11.9	0.2	0.7	7.7	1.6	5.1	2.7	0.0	0.0	0.0	0.7	0.0	0.6	1.6	2.1	22.2	23.3	0.4	0.2	1.1	0.9	2.3	3.2	2.1	4.8	2.4	3.7	11.0	1.1	5.5	3.1	1.7	8.2	9.0	18.4	0.2	3.5	1.4	0.2	3.6	0.0	1.0	0.6	0.1	1.5	1.1	8.6	4.7	0.3
SDR9C7	"RDHS, SDR-O"	ENSG00000170426	"Short chain dehydrogenase/reductase family 9C member 7"	Q8NEX9	12	56923154-56934405	"Disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 31.4;tongue: 27.8"	"Cell type enhanced"	"Detected in single"	38	"Suprabasal keratinocytes: 3.4"	"Group enriched"	"Detected in some"	6	"cervical cancer: 3.0;head and neck cancer: 11.0;melanoma: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTCEpi: 1.1;SK-BR-3: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (6.75e-2)"	"unprognostic (1.42e-1)"		"unprognostic (7.90e-5)"	"unprognostic (7.93e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.74e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.46e-1)"		"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.74e-3)"	0.1	0.0	0.1	0.1	0.4	0.0	2.4	0.2	0.1	9.6	0.1	0.1	0.1	0.0	0.7	0.1	8.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.7	0.1	0.0	0.1	2.0	0.1	0.5	31.4	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.6	0.1	27.8	9.9	0.1	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.4	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.2	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.1	0.1	0.0	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0
UGT1A1	"GNT1, UGT1, UGT1A"	ENSG00000241635	"UDP glucuronosyltransferase family 1 member A1"	P22309	2	233760248-233773299	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 48.6;liver: 120.3"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 83.9"	"Cancer enriched"	"Detected in some"	19	"liver cancer: 16.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.1;OE19: 35.4;RT4: 19.3"	"Not detected"	"Not detected"													NA	NA								"unprognostic (7.28e-2)"			"unprognostic (2.49e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.69e-2)"			"unprognostic (4.17e-3)"	"unprognostic (6.31e-3)"	"unprognostic (1.94e-5)"	"unprognostic (2.78e-3)"			"unprognostic (2.99e-4)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.2	35.6	0.1	0.1	48.6	0.1	0.1	4.3	0.0	0.3	0.1	0.1	0.0	4.5	120.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.4	0.1	0.7	0.1	0.1	0.9	48.2	0.5	0.1	0.1	1.3	0.2	0.1	0.1	0.2	0.1	0.1	5.2	0.8	1.0	0.4	4.7	0.4	1.1	0.5	0.2	0.2	0.6	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	3.1	0.2	0.1	1.4	0.0	0.0	8.1	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.8	0.0	0.3	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.4	0.0	0.2	0.3	35.4	3.6	0.0	0.1	0.3	0.0	19.3	0.1	0.2	1.4	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.4	0.2	0.1	2.1	0.4	0.4	0.4	0.3	0.3	0.4	0.4	0.3	0.1	1.0	0.4	0.5	4.7	1.1	0.4	0.4	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.7	6.8	1.8	0.0	0.0	0.0	0.2	2.8	0.0	3.5	0.0	0.0	0.0	0.0	0.9	0.0	83.9	0.0	0.0	0.0	1.3	3.3	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.5	1.4	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	6.2
UGT1A10	UGT1J	ENSG00000242515	"UDP glucuronosyltransferase family 1 member A10"	Q9HAW8	2	233636454-233773305	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 9.4;gallbladder: 8.4;intestine: 31.1;stomach 1: 12.4"	"Cell type enhanced"	"Detected in some"	22	"Club cells: 1.2;Enterocytes: 2.1"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	142	"RT4: 109.0"														"Intracellular and membrane"	NA	NA								"unprognostic (9.33e-2)"			"unprognostic (7.64e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.73e-1)"			"prognostic unfavorable (4.55e-4)"		"unprognostic (1.49e-10)"	"unprognostic (2.90e-1)"	"unprognostic (1.50e-1)"		"unprognostic (3.59e-3)"	0.3	0.0	0.3	2.6	0.3	0.0	0.3	0.3	0.3	0.3	19.2	0.3	0.3	31.1	0.3	0.3	9.4	0.1	8.4	0.3	0.3	0.0	0.3	1.4	0.6	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	14.3	0.3	0.9	0.3	0.3	0.3	20.2	0.5	0.3	0.3	12.4	1.0	0.3	0.3	0.3	0.3	1.4	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	109.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1
UGT1A3	UGT1C	ENSG00000243135	"UDP glucuronosyltransferase family 1 member A3"	P35503	2	233729108-233773299	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 40.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"liver cancer: 2.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HaCaT: 16.7"															NA	NA												"unprognostic (5.15e-2)"	"unprognostic (9.93e-2)"			"unprognostic (2.97e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.04e-4)"	"unprognostic (8.22e-2)"			"unprognostic (2.08e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.6	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT1A4	"HUG-BR2, UGT1D"	ENSG00000244474	"UDP glucuronosyltransferase family 1 member A4"	P22310	2	233718778-233773299	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	51	"liver: 99.4"	"Group enriched"	"Detected in some"	8	"Club cells: 4.5;Hepatocytes: 10.5"	"Cancer enriched"	"Detected in single"	487	"liver cancer: 24.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.6;HL-60: 1.4;RH-30: 2.2"															NA	NA												"unprognostic (9.89e-3)"						"unprognostic (6.77e-5)"	"unprognostic (2.59e-1)"			"unprognostic (3.50e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	99.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT1A5	UGT1E	ENSG00000240224	"UDP glucuronosyltransferase family 1 member A5"	P35504	2	233712992-233773299	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"gallbladder: 3.7;intestine: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.7;RT4: 1.6"															NA	NA												"unprognostic (2.18e-3)"							"unprognostic (1.36e-1)"				0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	11.2	0.0	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	9.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT1A6	"GNT1, HLUGP, UGT1F"	ENSG00000167165	"UDP glucuronosyltransferase family 1 member A6"	P19224	2	233691607-233773300	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 111.7;liver: 50.1;urinary bladder: 32.7"	"Group enriched"	"Detected in some"	5	"Early spermatids: 37.7;Late spermatids: 19.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 40.4;OE19: 160.5"									"CAB009819, HPA054065"	Enhanced					NA	NA					"CAB009819: AB_2241481, HPA054065: AB_2682367"		"unprognostic (9.09e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.43e-2)"		"unprognostic (6.03e-2)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.79e-1)"	"unprognostic (6.18e-2)"		"unprognostic (2.09e-3)"	"unprognostic (9.97e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.50e-2)"		"unprognostic (2.01e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.8	0.5	0.2	0.5	2.0	0.3	0.9	13.0	0.0	1.1	0.1	0.1	0.0	111.7	50.1	1.9	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.3	0.1	3.3	0.4	0.1	1.3	1.2	0.1	3.8	1.2	2.3	0.1	0.1	8.1	0.2	0.1	0.5	0.2	5.6	8.7	32.7	2.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.2	0.0	11.3	0.0	0.1	40.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	160.5	0.0	0.0	0.0	0.0	0.4	20.4	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.5	0.8	0.0	0.3	0.0	0.0	4.5	1.8	0.0	0.0	0.0	0.0	37.7	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.0	0.6	0.0	19.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.7	0.0	1.0	0.0	0.0	0.0	2.1
UGT1A7	UGT1G	ENSG00000244122	"UDP glucuronosyltransferase family 1 member A7"	Q9HAW7	2	233681938-233773299	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"esophagus: 54.4;lymphoid tissue: 40.2;tongue: 23.6"	"Cell type enriched"	"Detected in some"	5	"Urothelial cells: 8.4"	"Group enriched"	"Detected in some"	10	"cervical cancer: 1.2;head and neck cancer: 2.3;lung cancer: 3.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	14	"SiHa: 50.6"															NA	NA							"unprognostic (6.27e-2)"	"unprognostic (1.02e-1)"			"unprognostic (7.76e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.09e-1)"			"unprognostic (7.92e-2)"		"unprognostic (1.71e-7)"	"unprognostic (2.14e-1)"			"unprognostic (4.57e-2)"	0.1	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.1	0.0	0.0	0.1	0.0	0.0	54.4	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	40.2	0.2	2.8	0.2	0.1	1.6	0.2	0.6	0.1	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	50.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.0	0.2	0.6	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	8.4
UGT1A8	UGT1H	ENSG00000242366	"UDP glucuronosyltransferase family 1 member A8"	Q9HAW9	2	233617645-233773310	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 13.0;urinary bladder: 15.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	58	"RT4: 52.5"															NA	NA								"unprognostic (1.27e-2)"			"unprognostic (1.35e-1)"	"unprognostic (1.42e-3)"				"unprognostic (1.23e-1)"	"unprognostic (4.78e-1)"	"unprognostic (9.71e-12)"	"unprognostic (9.26e-2)"			"unprognostic (1.96e-1)"	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0		4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	7.3	0.0	0.0	0.0	0.0	0.0	3.3	5.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	3.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	52.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1
UGT1A9	"HLUGP4, LUGP4, UGT1AI"	ENSG00000241119	"UDP glucuronosyltransferase family 1 member A9"	O60656	2	233671853-233773300	"Cancer-related genes, Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 169.8"	"Cell type enhanced"	"Detected in some"	29	"Club cells: 1.2;Hepatocytes: 5.9;Proximal tubular cells: 3.3"	"Group enriched"	"Detected in some"	157	"liver cancer: 16.1;renal cancer: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"A549: 4.9;RT4: 4.0"															NA	NA												"unprognostic (2.46e-2)"				"unprognostic (3.56e-1)"		"prognostic unfavorable (5.04e-5)"	"unprognostic (4.26e-2)"			"unprognostic (1.60e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	169.8	39.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2A1		ENSG00000173610	"UDP glucuronosyltransferase family 2 member A1 complex locus"	Q9Y4X1	4	69588417-69653249	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 10.6;liver: 14.5;pituitary gland: 21.2"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 32.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.7"	"Region enriched"	"Detected in single"	17	"pons and medulla: 1.7"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.2;HUVEC TERT2: 1.9;U-266/70: 3.6"									"HPA017261, HPA045108"	Uncertain					NA	NA					"HPA017261: AB_10963582, HPA045108: AB_2679218"							"unprognostic (3.93e-3)"	"unprognostic (5.62e-1)"					"unprognostic (1.28e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	14.5	2.4	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	1.7	0.0	0.0	1.5	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.5	2.0	0.5	0.9	0.4	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.2	1.7	0.5	0.4	0.2	0.2	0.1	0.1	0.4	0.2	0.1	0.3	0.2	0.1	2.0	0.9	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	3.5	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2A3	FLJ21934	ENSG00000135220	"UDP glucuronosyltransferase family 2 member A3"	Q6UWM9	4	68928463-68951791	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 150.5;kidney: 43.2"	"Cell type enhanced"	"Detected in some"	11	"Cholangiocytes: 94.3;Enterocytes: 115.5;Hepatocytes: 49.3;Paneth cells: 52.6;Proximal tubular cells: 125.8;Undifferentiated cells: 72.7"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 46.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	10	"eosinophil: 5.3"	"Lineage enriched"	"Detected in single"	53	"granulocytes: 5.3"	"Cell line enriched"	"Detected in some"	9	"Hep G2: 21.0"									HPA045108	Supported					NA	NA					"HPA045108: AB_2679218"			"prognostic favorable (3.31e-4)"				"unprognostic (3.97e-3)"				"unprognostic (8.87e-3)"		"prognostic favorable (6.07e-7)"	"unprognostic (2.10e-2)"				0.1	0.1	0.1	4.3	0.1	0.0	0.7	0.1	0.1	0.1	63.8	0.1	0.1	31.9	0.1	1.7	0.1	0.1	14.6	0.3	0.1	0.1	43.2	9.6	0.1	0.1	0.1	0.1	0.1	12.0	0.0	0.1	0.1	0.1	0.1	8.6	0.1	0.1	0.1	0.1	0.1	150.5	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.1	94.3	0.0	0.0	3.5	0.0	0.0	10.0	21.3	0.0	0.0	115.5	0.0	2.3	0.0	0.0	0.0	0.0	49.3	0.0	0.0	11.7	0.0	1.8	0.0	0.0	0.0	0.0	0.0	28.2	0.0	6.0	52.6	0.0	125.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.7	0.0
UGT2B10		ENSG00000109181	"UDP glucuronosyltransferase family 2 member B10"	P36537	4	68815993-68831196	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	277	"liver: 120.4"	"Cell type enriched"	"Detected in some"	15	"Hepatocytes: 221.7"	"Cancer enriched"	"Detected in single"	296	"liver cancer: 93.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	39	"Hep G2: 16.1"									HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"			"unprognostic (3.50e-3)"				"unprognostic (1.92e-3)"						"unprognostic (4.17e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	120.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	221.7	0.0	0.0	0.0	1.3	4.7	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
UGT2B11		ENSG00000213759	"UDP glucuronosyltransferase family 2 member B11"	O75310	4	69199951-69214731	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"breast: 77.4"	"Cell type enriched"	"Detected in some"	7	"Cholangiocytes: 12.7"	"Group enriched"	"Detected in some"	17	"breast cancer: 17.4;liver cancer: 13.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	62	"basophil: 6.8;eosinophil: 5.6"	"Lineage enriched"	"Detected in single"	68	"granulocytes: 6.8"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.5;HL-60: 3.1;NB-4: 2.5;RPTEC TERT1: 3.7;U-2197: 1.5"									HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.12e-1)"						"unprognostic (1.18e-3)"			"unprognostic (1.49e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	77.4	0.1	0.1	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.0	3.3	0.1	0.1	0.0	1.2	7.3	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	7.0	0.1	0.1	1.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.0	0.1	0.0	3.7	0.2	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.6	0.0	0.0	6.8	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B15	UGT2B8	ENSG00000196620	"UDP glucuronosyltransferase family 2 member B15"	P54855	4	68646630-68670628	"Enzymes, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"gallbladder: 22.4;intestine: 50.7;liver: 65.4"	"Group enriched"	"Detected in some"	6	"Cholangiocytes: 168.2;Hepatocytes: 134.4"	"Cancer enriched"	"Detected in many"	10	"liver cancer: 120.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 2.7"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.7"	"Cell line enhanced"	"Detected in some"		"A549: 3.2;HL-60: 2.2;RH-30: 1.2;RPMI-8226: 1.1"									HPA045108	Approved					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.86e-1)"		"unprognostic (1.94e-1)"	"prognostic favorable (9.82e-4)"	"unprognostic (6.73e-2)"			"unprognostic (3.49e-2)"	"unprognostic (7.84e-2)"	"unprognostic (5.81e-3)"	"unprognostic (2.39e-2)"	"unprognostic (5.38e-2)"		"prognostic favorable (4.50e-4)"	0.1	0.0	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	48.0	0.1	0.1	5.4	0.1	0.1	0.2	0.0	22.4	0.1	0.1	0.0	0.1	65.4	0.1	0.1	0.1	0.1	0.1	5.3	0.0	0.1	0.1	0.1	0.2	1.6	0.1	0.1	0.1	0.1	0.0	50.7	0.1	0.1	0.1	5.7	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	2.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	1.2	1.1	0.0	0.2	0.1	0.6	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.8	0.2	0.4	0.1	0.5	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	168.2	0.0	0.0	0.0	0.0	0.0	0.0	14.9	1.9	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	134.4	0.0	0.0	0.0	1.8	2.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.5
UGT2B17		ENSG00000197888	"UDP glucuronosyltransferase family 2 member B17"	O75795	4	68537184-68568527	"Enzymes, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 68.1;liver: 21.6"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 2.2;Cholangiocytes: 2.5;Ciliated cells: 1.4;Club cells: 1.2;Hepatocytes: 1.3;Intestinal endocrine cells: 1.7;Melanocytes: 3.3"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 16.3;liver cancer: 10.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	38	"memory B-cell: 3.3;naive B-cell: 11.9"	"Lineage enriched"	"Detected in single"	59	"B-cells: 11.9"	"Group enriched"	"Detected in some"	7	"BEWO: 3.1;NB-4: 3.6;RPMI-8226: 5.2;SH-SY5Y: 2.3;U-2197: 2.1"									HPA045108	Supported					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.66e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (8.44e-3)"		"unprognostic (9.67e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.76e-1)"	0.4	0.1	0.4	4.7	0.4	0.0	0.4	0.4	0.4	0.4	55.6	0.4	0.4	54.1	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.1	0.4	21.6	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	20.7	0.4	0.4	0.4	0.4	0.1	68.1	1.1	0.4	0.4	0.1	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	11.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.2	0.0	0.0	0.0	5.2	0.2	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	2.5	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1
UGT2B28		ENSG00000135226	"UDP glucuronosyltransferase family 2 member B28"	Q9BY64	4	69280499-69295050	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"breast: 71.7;salivary gland: 25.6"	"Cell type enriched"	"Detected in single"	178	"Cholangiocytes: 17.8"	"Cancer enriched"	"Detected in single"	8	"breast cancer: 1.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"basophil: 2.5;eosinophil: 4.0"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 4.0"	"Group enriched"	"Detected in some"	10	"Daudi: 7.1;NB-4: 6.5"									HPA045108	Uncertain				"Intracellular and membrane"	NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.81e-1)"						"unprognostic (1.40e-1)"	"unprognostic (7.20e-3)"				"unprognostic (1.51e-2)"	"unprognostic (4.37e-5)"				"unprognostic (9.79e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	71.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	25.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.1	0.0	0.2	4.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B4	UGT2B11	ENSG00000156096	"UDP glucuronosyltransferase family 2 member B4"	P06133	4	69480165-69526014	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	105	"liver: 175.1"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 831.9"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 351.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"RH-30: 10.4"									"CAB033260, HPA045108"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB033260: AB_2241496, HPA045108: AB_2679218"	"unprognostic (7.46e-2)"						"unprognostic (1.50e-1)"	"unprognostic (9.37e-2)"			"unprognostic (1.51e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.52e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.1	175.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	10.4	0.1	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	34.2	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.0	0.0	0.0	0.0	0.0	0.0	831.9	0.1	0.0	0.0	14.7	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT2B7	UGT2B9	ENSG00000171234	"UDP glucuronosyltransferase family 2 member B7"	P16662	4	69051363-69112987	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 125.4;liver: 156.0"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 539.4;Proximal tubular cells: 775.7"	"Group enriched"	"Detected in many"	7	"liver cancer: 116.4;renal cancer: 101.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 21.0;RPTEC TERT1: 83.6"									HPA045108	Uncertain					NA	NA					"HPA045108: AB_2679218"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.65e-5)"	"unprognostic (1.11e-2)"		"unprognostic (2.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.98e-1)"	"prognostic favorable (3.79e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.23e-3)"	"prognostic favorable (5.38e-4)"	0.1	0.1	0.1	0.2	0.1	0.0	0.4	0.1	0.1	3.1	7.9	0.1	2.5	6.4	0.6	4.7	0.1	4.7	1.5	0.1	0.1	0.1	125.4	156.0	0.2	0.1	0.1	0.1	0.6	14.7	0.0	0.1	0.2	0.1	0.3	0.4	0.2	1.0	2.7	0.3	0.2	27.7	0.1	0.1	0.2	0.1	0.6	0.1	0.2	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	10.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	83.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	3.9	0.6	0.1	0.0	0.0	58.6	0.0	0.0	118.7	0.0	0.0	82.9	5.6	0.2	0.0	6.7	0.0	9.1	0.0	0.0	0.4	0.0	539.4	0.1	0.0	3.4	6.2	10.7	0.0	1.7	0.0	3.3	0.0	20.1	0.0	11.8	11.9	0.0	775.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	2.0
UGT3A1	FLJ34658	ENSG00000145626	"UDP glycosyltransferase family 3 member A1"	Q6NUS8	5	35951010-36001028	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"kidney: 44.0;liver: 47.7"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 47.1;Early spermatids: 91.4;Hepatocytes: 63.1;Proximal tubular cells: 58.6"	"Group enriched"	"Detected in some"	15	"liver cancer: 6.7;renal cancer: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	42	"RH-30: 25.3"									"HPA047697, HPA056290"	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA047697: AB_2680122, HPA056290: AB_2683088"				"unprognostic (2.41e-3)"			"unprognostic (4.47e-1)"			"unprognostic (4.04e-1)"	"unprognostic (4.62e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.05e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.76e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	5.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	44.0	47.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	3.2	0.1	6.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.4	0.2	0.2	0.0	0.4	0.2	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.4	0.0	0.0	0.0	47.1	0.0	0.0	3.3	0.0	91.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.1	0.1	0.0	0.0	2.5	2.2	12.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	58.6	0.3	6.5	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0
UGT3A2		ENSG00000168671	"UDP glycosyltransferase family 3 member A2"	Q3SY77	5	36035017-36071358	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 37.0;skin 1: 14.4;testis: 13.2"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 3.5;Early spermatids: 3.6;Late spermatids: 5.7;Proximal tubular cells: 3.3"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 4.4"	"Region enhanced"	"Detected in single"		"pons and medulla: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.2;MOLT-4: 9.3;REH: 21.8;SuSa: 9.8;T-47d: 5.7;THP-1: 12.8"									HPA059475	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		Yes	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059475: AB_2684031"	"unprognostic (1.83e-4)"	"unprognostic (9.94e-2)"	"unprognostic (8.87e-2)"	"unprognostic (4.82e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.56e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.36e-3)"	"unprognostic (6.65e-2)"	"unprognostic (7.52e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.52e-3)"	0.1	1.1	0.1	0.0	0.2	6.4	1.6	0.1	0.6	0.1	0.1	0.5	0.4	0.0	0.1	0.8	0.1	0.1	0.2	0.2	0.1	0.6	5.6	0.8	0.1	0.0	0.5	0.0	0.2	0.0	0.0	1.7	0.2	2.0	0.6	0.0	2.9	0.1	0.0	0.1	14.4	0.1	0.0	0.3	1.4	0.1	13.2	0.0	37.0	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	1.0	0.0	0.4	5.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	9.3	0.0	3.9	0.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	5.7	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.6	0.1	0.6	0.5	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0
WWOX	"FOR, SDR41C1, WOX1"	ENSG00000186153	"WW domain containing oxidoreductase"	Q9NZC7	16	78099413-79212667	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	Oxidoreductase	"Disease mutation, Epilepsy, Neurodegeneration, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 40.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050992	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA050992: AB_2681299"	"prognostic unfavorable (9.07e-5)"	"unprognostic (1.14e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.61e-3)"	"unprognostic (4.33e-2)"	"unprognostic (3.50e-2)"	"prognostic favorable (4.49e-5)"	"unprognostic (3.75e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.77e-1)"	13.2	7.4	19.2	10.5	17.9	5.3	11.9	21.5	14.6	8.9	5.9	20.5	14.8	8.9	12.6	17.1	11.6	13.4	10.0	6.1	17.0	17.7	19.2	17.8	7.1	6.5	19.7	12.5	9.4	10.5	22.3	11.5	7.6	16.1	10.9	5.3	11.4	10.6	15.4	4.9	9.6	7.2	11.9	20.9	5.4	7.6	15.8	17.9	10.3	29.4	4.9	8.9	8.7	8.6	8.5	13.8	5.4	8.8	7.8	12.3	5.4	5.0	4.5	5.0	3.2	5.3	2.4	5.3	0.7	1.5	1.7	1.5	3.5	4.3	9.5	3.8	0.7	2.4	4.4	2.5	0.6	1.3	5.0	12.8	3.1	0.8	7.2	4.0	7.8	1.5	2.9	1.8	1.1	1.0	0.4	2.2	13.4	4.2	1.9	1.2	40.0	13.4	10.6	4.3	3.1	2.6	14.2	1.9	9.6	2.4	1.7	8.1	5.2	3.1	5.8	1.7	5.0	5.7	5.4	0.5	1.3	4.5	1.0	2.9	0.0	8.9	19.4	5.1	4.0	2.2	5.4	8.8	1.9	10.5	7.2	12.3	8.5	8.5	9.2	6.8	6.4	8.4	8.9	0.8	7.8	5.0	13.8	12.3	5.4	19.2	17.9	21.5	14.2	17.0	17.7	19.7	12.5	16.1	17.9	6.0	5.8	8.5	14.2	8.1	6.9	6.9	17.8	24.1	17.0	14.0	3.9	21.1	28.2	10.9	34.6	9.0	5.1	0.0	9.1	10.9	9.9	12.1	12.7	16.6	7.7	4.8	9.2	8.6	5.4	34.4	13.0	6.5	5.0	2.8	4.5	36.6	4.6	5.8	16.6	15.7	11.6	6.5	8.3	14.4	12.4	5.9	14.5	6.4	6.3	11.1
